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ABSTRACT 
 
Epilepsy is characterized by abnormal electrical activity within the brain, which can 
result in either generalized or partial seizures. In order to control seizure activity a 
person must take anti-epilepsy medication, normally in the form of a tablet. The goal 
is to deliver the drug to the brain in quantities sufficient to eliminate seizures without 
causing adverse effects. In 30% of the cases, sufferers of epilepsy are unable to be 
medicated due to the dose required to suppress seizures causing adverse side effects. 
In addition, other anti-epilepsy treatment such as brain surgery or vagus nerve 
stimulator (VNS) implantation are very expensive treatments and needs high 
technology and advanced equipment. Therefore there is a need to develop a delivery 
system for these epilepsy sufferers that is therapeutic but not toxic and also 
accessible and affordable for every patient all over the world.  
Recently there has been much interest in the use of polymeric carriers as localized 
delivery devices especially for the central nervous system. Bypassing the blood-brain 
barrier, a polymeric carrier implanted directly into the brain tissue allows the 
possibility of therapeutic levels of drug being confined to the region of interest, thus 
eliminating systemic toxicity compared to oral drug administration. Among polymers 
conducting polymers (CPs) have been shown to act as very effective drug reservoir 
with the ability to deliver drugs upon electrical stimulation. Polymeric carriers also 
offer potential advantages, such as partially protecting labile drugs from degradation 
and releasing multi-drug combinations in a controlled manner from the same 
implant. 
However, one limiting factor for these CP systems is their limited drug loading 
capacity which restricts the life time of delivery. In order to improve the drug 
delivery lifetime of the CP device we aimed to develop a CP drug delivery system 
whereby the drug is encapsulated within a reservoir and release is mitigated by 
opening and closing a CP “gate”. During my research designing and producing of 
this gate has been done. I have produced a CP gate which is a platinised 
polyvinylidene difluoride (PVDF) membrane upon which polypyrrole with different 
counterions including p-Toluenesulfonic acid (pTS), polystyrene sulfonates (PSS), 
chondroitin sulfate (CS), dodecylbenzenesulfonate (DBSA), dextran sulfate (DS) and 
hyaluronic acid (HA) has been deposited. I have demonstrated that it is possible to 
 
iv 
 
open and close this gate as a function of applied electrical stimulation. Therefore, I 
have investigated and successfully controlled the transport of lacosamide which is an 
anti-epilepsy drug (AED) through this gate under non-stimulated, stimulated and 
pulsed potential conditions. Results of these series of experiments have been 
presented in chapter 3. Also, in chapter 4, I have been investigating a new gate 
design that utilizes a PVDF tube which acts as a drug reservoir and transport gate 
simultaneously. The tubes are platinised and then coated with polypyrrole with 
different counterions. Drug release from inside of these fibres to outside was 
investigated at non-stimulated, stimulated and pulsed potential states. 
At the next stage of my research I studied the interaction of the drug molecules with 
the surface of conducting polymer and demonstrated that the affinity of drug 
molecules to the surface of CP gate can affect the transport behaviour. In chapter 5 
the outcomes of these studies have been shown. 
Epilepsy is a chronic disease which unfortunately causes so many difficulties in 
patients’ personal life and can impose severe limitations to their life. The current 
anti-epilepsy treatments have some severe side effects or they are very expensive 
treatments which is not affordable for all patients everywhere in the world. I hope my 
research is the beginning of a promising pathway to find a treatment for epileptic 
patients whom can be treated with a reasonable price and minimum side effects 
method, and also bring hope and happiness to their life. 
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1 INTRODUCTION  
  
1.1 Epilepsy and Current Treatments  
A deviant electrical activity in the brain represents epilepsy disorder, which can lead 
to seizures which can happen generally or partially within the brain. In generalized 
seizures both hemispheres of the brain will are affected. Adversely, a focus or 
confined area of the brain generates the partial seizure[1, 2]. An epileptic seizure has 
been defined by the International Bureau of Epilepsy as a “transient occurrence of 
signs and/or symptoms due to abnormal and excessive neuronal activity in the brain” 
[3]. A typical Electroencephalography (EEG) signal of a person without epilepsy (a) 
and an epileptic patient (b) is demonstrated in Figure 1.1.  
 
Figure 1.1  (a) EEG signals of a normal person, and (b) EEG signals of an epileptic 
patient. Adapted from Ref [4]. 
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According to a World health organization (WHO) report published in October 2012 
around 50 million people suffers from epilepsy. During a seizure the person’s 
movement, action and consciousness may alter for a short period of time. 
Approximately three quarters of epilepsy sufferers especially in developing countries 
remain untreated[5]. In order to control seizure activity a person must take anti-
epilepsy drugs (AEDs), normally in the form of a tablet with the goal being to deliver 
the drug to the brain in quantities sufficient to eliminate seizures without causing 
adverse effects. In 30% of the cases, sufferers of epilepsy are unable to be medicated 
due to the dose required to suppress seizures causing adverse side effects. Some 
patients respond to one specific AED while some patients require a combination of 
more than one in order to control their epilepsy [6]. Choice of the correct AED is 
critical as it has been reported that some AEDs can increase the risk of intensifying 
the seizure occurring condition accompanied with the other adverse side effects [7]. 
 
In addition, other anti-epilepsy treatments such as surgical resection of the epileptic 
region of the brain carry a very high level of risk. Cerebrum is the largest part of the 
brain which is divided into four paired sections. These sections are frontal, parietal, 
occipital and temporal lobes. A specific group of human activities are controlled by 
each lobe. For instance, temporal is responsible to control the brain ability in hearing, 
language and memory. Unfortunately, the most usual type of epilepsy in confined 
into the temporal lobe and temporal lobe surgical resection can be performed to 
control the seizures. By resecting or cutting away the brain tissue in this area, the 
seizure focused brain tissue will be removed. The most common areas of the 
temporal lobe which is involved with seizures are anterior and mesial portions. For 
those epileptic patients whom medication does not control the seizures or the dose 
causes serious side effects, temporal lobe resection is an option. Vital functions 
including movement, sensation, language and memory should not be damaged during 
the surgery [8, 9]. 
 
Another non-drug treatment option for treating epilepsy is an implantable device 
called a vagus nerve stimulator (VNS) (Figure 1.2). In this method a device is 
implanted in the left side of a patient’s chest cavity accompanied with a stimulating 
lead which wraps around the left vagus nerve in the neck. The device applies 
electrical stimulation pulses with these mild stimulation signals being transferred to 
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the brain via the vagus nerve. This approach activates various regions of the brain to 
prevent electrical irregularities which cause seizures[10].  
 
 
Figure 1.2  Schematic of vagus nerve stimulation (VNS) treatment option for the 
epilepsy. Adapted from Ref[10]. 
 
Another epilepsy treatment option especially for is the ketogenic diet. This special 
diet includes high fat and low carbohydrate that causes the body to burn fat instead of 
carbohydrate (such as sugar, bread and etc.,) as a source of energy resulting in the 
formation of ketones. Higher ketones level has been shown to lead to having more 
appropriate control of seizure[11]. In some patients a very specific trigger will evoke 
a seizure and in these infrequent cases avoiding these triggers is helpful with these 
particular triggers varying from patient to patient. Some possible triggers are lack of 
sleep, alcohol, flickering lights or patterns, stress, menstruation or significant 
variation in temperature and overheating[8]. 
 
If AED delivery is confined only to the region of interest in the brain, then the 
unsatisfactory and distractive effects on the other living tissues of the body will be 
minimised[12]. To feasible this approach two important parameters of an AED has to 
be considered; (i) the efficiency of the drug (i.e., the minimum level of drug in 
bloodstream to achieve an appropriate response) and (ii) the therapeutic window of 
the drug. This window represents the difference between the minimum effective dose 
and the highest level of drug concentration that causes toxic effects. Hence, 
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development of a controlled drug delivery device, that takes into consideration these 
two substantial parameters could increase the number of patients whom can be 
treated with AEDs without suffering from severe side effects and avoid the more 
risky and costly surgical and/or implantation  treatment options.  
 
1.2 Thesis overview 
 
Giving consideration to all of the advantages and disadvantages of currently 
available treatment options for the epilepsy, there is a need to develop a drug 
delivery system for the epilepsy sufferers, especially 30% of them who remained 
untreated. Most importantly this novel treatment method should be therapeutic but 
not toxic. Recently, there has been much interest in the use of polymeric carriers as 
localized delivery devices especially for the central nervous system. Bypassing the 
blood brain barrier by implanting a polymeric carrier containing an AED directly 
into the brain tissue would allow the possibility of delivering therapeutic doses 
directly to the specific region of the brain associated with the epileptic seizures. This 
targeted approach may overcome the whole body side effects associated with current 
systemic delivery and therefore offer a treatment option to the 30% untreatable 
patients as well as the other epilepsy sufferers. Polymeric carriers also offer potential 
advantages, such as partially protecting labile drugs from degradation and releasing 
multi-drug combinations in a controlled manner from the same implant. 
 
Conducting polymers (CPs) have been shown to act as very effective drug reservoir 
with the ability to deliver drugs upon electrical stimulation. However, one limiting 
factor for these CP systems is their limited drug loading capacity which restricts the 
life time of delivery. In order to improve the drug delivery lifetime of the CP device 
the work outlined in this thesis set out to develop a CP drug delivery system whereby 
the drug is encapsulated within a reservoir and release is mitigated by opening and 
closing a conducting polymer  “gate”. This gate has a porous structure and applying 
an external electrical stimulation will drive drug release. Figure 1.3 demonstrates a 
schematic of this CP gating system. Application of suitable electrical stimulation to 
the CP layer will open and close the porous gate and drive drug release from inside 
of the reservoir into the body tissue. 
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Figure 1.3 Schematic of drug release using a conducting polymer coated gating 
system.  
 
This thesis aims to design and fabricate this CP coated gating system to develop a 
prototype of an implantable controlled drug delivery device for the treatment of 
epilepsy. The preliminary concern of this project was fabrication and 
characterization of this CP gating system and also the drug reservoir for the intended 
application. This CP gate (Figure 1.4) is a platinised PVDF membrane which 
conducting polymer has been deposited on one side of the membrane. This gate 
will open and close as a function of applied electrical stimulation. Therefore, in this 
project an electro-responsive polymeric system which c a n  be mitigated by 
electrical stimulation has been investigated. This device is i n t e n d e d  f o r  t he  
t r e a tm e n t  of epilepsy. 
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Figure 1.4 Polymer coated Pt/PVDF membrane. 
 
Among all of conducting polymer PPy was chosen to be investigated in this project 
because this CP is Syntheticesised from aqueous solutions and possess great i n  
v i v o a n d  i n  v i t r o  biocompatibility.  Po lypyr ro le  has a low toxicity and, 
some researches have focused on the use of this polymer for drug delivery 
application [13]. In the third and fourth chapters, release of anti-epilepsy drug from 
the conducting polymer coated flat and hollow fibre Pt/PVDF membrane has been 
investigated. Release studies were carried out at under non-stimulated and 
stimulated states. 
 
Interaction of AEDs with the surface of CP coated reservoir was also investigated to 
achieve a more comprehensive understanding of how the CP gating system and 
reservoir acts as a drug delivery device. Results of this interaction studies has been 
presented in the fifth chapter.   
 
 
1.3 Drug delivery methods 
 
1.3.1 Sustained drug release 
 
The most important characteristics of a drug delivery system is providing desirable 
dosage of drug at regular time interval and also at the region of the body which is 
confined with a disease. Therefore, by using these drug delivery systems the 
therapeutic level of drug in blood plasma is provided. Sustained drug delivery 
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systems have been designed to supply a delivery system with reduced dosing 
frequency and uniform drug dosage. Sustained drug release system includes drug 
delivery systems which are not depended on time and release therapeutic levels of a 
drug over an extended time[14, 15].  
 
Peroral and injection are two common methods for delivering drugs with most drugs 
developed on the basis of oral or injection  delivery  routes[16] with  oral  drug  
delivery  being  most  preferred  delivery  method  by patients and doctors[17]. 
However this method has some disadvantages like damaging the hepatic and 
enzymatic degradation of the drug whilst there is very little control of release in from 
the per-oral method. In oral administration of drug, effective levels of the drug can 
be achieved by administration of extra doses which often results in changes in 
plasma that can be lead to different side effects. A desired peroral drug delivery 
system has to deliver sufficient levels of drug in a reproducible manner. In addition, 
the other absorptive tissues have been considered as potential sites for drug delivery 
such as nasal, rectal, vaginal, ocular and oral cavity[18]. It is well documented that 
systemic drug delivery results in high level of drugs in the bloodstream and this 
phenomenon can adversely affect the rest of body because of toxic levels of the drug. 
Figure 1.5 exhibits an example of therapeutic window of a typical drug and shows 
the concentration versus time profiles for conventional and sustained controlled drug 
release[19]. Drug release profile can be optimised by reducing the effective level of 
administrated drug to the minimum threshold with injecting or ingesting a drug 
release that follows first-order kinetics. In this form of kinetics profile, there is an 
initial high blood level of the drug followed by an exponential fall in drug 
concentration in the bloodstream. When blood drug level reaches more than the 
therapeutic level (Figure    1.5 (a)) body toxicity occurs. At this state drug kinetics is 
undesirable, especially for a drug with a narrow therapeutic range. Sustained drug 
release provide a zero-order release profile if the release is constant and not limited 
by Fick’s diffusion law[20]. The advantage of zero order drug delivery kinetics lies 
in reducing drug toxicity of the patient and improving drug efficacy (Figure 1.5 (b)). 
 
For AEDs which have been designed to affect the brain tissue, the concentration of 
penetrated drug through the blood brain barrier (BBB) is much less than the drug 
concentration in the circulatory system[12, 21]. Therefore, to reach the therapeutic 
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level of AEDs in the target region of the brain tissue, it is required to deliver daily 
systemic doses of AEDs[22]. 
 
Figure 1.5 Kinetics of first-order (a) versus zero-order (b) in drug delivery systems; 
First-order kinetics represents plasma concentration versus time curve for 
intravenous administration of a drug. Zero-order kinetics is represented by sustained 
or pulsatile release of a drug. Adapted from Ref[23]. 
 
The delivery method of a drug plays an important role in how successful the drug is 
taken up by the body and therefore is therapeutic benefit. As mentioned above 
systemic drug delivery has a variety of problems and side effects. Therefore, 
researchers are developing alternative delivery methods such as targeted drug 
delivery. Drug targeting enables the delivery of drugs directly to the region of 
interest with decreasing the systemic side effects of the drug being one of the most 
important advantages of this method. The effectiveness of delivering drug to 
different parts of the body is also affected by the size of the drug carrier[24] and 
utilizing targeted drug delivery the efficiency of the drug will be enhanced. Drug 
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doses used in this method are typically smaller than that used for oral administration 
of drugs, thus as it has been mentioned before the side effects will be eliminated or 
reduced. In addition, the patient’s acquiescence with this method is higher than using 
the usual drug delivery systems[25].  
 
There are four different strategies for producing sustained targeted drug delivery 
systems, namely (1) diffusion controlled and transdermal patches; (2) Water 
penetration controlled where osmotic drug delivery devices release of the drug is 
driven by water penetration into the device (3) Chemically controlled where 
biodegradable reservoir systems used chemically controlled release of encapsulated 
drug and (4) responsive where mechanical pumps and magnetic systems are 
examples of some drug delivery systems which release the drug because of the 
response to the environmental changes[18]. Grimshaw et al.[26] have demonstrated 
mechanisms of selective controlled transport of protein molecules and neutral solutes 
through hydrogel membranes.  
 
1.3.2 Controlled release 
 
Delivering a drug directly to a particular diseased tissue or organ is one of the goals 
of controlled release. By utilizing this system the systemic toxicity will be reduced 
and provide therapeutic levels of a drug directly at the target organ[27]. Wurster[28] 
introduced the concept of controlled release in a patent in 1953. There are a wide 
range of drug delivery mechanisms and Table 1.1 presents some of the commercially 
available controlled release systems. These systems are classified on the base of 
therapeutic agent release mechanisms. Recently, various mechanisms by which 
controlled release can be operated have been reviewed by McCoy et al[29]. These 
mechanisms include release mitigated by light, heat, magnetism, and ultrasound, 
mechanical and electrical stimuli[30]. Table 1.1 provides an overview for all of the 
currently available drug delivery methods. 
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Table1.1 Different controlled drug delivery systems[42]. 
Type of delivery system Mechanism of rate-control 
Diffusion Controlled 
- Reservoir devices 
- Monolithic devices 
 
- Diffusion through membrane 
- Diffusion through bulk polymer. 
Water Penetration Controlled 
- Osmotic systems 
 
- Swelling systems 
  
- Osmotic   transport   of   water through 
semi-permeable membrane. 
- Water penetration into glassy polymer. 
Chemically Controlled 
- Monolithic systems 
 
- Pendant chain systems 
 
- Pure    polymer    erosion    or 
combination of erosion and diffusion. 
- Combination of hydrolysis of pendant 
chain groups and diffusion from bulk 
polymer. 
Regulated Systems 
- Magnetic or ultrasound 
 
- Chemical 
 
- External application of magnetic field 
or ultrasound to device. 
- Use of competitive desorption of 
enzyme-substrate reactions. 
 
In addition to the drug delivery systems presented in Table 1.1 recently there has 
been an intense interest in developing an advanced intelligent drug delivery systems 
based on in vivo stimuli. These novel systems have been identified as self-
regulating[31] or closed-loop systems[32]. For epilepsy treatment using these 
intelligent delivery systems, an AED can be delivered to the brain tissue in a timely 
manner upon the response of seizure activity within the brain. According to Figure 
1.1 (b) a seizure signal starts very quickly, within one second and these drug delivery 
devices are capable of initiating drug release in a similar time frame. Therefore, a 
seizure prediction[33] or detection[4] programmable device is needed to be added to 
the whole drug delivery system. 
 
There has been much research undertaken in using materials for controlled release 
systems and the main focus of these studies is on polymers. Furthermore, researches 
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have used developed novel strategies to make drug release more controllable[34].  
These  new polymeric systems include polypeptides[13, 35], nucleic acid[36], and  
polysaccharides  functional  groups[37-40].  Some researchers have focused on the 
use of Syntheticetic polymer materials including degradable and non-degradable 
materials[36]. 
 
Hydrogels are cross-linked polymers that have high-water content and possess many 
advantages for controlled release. One advantage is their ability for localized release 
of a wide variety of therapeutic agents with a sustained manner. In addition, 
hydrogels are very sensitive to environmental parameters such as pH, temperature 
and ionic strength[39]. Recently, Bajpai et al[41] reviewed the different applications 
of polymeric hydrogels for controllable delivery. Polymeric nanocarriers such as 
dendrimer, liposoms and micelles also play an important role in the development of 
controlled release systems due to their ability to encapsulate drug molecules and 
carry them into the desired body tissue.  Using inorganic nanocarriers like nanotubes, 
nanoshells and mesoporous nanoparticles are also of interest for the progress of 
therapeutic delivery applications[39]. 
 
1.3.2.1 Controlled release devices 
 
Varieties of controlled drug release devices have been developed over recent years. 
These devices contain; pumps such as osmotic pumps and micropumps, polymeric 
devices and also systems which are based on microelectromechanical property of the 
materials and are commonly referred to as MEMS[23].  In 1970s the first controlled 
drug delivery device was used extensively [43-46] which consisted of a bellows-type 
pump which was activated by partially liquefied Freon® (DuPont) and provided 
constant drug administration. This early work inspired many researchers to focus 
their efforts into this research area and the outcomes of their work provided the 
opportunity of designing and developing more sophisticated implantable drug 
delivery devices with the ability to deliver therapeutic levels of drug in a controlled 
manner. 
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In 1986 Medtronic Pty. Ltd. developed a novel controlled drug delivery device which 
worked on the basis of an electronic controllable peristaltic pump[47]. Three years 
later, MimiMed Technologies revealed an advanced drug delivery device[48] 
comprising of a combination of a solenoid pump, a reservoir and an advanced 
electronic control system. A programmable and implantable pump was introduced 
into the market place by InfusAID Pty. Ltd. [49] Which employed bellows-type 
pump which was accompanied by a solenoid valve to monitor and control the release 
of a drug. 
 
Using polymeric materials to fabricate controlled drug delivery devices has been 
considered. In general, polymeric drug delivery devices can be classified into two 
different groups [23, 50-56]; 
I. Non-degradable polymeric reservoirs and matrices, 
II. Biodegradable polymeric devices. 
An approach that falls into the non-degradable category is devices built by the 
microfabrication of silicon. Using this approach researchers have developed systems 
that provide drug release profiles with high precision and control [57-61]. Another 
novel drug delivery technology has been introduced by MEMS which utilizes 
microneedle-based chips that provide an alternative to the conventional transdermal 
drug delivery method [62-68]. Existence of the stratum corneum is the major barrier 
in transdermal delivery method so by using microneedle-based chips, poor 
permeability of the skin increases because of creation of micro channels to transport 
therapeutics across the stratum [67, 69]. Microneedle-based chips can be classified in 
the following categories; 
I. In-plane microneedle, 
II. Out-of plane microneedle. 
Figure 1.6(a) shows the penetration of two silicon processed microneedle to a 
porterhouse steak with Figure 1.6(b) showing the injection of an in-plane single 
crystal silicon microneedle. In this procedure Rhodamin B dye was injected into an 
anesthetised rabbit[70, 71]. 
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Figure 1.6 Silicon-based microneedle drug delivery chips in use; (a): penetration Of 
two microneedle into a porterhouse steak; (b): injection of Rhodamin B dye into a 
rabbit ear using a microneedle.   
 
Silicon microfabrication technology is currently being used by Microchips Biotech 
Inc. (USA) to develop a device that is capable of delivering proteins, hormones, pain 
medications and the other drugs or therapeutics[72]. Figure 1.7 demonstrates a 
section cut of a silicon microchip which has been used for controlled release and 
highlights the anodes, cathodes and reservoir of this device. The main body of the 
device is shown in Figure 1.7 (b) that includes a reservoir which is fabricated using a 
degradable polymer. The truncated conical reservoirs are sealed with polymeric 
material from the top and a sealant polyester tape layer from the bottom.    
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Figure 1.7 Schematic of a Microchips Biotech Inc. silicon microchip used for 
controlled drug delivery applications. (a): cut off section of the drug delivery device; 
(b): schematic of the main body[72].  
 
   
Nano porous and nano channel silicon microchips for drug delivery have also been 
created by Ferrari and co-workers [73-93] which can also be used as a device for bio-
separation and immunoisolation. The device possess a very uniform pore size and 
very thin thickness which provides sophisticated diffusion and sustained drug release 
profile [20,62,94,95]. Figure 1.8 presents a microchip which uses the NanoGATE 
drug delivery implantable device which has been designed by iMEDD Inc. [96]. 
These nanoporous microchips provide sustained release of drugs for long durations. 
Therefore the NanoGATE device is an appropriate candidate where a prolonged 
sustained release of drug is required. One the most unique characteristics of 
NanoGATE device is its permeability that prevents ingress of fouling agents. Figure 
1.8(a) exhibits an implantable device which has been fitted with a nanoporous 
microchip with the possible diffusion pathway of a drug has been illustrated by 
dashed arrow. Figure 1.8(b) is a picture of implanted device in the body of a rat[20, 
97]. 
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Figure 1.8 NanoGATE microchips drug delivery devices. (a): schematic of 
NanoGATE microchip; (b): picture of implanted NanoGATE microchip in the body 
of a rat. 
 
A novel nanochannel drug delivery system called nDS was developed by Ferrari and 
his colleagues in 2004[98]. The main structure of this nDS device consists of two 
conjugated wafers. One of them is a filtration wafer which is structured by 
micromachining and the other one is the cap wafer (Figure 1.9 (a) and (b)). There is a 
hole in the cap wafer and fluid transfers into the device via this hole where the fluid 
then flows through the device by horizontal movement and via the filtration 
channels. At the end of the filtration wafer there is another hole which allows the 
fluid to exit the device. The nDS drug delivery microchip which has utilized 
nanochannel technology could be used for sustained release application. For 
instance, release of IFN-α has been studied using the nDS nanochannel drug delivery 
device. In this study, IFN-α exhibited a sustained release at the investigated time[99]. 
Figure 1.9 (a) exhibits the cross section of this device and (b) presents top and cross 
section view of the nanochannel device. 
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Figure 1.9 Microchip with nanochannel technology; (a) Cross section view; (b) top 
and cross section view of the device[100].  
 
1.4 Conducting polymers  
 
In 1977 Shirakawa [42], Heeger and MacDiarmid [101] discovered a class of 
organic polymers and called them conducting polymers (CPs) and in 2000 these 
researchers won the Noble Prize for Chemistry as a result of their studies in this 
area. There has been a lot of interest in the use of conducting polymers in wide 
range of applications such as energy storage [102-106], photovoltaics [107-109], 
electrochromics [110-113], electromechanical actuation [114-117], separation 
membranes [118-120], corrosion protection [121, 122] and chemical sensors [123-
127]. Conducting polymers are generally biocompatible and non-degradable [128]. 
Also, this category of polymers are relatively simple to Syntheticesis and 
demonstrate conductivity as well as “redox switching” which can also be associated 
with hydrophilic/hydrophobic, colour and mechanical properties changes [129]. The 
last few decades of research in the CP area has revealed that the most pragmatically 
applicable and stable conducting polymers are based on polypyrrole (PPy), 
polythiophene (PTh) and polyaniline (PAn) [129]. The chemical structure of these 
conducting polymers has been shown in Figure 1.10. 
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Figure 1.10 chemical structure of (a) polypyrrole (PPy); polythiophene (PTh) and 
polyaniline (PAn). 
 
The electropolymerized Polypyrrole is widely used in this thesis. Therefore, the 
electropolymerization mechanism of this conducting polymer is presented in Figure 
1.11.   
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Figure 1.11 Mechanism of electropolymerization of polypyrrole; A- represents the 
counterion. 
 
Some advantages of electrochemical polymerization are simplicity, ability to control 
the thickness, geometry and location [130]. 
In electropolymerisation method, by absorption of monomers to the surface of 
working electrode, on-electron oxidation is formed which called as pyrrole cation 
radical. This cation radical is able to couple with the other cation radicals and also 
the neutral monomers in the solution. These reactions lead to formation of dimers. 
Then the polymer chain grows by coupling of dimers with the other dimers or 
monomers. The role of counterion (A-) is providing the electroneutrality [130].  
 
When a conducting polymer such as PPy is oxidized or reduced the counterion or 
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dopant can leave the main structure of the polymer freely and again is incorporated 
into the polymer matrix [130]. Figure 1.12 shows the redox of PPy where A- 
represents a counterion (dopant) molecule. 
 
 
Figure 1.12 Oxidation and reduction process of PPy 
  
Because of the simple redox switching of CPs and the subsequent physical changes, 
they offer a the possibility of widespread application in actuators, micro-fluidic  
devices  and  biomedical science such as controlled drug delivery systems [101].The 
other great property of conducting polymer is their ability for actuation which has 
been utilized to produce PPy valves where these valves can control the release of 
agents from reservoirs [35]. For example, Tsai et al. [36] doped PPy with 
dodecylbenzene sulphate (DBSA) using electrochemical deposition onto a gold 
layer. During application of a voltage the PPy/DBSA volume changes due to dopant 
ion moving into and out of the polymer. Therefore, the gate will open and close as a 
function of electrical stimulation. In similar work, Wang et al developed a PPy valve 
actuator to control release of drug. Figure 1.13 and 1.14 show the photo and 
schematic of this drug delivery device.  
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Figure 1.13 photographs of the actuation of polypyrrole valve in a prototype drug 
release device; (a) before and (b) after applying voltage to the PPy/DBSA valve 
[131].  
 
 
Figure 1.14 Schematic of drug delivery device from the cross section view [131].  
 
Figure 1.13 exhibits the application of +0.3 V to the surface of PPy/DBSA valve 
leads to actuation of this part and opening the gate of drug delivery reservoir [131]. 
PPy valves which can actuate using electrical stimulation have been developed by 
Xu et al [37]. These valves have been used over a set drug reservoirs and have 
demonstrated linear and pulsatile release behaviour. 
 
This thesis focuses only on the use of PPy coated membranes for controlled delivery 
studies; therefore, PPy has been utilized extensively. Hence, PPy, its polymerization 
method, and also its structure and characteristics will be introduced through the 
following sections. 
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1.5 Polypyrrole for controlled drug delivery 
 
Controlled release using conducting polymers was introduced first by Zinger and 
Miller in 1984. They had used PPy as the substrate and studied the release of 
glutamate[35].Therapeutic drugs, pesticides, fungicides, and the other drugs can be 
released in a controlled manner from conducting polymer structures. These drugs can 
be used as incorporated dopants (A- as shown in Figure 1.5). Therefore by applying a 
desired potential the incorporated drug will release from the structure of the polymer. 
In the other word, conducting electroactive polymers are able to incorporate 
biomolecules during their growth and then by using electrical stimulation these 
molecules will be expelled. These strategies were seen as a novel development of 
controlled release systems for active ingredients such as anticancer drugs and anti-
inflammatories[35].Among all of conducting polymers, PPy and its derivatives have 
engaged the most of researchers in this area. High electrical conductivity, 
environmental stability and high mechanical strength are the main reasons of using 
PPy in most of research. Also this conducting polymer can be easily synthesised  
using chemical or electrochemical methods [128, 129]. The electropolymerisation can 
be used to synthesize thin films with awide range of counterions [72-76]. In chemical 
polymerization method, the pyrrole monomer has to be mixed with an oxidant in a 
solvent. The advantage of this method is the possibility of conducting the 
polymerization reaction withoud requiring any special equipment. However, the 
disadvantage of the chemical polymerization is the availability of the number and 
limitation of oxidants and counterions. On the other hand, electropolymerisation 
method is a facil way to vary the properties of polymer by changing the counterions or 
even the electropolymerisation condition [48]. 
 In addition, PPy is the most widely used conducting polymer because of its low 
toxicity of the monomer and good biocompatibility of the resulting polymer [132]. 
Also PPy possesses good stability in various solution such as aqueous environments in 
vivo and in vitro. In the other word PPy is not biodegradable [132]. Wang et al. [133] 
was atudied the biocompatibility of PPy. In this study PPy did not show any adverse 
impacts on the lines or animal models’s cells. In a study conducted by Georgeet al 
[134] the neural networks which were grown on PPy elelctrodes and implantedinto 
rats. These PPy electrodes were compeletely biocompatible. Recentely, Alteh et al. 
[135] concluded based on their research that PPy could provide a new category of 
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biomaterilas because of its biocompatibility and flexible properties.  
 
 
1.5.1 Electrochemical polymerization 
 
Conducting polymers can be synthesized by either chemical [136, 137] or 
electrochemical methods [130, 138, 139]. In both methods, charged specises are 
incorporated into the polymer structure and this process is termed doping. Figure 
1.15 exhibits the polymerisation process of PPy. The A- is representative of the 
counterion or dopant being incorporated into the PPy structure during the 
polymerization process, and also n presents number of pyrrole monomers which is 
used during Syntheticesis reaction. 
 
 
 
 
Figure 1.15 Schematic of the Syntheticesis of pyrrole monomer in the presence of 
a counterion (A-), and n is pyrrole monomer unit’s number per counterion. Ox 
represents oxidation and can be performed using a suitable chemical oxidant or by 
applying a suitable electrical stimulation sufficient to initiate oxidation of the pyrrole 
monomer. 
 
In this thesis only electrochemical polymerization has been used, therefore, this 
method will be discussed in detail. Using a three-electrode electrochemical cell the 
electropolymerisation of PPy doped with a wide variety of counterions is possible. 
This three-electrode system consists of reference, working and auxiliary electrodes 
(Figure 2.2 in Chapter 2). Polymerization occurs at the working electrode and the 
process starts with oligomers (several monomer units attached to each other) 
generation and then when the molecular weight of these oligomers become large 
enough, the oligomers turn into insoluble large structures and absorb onto the 
working electrode surface. The polymerization reaction continues by spreading from 
these active sites until the whole surface of working electrode is covered [140, 141]. 
The extended explanation regards polymerisation mechanism of PPy has been 
provided in a review paper by Sadki et al [142]. The accurate and exact chemical 
structure of PPy is not still completely understood. Using X-ray photoelectron 
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spectroscopy (XPS) [143], UV-photoemission and optical adsorption spectra [144] 
revealed the linear chains of planar pyrrole rings in PPy structure. These pyrrole 
rings have been attached to each other in the 2,5-position and roughly two to four 
(three in average) pyrrole units possess one positive charge. Negative charge from 
the incorporated counterion balances the positive charge of the PPy during 
polymerization. A significant number of pyrrole rings have been linked through 2,3- 
positions. This phenomenon has been introduced as a defect in the hypothetical idea 
of linear arrangement of PPy chain which leads to decline of PPy conjugation length 
and the polymer conductivity [138]. Figure 1.16 demonstrates the chemical structure 
of PPy and also shows some of its structural disorder [138]. Characteristics of the 
grown PPy can be affected by a number of experimental parameters during synthesis, 
especially the electropolymerisation method. For instance, concentration of 
counterion and monomer, temperature of polymerization solution, substrate or 
working electrode type and growth time can also have an effect [71, 140]. In this 
study, PPy with different dopants has been deposited on the surface of working 
electrode under a constant current (i.e., galvanostaticly). During the 
electropolymerisation process the amount of charge passed (A.s) and potential (V) 
versus time was monitored. A linear relationship between passing charge through the 
surface of working electrode and amount of deposited PPy on the surface of working 
electrode has been shown by Fonner et al [140]. Also monitoring the oxidation 
potential provides some useful data about the degree of PPy oxidation during 
Syntheticesis process. In conclusion, observing and recording the polymer deposition 
process parameters is important to adjust and recognize any problem which may 
occur in the system set up [130].  
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Figure 1.15 Chemical structure of PPy; 2,5 coupling leads to having linear structure 
while with 2,3 linkage structural disorder is happened into the PPy structure. 
Adapted from Ref [138]. 
 
Pyrrole monomer is an appropriate candidate to use for biomedical and biomaterial 
applications as this this monomer is relatively soluble in aqueous solvents and  most 
of the biomolecules carry negative charges which can be incorporated into the 
polymer structure as counter ions, and also these biomolecules are usually water 
soluble [71, 140].  
 
1.5.2 Properties and characterisation  
 
Electrical property or the ability to transfer electron across the polymer structure is 
the main and fundamental difference between non-conductive insulating polymers 
and conducting polymers. Conjugation is the main reason of this phenomenon. 
Conjugation s defined as the presence of alternate single and double carbon-carbon 
bonds which are repeated continuously into the structure of conducting polymer 
chain (Figure 1.17). 
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Figure 1.16 The chemical structure of PPy.  
 
Conjugation in the structure of conducting polymers such as PPy provides the 
overlapping opportunity between two sp2-hybridised orbitals.  When these 
overlapped sp2 orbitals are full as presented in Figure 1.17, PPy is in its natural state. 
Figure 1.18 exhibits the band structure evolution upon doping process of PPy. 
 
 
Figure 1.17 Process of band structure of PPy doping; (a) Natural polymer, (b) 
Polaron, (c) Bipolaron at the intermediate level and (d) Bipolaron band at the high 
doping levels [145]. 
 
4.0 eV
( a)                       (b)                      (c)                     (d)
Conduction Band
Valence Band
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At natural state PPy has the lowest electrical activity and acts as a moderate 
insulator. By polymerization of PPy using doping molecules the sp2 orbitals will be 
occupied. The electrical conductivity of PPy will be at the highest level when every 
three monomers are conjugated by one doping molecule. According to this theory the 
large band gap for PPy is 4.0eV. The bad gap means the difference between the 
highest conducting level of a material (highest occupied molecular orbitals, HOMO) 
and the lowest occupation capacity (lowest occupied molecular orbitals, LUMO). For 
PPy a molecule need 4.0eV energy to transit across this gap. This amount of energy 
has been calculated using valence-effective Hamiltonian method [146]. When PPy is 
syntheticesized in the presence of a doping molecule, the addition or subtraction of 
charge from the neutral state occurs because of adsorption and desorption of doping 
molecules. Polymerization of PPy with a counterion molecule ensures occupation of 
sp2 orbitals and facilitates electrical conductivity. Oxidation of pyrrole monomer in 
the presence of an anion molecules (dopant) leads to p-type doping of conducting 
polymer and balance the PPy polymer chain charge, and also results in a positive 
charge or polaron formation. On average for every 3 units of pyrrole monomer there 
is one positive charge in the backbone [147]. Addition of another polaron causes a 
bipolaron or a pair of polarons formation which is energetically desirable. With the 
highest level of doping, bipolaron bands blends with conducting band, and also the 
valence band. At this state the band gap is low enough to classify the material as a 
conducting material [148]. 
 
Measurement of the electrochemical, chemical and physical properties of CPs is the 
major characterization properties of these materials. A variety of characterization 
methods have been utilized to study these properties with Table 1.2 presenting some 
of the most common characterization techniques. 
Table1.2 Characterization technique of conducting polymers [130]. 
Conducting polymer 
property 
Characterization 
method 
Information achieved 
 
 
Electrochemical 
Cyclic voltammetry 
Potentiometry 
Amperometry 
Impedance analysis 
 
Electrochemical 
properties and 
polymerization 
 
49 
 
mechanism 
 
 
Chemical  
Elemental analysis 
NMR 
XPS 
Raman spectroscopy 
FTIR-ATR 
 
Chemical structure of 
polymer and chemical 
analysis of incorporated 
counter ion 
 
 
Physical  
SEM 
AFM 
Four point probe 
conductivity 
Tensile strength 
Permeability 
Porosity analysis 
 
 
Morphology, porosity 
structure, mechanical 
property and conductivity 
1.5.3 Controlled drug delivery 
 
Two approaches to drug delivery using PPy are presented in this thesis namely 
release from a reservoir in (i) flat and (ii) hollow fiber shape, using a CP coated 
porous membrane, termed “gated release”. 
 
1.5.3.1 Direct stimulated release 
 
Release of incorporated therapeutics for PPy can occur under passive conditions (i.e., 
in aqueous media at room temperature and pressure), as well as under applied 
electrical stimulation. Through the use of electrical stimulation the rate of release 
from PPy is significantly altered. Therefore, in comparison with the currently 
available drug delivery devices on the market, using conducting polymer provides 
the ability to have fine control over release upon application of electrical stimulation. 
The ability to have control of the release of therapeutics from PPy is highly desirable, 
if not essential, for the intended clinical application addressed in this thesis. 
 
The chemical structure of therapeutic drugs which have been chosen for this project 
is presented in Figure 1.19.  
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Figure 1.18 Chemical structure of Lacosamide (LCM) 
 
Figure 1.19 exhibits the chemical structure of lacosamide (LCM). Lacosamide or 
(R)-2acetamido-N-benzyl-3-methoxypropionamide, is a functionalized amino acid 
which is specifically designed and Syntheticesized to act as an anticonvulsive drug. 
Various animal test of LCM have demonstrates the effectiveness of this drug to 
control seizures [151].  
 
The first application of PPy as a drug carrier for targeted drug delivery was 
investigated by Zinger and Miller at 1984 [152]. They studied the release of 
neurotransmitter from an electrode which was coated by PPy. The neurotransmitter 
was attached to the backbone of polymer by a covalent bound. Therefore, it was 
stable on the surface of polymeric electrode until an external pulse from a cathodic 
current initiate the release of this molecule [153].   
 
Afterwards, PPy was studied as drug release substrate for the treatment of 
schizophrenia, neural electrode coatings and implantable microchips with controlled 
drug delivery targets [154-156].Also, PPy coated electrodes were utilized to study 
the incorporation and release of I-labelled NT-3 growth factor. Release of NT-3 was 
investigated by applying pulsed voltage, pulsed current and cyclic voltammetry [157, 
158].   
1.5.3.2 Gated release 
 
In this thesis gated release was mitigated by the use of a PPy coated porous 
membrane. The choice of the membrane is critical as it is important for it to act 
selectively in terms of what can pass through. There are many different classification 
strategies for membranes. For instance, membranes can be classified into two 
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different categories including Syntheticetic and natural membranes. The structure 
and functionality of these two groups of membranes are totally different [159, 160]. 
 
Biological membranes respond to environmental changes to make the transport 
process possible. By changing the environment condition such as pH or temperature 
a biological membrane adjust its permeability on the base of obtained biological data. 
Then this membrane transfers specific species selectively from one side to the other 
side. These membranes are made from a great variety of proteins and lipids and assist 
in chemical transport through the membranes [161]. 
 
Syntheticetic membranes can be classified in terms of their application or their 
physical and chemical dimensions and are composed of ceramic and polymeric 
materials [162]. Some researchers have divided Syntheticetic membranes in three 
groups based on the separation mechanism and the application of membranes [163]. 
According to this classification membranes function with reverse osmosis, 
ultrafiltration or microfiltration mechanism. In all of these mechanisms the driving 
force for filtration is pressure. Also, the particle or molecular size of the transition 
species is important and effective on the transport behavior across the membrane. 
 
The physical dimensions of a membrane is another important aspect which leads to 
the other classification strategy [164]. In this classification membranes include 
heterogeneous and homogenous or symmetric and asymmetric. A bulk liquid 
membrane is a very good example of a homogenous and symmetric membrane. 
Beside, a supported liquid membrane is called a heterogeneous and symmetric 
membrane. Figure 1.20 presents classified membranes in a diagram. In this 
classification the physical dimension and chemical structure of membranes have 
been combined [161, 165].  
 
 
52 
 
 
Figure 1.19 Classification of membranes; Adapted from Ref [161].   
 
1.6.1 Membrane separation mechanisms and processes 
 
Different species and chemical reagents transport across the membrane by either 
active or passive mechanisms with the type of membrane and the transport condition 
being two effective factors. In active transport an external driving force is needed, 
while, passive mechanism happens because of a difference in chemical or 
electrochemical potential between two sides of the membrane. Passive transport is 
the major transport mechanism which has been employed to develop membranes for 
industrial uses. Table 1.3 exhibits the classification of membranes which are utilized 
for different transport mechanisms with employing a variety of driving forces [159, 
166].  
 
Table1.3  Classification of membranes processes on the base of membrane 
transport mechanisms 
Pressure 
difference 
Concentration 
difference 
Temperature 
difference 
Electrical 
potential 
difference 
Microfiltration Pervaporation Thermo-osmosis Electrodialysis 
Thin (<100 °A)
Thick (>100 °A)
unexcitable
Membranes
Biological membrane (cell) Excitable (e.g., nerve and muscle cells)
Parlodion (e.g., nitrocellulose) Unexcitable
Amophipathic molecules 
(e.g., phospholipids, 
oxidized cholestrable) Bilayer-Inexitable
Doped bilayer-Exitable (e.g., 
alamethicin, exitability inducing 
material)
Charged (e.g., ion exchangers)
Uncharged
Solid (e.g., 
quartz)
Liquid (e.g., 
hydrocarbon 
oil)
Charges, fixed 
(solids)
Charges, 
mobile 
(liquids)
Associated 
(membranes 
with narrow 
pores)
Dissociated 
(membranes 
with wide 
pores)
Associated (solvents of 
low dielectric constant
Dissociated (solvents of 
high dielectric constant with 
strong acid or basic groups)
Solid (inorganic)
Solid (organic)
Solid (inorganic)
Solid (organic)
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Ultrafiltration Gas separation Membrane 
distillation 
Electro-osmosis 
Hyperfiltration Dialysis   
Piezodialysis Liquid membranes   
 
1.6.1.1 Osmosis transport mechanism across a membrane 
 
When a membrane is placed between two solutions which have different 
concentrations, an osmotic pressure is the driving force of transport mechanism 
through the membrane. In addition, in some case which the membrane possesses 
selective permeability the osmotic pressure occurs. However, for microfiltration and 
ultrafiltration membranes which have porous structure the osmotic pressure is 
negligible. Osmotic pressure of a non-porous membrane is a function of solute 
concentration, molar weight of immigrant species and the experiment temperature 
[159, 167, 168].  
 
 
1.6.1.2 Pressure driven transport mechanism across a membrane 
 
When an external pressure is a driven force to initiate transport through a membrane, 
differences between membrane pore sizes and the particle size of the immigrant 
solute are two effective factors. In addition, solubility of the solute and diffusion 
power of this solute in the membrane matrix is significant. These types of 
membranes can be divided into three different classes as it has been presented in 
Table 1.4. 
 
Table1.4 Classification of membrane on the base of pressure driven mechanism 
Type of 
membrane 
Microfiltration Ultrafiltration Hyperfiltration 
Immigrant 
particle size 
range (nm) 
>100 1-100 0.1-1 nm 
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Applied 
pressure (bar) 
<2 1-10 0.1-1 
Separation 
mechanism 
Separation based on 
particle size 
Separation based on 
particle size 
Separation based on 
difference in 
solubility and 
diffusivity 
 
1.6.1.3 Concentration gradient driven transport across a membrane 
 
In general, concentration gradient as a transport mechanism happens for non-porous 
membranes. These type of membranes includes, gas separation, evaporation, liquid 
and dialysis membranes. For separation of gas a pressure from upstream to 
downstream with the value of 100 bar is required. Evaporation membranes utilized 
the vapor pressure the activity difference as a driving force for transport across the 
membrane. In liquid and dialysis membranes the difference between concentrations 
in two sided of the membrane initiated transport through these membranes. Affinity 
between m species and the membrane or diffusion is two effective factors in 
transition mechanism.  
1.6.1.4 Thermally driven transport mechanism across the membrane 
 
In some separation or transport systems which utilized a non-porous membrane, the 
temperature between two sides of the membrane in different. Mass flow induction 
across the membrane occurs due to temperature gradient across the membrane which 
is called Soret effect. Fourier’s law can explain this phenomenon [159]. In membrane 
distillation process two liquids with different temperature are separated by a porous 
membrane. In this process the membrane is not directly involved in the separation 
mechanism. The transport driving force is vapor-liquid equilibrium. Different 
industrial areas such as, water purification in semiconductor industries, feeding 
boiler water for power plants and seawater desalination are using these type of 
membranes [169].  
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1.6.1.5 Electrically driven transport across a membrane 
 
Ion-exchange membranes are classified in this category. A different between 
electrical potential mitigates the transport of charged species through the membrane. 
Donnan exclusion mechanism explains the principle of this transport mechanism. For 
instance, this separation mechanism is being used for desalination of either water or 
food and also in pharmaceutical industries. In addition, for producing of sulfuric acid 
and sodium hydroxide these membranes are being applied [170]. It has to be noted 
that the chemical nature of the membrane is an effective factor. The other significant 
factor is the member morphology.    
 
1.6.2 Conducting polymer coated membranes 
1.6.2.1 Development of conducting polymer coated membranes 
 
Movement of conducting polymers as a result of redox switching has been used to 
develop a new strategy for producing smart membranes. These membranes have 
been coated with a CP such as PPy and stimulated by applying the oxidation and 
reduction potentials of the CP. By using these electrical pulses redox switching will 
occur, so the counterion will move between the electrolyte and the coated membrane 
in situ or ex situ. This property of conducting polymers enables them to be 
applicable in ion separation such as K+  and Na+, transition metal ions (i.e., 
sulfonated aromatics) and large molecules such as proteins[101]. Previously 
researches have studied the fabrication and application of these smart membranes 
which has been shown in Figure 1.20 [171-176]. 
 
The mechanical strength of PPy films are not sufficient to be used as free standing 
membrane, therefore, most research has been performed using a supporting 
substrate. For instance a gold mini grid membrane was used to support PPy 
membrane for ion transition studies by Burgmayer et al [175,176]. According to 
their study alteration the redox state of PPy can change the ion permeability of PPy. 
Also, they reported that when PPy was at its oxidized state the ion transition rate 
was much higher than the permeation rate at reduced state. Wang and co-workers 
[177] developed the first free standing PPy membrane to study the transport of 
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monovalent cation such as H+, K+, Na+ and NH4+. Ion permeability through this free-
standing PPy membrane was investigated by applying an external electrical field to 
the surface of PPy film. Size and charge of the cations and also the surface property 
of the PPy membrane had significant effects on the permeation rate of cations 
between two electrolyte solutions. 
 
Polypyrrole free-standing membranes were also used by Zhao et al [178-181] to 
study the transport of metal ions. In these studies metal ion transport initiation and 
control was carried out by using electrochemical stimulation such as applying pulse 
potentials. The on/off metal ion transport profile was achieved by varying the 
external electrical stimulation of the PPy membranes.  As a consequence of this 
research, transport of small organic molecules through PPy membranes, as a result 
of applying electrical stimulation to the surface of the membrane, was investigated 
by Mirmohseni et al [182].  
 
Research was also undertaken to study the permeation of gaseous and volatile 
reagents across PPy coated membranes [183] and it was revealed that the redox 
status of PPy had a significant effect on the conducting polymer permeation 
properties. Higher transition rate was achieved at reduced state of conducting 
polymer compared to the oxidizing state [175,176]. Another conducting polymer 
called polyaniline (PAni) as well as PPy free-standing membranes were fabricated to 
study the separation of gas [184-186]. A novel technique to improve gas separation 
using a PAni coated membrane was reported that involved subsequent 
dedoping/doping processes which caused permanent morphological structural 
changes in the surface of conducting polymer membranes. 
1.6.2.2 Fabrication and characterization of conducting polymer membranes 
 
Fabrication of conducting polymer coated membranes is the same as Syntheticesise 
process of conducting polymer films. Either chemical or electrochemical methods 
can be utilized to prepare these membranes. However, some effective factors such as 
uniformity, mechanical property, electrical conductivity and electroactivity must be 
monitored and considered while the polymerization process is being held. Also 
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characterization of conducting polymer coated membranes is similar to 
characterization methods of conducting polymer films.  
 
1.6.2.3 Electrochemically controlled transport through conducting polymer 
coated membranes 
 
Permeability changes of the polymer coated membrane occur due to differences in 
densities and charges of the CP in oxidation and reduction state [187]. In situ 
electrochemical stimulation of these membranes has been carried out to evoke their 
appropriate chemical and physical responses such as ion-exchange that result in the 
desired physical responses such as changes in their hydrophobic/hydrophilic 
properties. These particular properties are very useful in terms of designing, 
fabricating and operating the intelligent electrodynamic membranes for a variety of 
applications, and especially controlled drug delivery systems (the main focus of this 
thesis). An electrical field can cause swelling, shrinking or bending in CPs [188].  
 
The transition of biomolecules and charged species through electroactive CP coated 
membranes is influenced by a range of different processes with the redox state of CP 
being a major contributing factor. The redox switching property of a CP coated 
membrane largely depends on the nature of the incorporated counterion. Other 
influencing factors are diffusion phenomenon which occurs in the solution and across 
the membrane. Ion insertion/expulsion during the transport experiment happens as a 
result of diffusion and electrochemical properties of the conducting polymer 
membrane. There are some effective factors which dictate the diffusion such as 
diffusion coefficient, density and chemical potential of the ion, velocity of the fluid, 
mass density, pressure and viscosity of the fluid. Also, osmotic, magnetic and 
electrostatic forces as well as antiparticle interactions can control the diffusion 
process [189]. In addition, empirical studies about polymer base membranes have 
revealed that permeability of a membrane is a function of the selectivity of that 
membrane [190, 191]. 
 
Whilst the membrane type and the CP growth conditions all have an influence of ion 
transport through the membrane another influencing factor is the application of an 
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electrical stimulation to the CP membrane. As discussed above electrical stimulation 
evokes a wide range of changes within the CP that in turn has a profound effect on 
the transport kinetics. Figure 1.21 presents a diagram of different electrostimulation 
methods that can be utilized to stimulate the surface of conducting polymer coated 
intelligent membranes. In addition to the stimulation properties other factors such as 
the electrochemical cell set up and design need to be considered. The combination of 
all of these elements and circumstances contributes to the final performance of the 
transport through the intelligent membrane system [179].  
 
 
Figure 1.20 Effective factors on electrochemically transport across intelligent 
conducting polymer coated membrane 
 
 
 
 
 
 
 
 
 
 
 
1.7 References 
1. M.F Bennewitz, W.M Saltzman, Neurotherapeutics, 2009. 6(2): 323-336. 
Electrochemical 
control factors
Cell adjustment
Applied potential
Applied current
Constant potential 
waveform
Pulsed potential 
waveform
Sweep potential 
waveform
Potential range
Potential range 
pulse width
Potential range 
scan rate
Cell adjustment     
( orientation of 
electrodes, volume 
of cell, cell 
geometry, etc)
 
59 
 
2. X.D Tiege, H laufos, S.G Boyd, W Harkness, P.J Allen, C.A Clark, A 
Connelly, J.H Cross, Epilepsia, 2007. 48: 385-389. 
3. R.S Fisher, B.W van Emde, W Blume, C Elger, P Genton, P Lee, J Enge, 
Epilepsia, 2005. 46(4): 470-472. 
4. A Alkan, E Koklukay, A Subasi, J NeuroSci Meth, 2005. 148(2): 76-167. 
5. Epilepsy. 2012  [cited 2012; Fact Sheet No 999]; 
           http://www.who.int/mediacentre/factsheets/fs999/en/ . 
6. C.D Ferrie, J.H Livingston, EJPN, 1997. 1(5-6): 139-147. 
7. O Dulac, Epilepsia, 2001. 42(3): 23-26. 
8. Avoiding triggers for epileptic seizures. 2014  [cited 2014 12.8.2014]; 
http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/epilepsy]. 
9. A.K Sharma, E Rani, A Waheed, S.K Rajput, J Epilepsy Res, 2015. 5(1): 1-8. 
10. How VNS Therapy works. 2014  [cited 2014 12.8.14]; 
http://us.cyberonics.com/vns-therapy/how-vns-therapy-works]. 
11. Ketogenic Diet. 2014  [cited 2014 12.8.2014]; 
http://www.epilepsy.com/learn/treating-seizures-and-epilepsy/dietary 
therapies/ketogenic-diet]. 
12. A.J Hlliday, G.G Wallace, M.J Cook, Adv. Drug Delive. Rev, 2012. 64(10): 
953-964. 
13. T.J Cook, V.C Yang, IJP, 1997. 159(2): 197-206. 
14. M.P Ratnaparkhi, J.P Gupta, IJPR, 2013. 2(3): 11-21. 
15. N Dixit, S.D Maurya, B.P.S Sagar, IRPB, 2013. 1(3): 305-310. 
16. A.G Hughes, Nanomedicine, 2005. 1: 22-30. 
17. A.H Shojaei, J. Pharmacy and Pharmaceutical Sci, 1998. 1(1): 5-30. 
18. R.J Tamargo, J.I Epstein, M.B Yang, M Chasin, H Brem, Cancer Res, 1993. 
53: 329-333. 
19. R Langer, J.T Santini, A.C Richards, R Scheidt, Chem. Int. Ed, 2000. 39: 
2396-2407. 
20. F Martin, A Boiarski, JCR, 2005. 102: 123-133. 
21. E Oby, D Janigro, Epilepsia, 2006. 47(11): 1761-1774. 
22. A Nayak, D.B Das, Biotechnol Lett, 2013. 35:1351–1363. 
23. S Sharma, P.M Sinha, R.J Walczak, X Liu, M.C Cheng, M Ferrari, Expert 
Opin. Drug Deliv., 2006. 3(3): 379-394. 
24. R.K Verma, S Garg, J Pharm Pharmacol, 2001. 25(2): 1-14. 
 
60 
 
25. N Rajgor, M Patel, V.H Bhaskar, Syst. Rev. Pharm, 2011. 2(2): 91-95. 
26. P.E Grimshaw, M.L Yarmush, 1992: Oxford University Press, New York, 
NY, USA. 
27. R.L Juliano, 1980: Oxford University Press, New York, NY, USA. 
28. D.E Wurster, Wurster Air Diverter. 1953: US. 
29. C.P Mc Coy, J.F Cowley, S.M Mcglinchey, N Mcgoldrick, D.J Kinnear, G.P 
Andrews, D.S Jones, Expert Opin. Drug Deliv, 2010. 7(5): 605-616. 
30. T.M Allen, P.R Cullis, Drug. Deliv. Sys, 2004. 303(5665): 1818-1822. 
31. P Broz, J Ziegler, Nano Letters, 2006. 6(10): 2349-2353. 
32. T Traite, R Goldbart, J Kost, J. Biomater. Sci. Polymer Edn, 2008. 19(6): 
755-767. 
33. D.R Freestone, D.B Grayden, E & B, 2011. 22(S): 110-118. 
34. N Bhattarai, M.Q Zhang, Adv. Drug Deliv. Rev, 2010. 62(1): 83-99. 
35. Y Zhong, L Zhang, D.T Haynie, Nanomed. Nanotech. Biol. Med, 2007. 3(2): 
154-160. 
36. W.K Wan, D.T Padavan, NanoMed, 2007. 2(4): 483-509. 
37. C.K Kim, E.J Lee, IJP, 1992. 79(1-3): 11-19. 
38. M.T Maeda, A Sano, K Fujioka, JCR, 1999. 62(3): 313-324. 
39. R Herrero-Vanrell, M Alonso, V Reboto, I.T Molina-Martinez, J.C 
Rodriguez-Cabello, JCR, 2005. 102(1): 113-122. 
40. H Eroglu, L Oner, Drug. Dev. Ind. Pharm, 2007. 33(3): 265-271. 
41. A.K Bajpai, S Bhanu, S Kankane, Prog. Plym. Sci, 2008. 33(11): 1088-1118. 
42. H Shirakawa, A.G Macdiarmid, C.K Chiang, A.J Heeger, Chem. Soc, 
Chemical comunications, 1977. 16: 578-580. 
43. W Greatbatch, C.F Holmes, IEEE. Eng. Med. Biol. Mag. , 1991. 10(3): 38-
49. 
44. P.J Blackshear, P.L Blackshear, R.L Varco, H Buchwald H, Surg. Forum 
1970. 21: 136-137. 
45. P.J Blachshear, F Prosl, H Buchwald, Med. Prog. Tech, 1979. 6:149-161. 
46. W.M Rupp, P.J Blackshear, H.B Mccarthy, T.D Rohde, Engl. J. Med, 1982. 
307: 265-270. 
47. A.J Salkind, B.V Berkovits, B.B Owens, K.B Stokes, M Bilitch, 1986: 
Plenum Press, New York, NY, USA.  
 
61 
 
48. C.D Saudek, H.A Pitt, K Waxman, M Rubio, Engl. J. Med., 1989. 321: 574-
579. 
49. H Fogel, P.R Eaton, P Micossi, J.L Selami, Rev. Euro. Technol. Biomedicale 
1990. 12: 196. 
50. M Danckwerts,A Fassihi, Drug Dev. Ind. Pharm, 1991. 17(11): 1465-1502. 
51. E.A.H Hall, EMT, 1986. 8(11): 651-658. 
52. M.B Yang, R.J Tamargo, H Brem, Cancer Res, 1989. 49: 5103-5107. 
53. S.W Kim, Y.H Bae, T Okano, Pharm Res, 1992. 9(3): 283-290. 
54. A.D Emanuele, J.N Staniforth, Pharm. Res, 1991. 8: 913-918. 
55. K.F Lawrence, W.M Saltzman, Adv. Drug Del. Rev, 1997. 26: 209-230. 
56. S Sershen, J West, Adv. Drug Del. Rev, 2002. 54: 1225-1235. 
57. M.J Schoening, R Otto, F Johnen, Electroanalysis, 2000. 12(9): 703-715. 
58. J Wang, Talanta, 2002. 56: 223-231. 
59. P.C Simpson, A.T Woolley, R.A Mathies, Biomed Microdevices, 1998. 11: 
7-26. 
 
60. Sh Liu, A Guttman, Trends Analyt. Chem, 2004. 23(6): 422-431. 
61. A.T Woolley, A.N Glazer, R.A Mathies, Anal. Chem. , 1998. 70: 684-688. 
62. J.R Lewis, Oosterbroek. 2003: Elsevier, New York, NY, USA.  
63. D.L Polla, A.G Erdman, W.P Robbins, D.T Markus, J Diaz-Diaz, R Rizq, Y 
Nam, H.T Brickner, Annu. Rev. Biomed. Eng, 2000. 2:551–576. 
64. R.G.J Hadgraft. 1989: , New York, NY, USA.  
65. H.M Smith. 1995: CRC Press, Boca Raton, FL, USA. 
66. B.G Amsden, M.F.A Goosen, AIChE J, 1995. 41(8): 1972-1997. 
67. S Henry S, M.G Allen, M.R Prausnitz MR, J. Pharm. Sci. , 1998. 87: 922-
925. 
68. Sh Kaushik, A.H Hord, D.D Denson, D.V McAllister, S Smitra, M.G Allen, 
M.R Prausnitz, Anesth Analg. , 2001. 92: 502-504. 
 
69. D.V McAllister, M.G Allen, M.R Prausnitz, Annu. Rev. Biomed. Eng, 2000. 
2:289–313. 
 
70. L Lin , A.P Pisano, J. Microelectromech. Syst. , 1999. 8(1): 78-84. 
 
62 
 
71. T Patois, B Lakard, N Martin, P Fievet, Synt Met, 2010. 160(19-20):    2180-
2185. 
72. S Sharma, A.J Nijdam, P.M Sinha, R Walczak, X Liu, M M-C Cheng, M                                              
Ferrari, Expert Opin. Drug Deliv, 2006. 3(3): 379-394. 
73. J.T Santini, M. J. Cima, R Langer, Nature, 1999. 397: 335-338. 
74. T.A Desai, D.J Hansford, M Ferrari, Biomol. Eng, 2000. 17: 23-36. 
75. W Chu, T Huen, J Tu, M Ferari, SPIE, 1996. 2978: 111-122. 
76. W.H Chu, T Huen, M Ferrari, J. Microelectromech. Syst, 1999. 8: 34-42. 
77. J.K Tu , R Szema, M Ferrari, Biomed. Microdev, 1999. 1(2): 113-120. 
78. T.A Desai, D.J Hansford, L Kulinsky, A.H Nashat, G Rasi, J Tu, Y Wang, M 
Zhang, M Ferrari, Biomed Microdevices, 1999. 2(1): 11-40. 
79. M Ferrari, W.H Chu, T Desai, D Hansford, T Huen, G Mazzoni,M Zhang, 
Proc. MRS, 1996. 414: 101-106. 
80. T.A Desai, D.J Hansford, L Leoni, M Essenpreis, M Ferrari, Biosens. 
Bioelectron, 2000. 15: 453-462. 
81. R Walczak, A Boiarski, T West, J Shapiro, S Sharma, M Ferrari, 
Nanobiotech, 2005. 1(1): 35. 
82. K.R Kidd, D.P Dal Ponte, R.S Kellar, S.K Williams, J. Biomed.Mater. Res, 
2002. 59(4): 682-689. 
83. P.M Sinha, G Valco, S Sharma, X Lui, M Ferrari, Nanotechnology, 2004. 15: 
585-589. 
84. Global drug delivery: Industry profile. Datamonitor, 2003. Available at 
http://www.datamonitor.com. 
85. L.A Clark, G.T Ye, R.Q Snurr, Phys. Rev. Letter, 2000. 84: 2893-2896. 
86. Q Wei, C Bechinger, P Leiderer, Science, 2000. 287: 625-627. 
87. B Lin, J Yu, S Rice, Phys. Rev. E Stat. Phys. Plasmas Fluids Relat. 
Interdiscip. Topics, 2000. 62(3 Pt B): 3909-3919. 
88. C Consentino, F Amato, R Walczak, A Boiarski, M Ferrari, J. Phys. Chem. 
B. 2005. 109(15): 7358-7364. 
 
89. J.K Tu, T Huen, R Szema, M Ferrari, Biomed. Microdev, 1999. 1(2): 113-
120. 
90. V.V Ranade, M.A Hollinger, CRC Press, Inc., Boca Raton, FL, USA, 1996. 
 
63 
 
91. G.B Lesinski, S Sharma, K Varker, P Sinha, M Ferrari, W.E Carson, Biomed. 
Microdev, 2004. 6(3): 183-190. 
92. T.A Desai, D Hansford, M Ferrari, J. Memb. Sci, 1999. 159: 221-231. 
93. F Martin, R Walczak, A Boiarski, J. Control. Release, 2005. 102: 123-133. 
94. F.J Martin, C Grove, Biomed Microdevices, 2001. 3(2): 97-108. 
95. G.B Lesinski, K Varker, P Sinha, M Ferrari, W.E Carson, Biomed Microdev, 
2004. 6(3): 183-190. 
96. S Sharma, P.M Sinha, R.J Walczak, X Liu, M M-C Cheng, M Ferrari, Expert 
Opin. Drug Deliv, 2006. 3(3): 379-394. 
97. R Walczak, T West, J Shapiro, S Sharma, M Ferrari, Nano. Bio. Tech, 2005. 
1(1): 35. 
98. P.M Sinha, S Sharmam, X Lui, M Ferrari, NanoTech, 2004. 15(S): 585-589. 
99. G.B Lesinski, K Varker, P Sinha, M Ferrari, W. E Carson, Biomed Microdev, 
2004. 6(3): 183-190. 
100. F Martin, R Walczak, A Boiarski, M Cohen, T West, C Cosentino, M Ferrari, 
JCR, 2005. 120: 123-133. 
101. C.K Chiang, Y.W Park , A.J Heeger, H Shirakawa, E.J Louis, S.C Gau, A.G 
MacDiarmid, Phys. Rev. Letters, 1977. 39(17): 1098-1101. 
102. P.R Teasdale, M.J Spencer, G.G Wallace, Electroanal, 1989. 1:541. 
103. W Zheng, A.G MacDiarmid, M Angelopoulos, Y Liao, A.J Epstein, 
Synthetic.Met, 1997. 84: 63. 
104. J Stejskal, J Prokes, J Zemek, Synt Met, 1999. 105: 195. 
105. Z Huang, A.G MacDiarmid, Y Xia, G Whitesides, Langmuir, 1997. 13: 6480. 
106. L.A.P Kane-Maguire, I.D Norris, G.G Wallace, W Zheng, Synt Met, 1999. 
106: 171. 
107. R.V Gregory, W.C Kimbrell, H.H Kuhn,  Synt Met, 1989. 28(C): 823. 
108. S.P Armes, J.G Beery, F Garzon, C Mombourquette, M Hawley, H.H Kuhn, 
J. Mater. Chem, 1991. 1: 525. 
109. S.W Byun, S.S Im, Polymer, 1998. 39(2): 485-489. 
110. D.S Kelkar, N.V Bhat, Polymer, 1993. 34(5): 986-989. 
111. B Zinger, D Kijel,  Synt Met, 1991. 41-43: 1013-1023. 
112. S Pouzet, A Richard, F Jousse, Synt Met, 1993. 55: 1079. 
113. Sh Yang, E Ruckenstein,  Synt Met, 1993. 60: 249-254. 
 
64 
 
114. A Mohammadi, O Inganas, J.O Nilsson, I Lundstrom, J. Polym. Sci. Part A. 
Polym. Chem, 1994. 32: 495. 
115. T Iyoda, K Honda, T Simidzu, Macromol, 1990. 23: 1971. 
116. N.S Sariciftci, D Braun, C Zhang, V.I Srdanov, A.J Heeger, G Stucky, F 
Wudl, Appt. Phys. Lett, 1993. 62 (6): 585-587. 
117. Y.A Dubitsky, B.A Zhubanov, Synt Met, 1993. 53: 303. 
118. U Geibler, M.L Hallensleben, L Toppare, Adv. Mater, 1991. 3: 104. 
119. S Dogan, U Akbulut, L Toppare, Synt. Met, 1992. 53: 29-35. 
120. Y.H Park, J. Appl. Polym.Sci, 1973. 45: 992. 
121. H Okuzaki, T Kira, T Kunugi, J.Appl. Polym.Sci, 2000. 75: 566-571. 
122. S.J Pomfret, N.P Comfort, A.P Monkman, Polymer, 2000. 41: 2265. 
123. H Sirringhaus, R.H Friend, T Shimida, M Inbasekaran, W Wu, E.P Woo, 
Science, 2000. 290: 2123. 
124. Y Yoshioka, G.E Jabbour  Synt Met, 2006. 156: 779. 
125. O Ngamna, A.J Killard, S.E Moulton, M.R Smyth, G.G Wallace, Langmuir, 
2007. 23: 8569. 
126. B Winther-Jensen, P Subramanian, R Helmer, S Ashraf, G.G Wallace, L 
Spiccia, D MacFarlane, J.Appl. Polym.Sci, 2007. 104: 3938. 
127. W.R Small, G.G Wallace, M in het Panhuis, J. Mat. Chem, 2007. 17: 4359. 
128.     B Guo, L Glavas, A.C Albertsson, Prog. Polym. Sci, 2013. 38 (9): 1263-
1286. 
129. G.G Wallace, M.J Higgins, R.M.I Kapsa, Organic Bionics. 2012. 
130. G.G Wallace, L.A.P Kane-Maguire, P.R Teasdale, ed. third. 2009: CRC 
Press. 
131. C.H Wang, C.L Wang, J Zoval, M Madou, Electroactive Plym. Actu. Dev, 
2004. 5385: 468-474. 
132. A.F Diaz, K.K Kanazawa, G.P Gardini, J.C.S. Chem. Comm, 1979 : 635-636. 
133.    K Kontturi, P Pentti, G Sundholm, J. Electroanal. Chem, 1998. 453(1-2): 231-
238. 
134.    X.D Wang, X.S Gu, C.W Yuan, S.J Chen, P.Y Zhang, T.Y ZhangJ Yao, F 
Chen, G Chen, J. Biomed. Mater. Res, 2004. 68A (3): 411-422.   
135.    P.M George, A.W Lyckman, D.A Lavan, A Hegde, Y Leung, R Avasare, C 
Testa, P.M Alexander, R Langer, M Sur. Biomater, 2005. 26 (17): 3511-
3519.  
 
65 
 
136.     D.D Ateh, H.A Navsaria, P Vadgama, J. R. Soc. Interface, 2006. 3 (11): 741-
752.   
137. K.K Kanazawa, R.H Geiss, W.D Gill, J.F Wak, J.A Logan, J.F Rabolt, G.B 
Street, J.C.S. Chem. Comm, 1979: 854-855. 
138. K.J Kim, D.E Whiley, A.G Fane, J. Membr. Sci, 1993. 80: 241-249. 
139. W.R Bowen, R.S Kingdon, H.A.M Sabuni, J. Membr. Sci, 1989. 40: 219-229. 
140. J.M Fonner, L Forciniti, H Nguyen, J.D Byrne,Y.F Kou, J Syeda-Nawaz, C.E 
Schmidt, Biomed. Mater, 2008. 3(3): 034124. 
141. T.V Vernitskaya, O.N Efimov, Russ. Chem. Rev, 1997. 66(5): 443-457. 
142. S Sadki, N Brodie, G Sabouraud, Chem. Soc. Rev, 2000. 29(5): 283-293. 
143. W.R Salaneck, Synt Met, 1983. 5(2): 125-139. 
144. W.K Ford, C.B Duke, W.R Salaneck, J. Chem. Phys, 1982. 77(10): 5030-
5039. 
145. J.L Brédas, B Thémans, J.M André, Phys. Rev-B, 1983. 27(12): 7827-7830. 
146. J.M Andre, J.L Bredas, Phys. Rev-B, 1983. 27(12): 7827-7830. 
147. J.L BrLdas, G.B Street , Acc. Chem. Res, 1985. 18(4): 309-315. 
148. A.G MacDiarmid, Angew. Chem. Int. Ed, 2001. 40:2581-2590, 2001. 
149. K Kontturi, P Pentti, G Sundholm, Electroanal. Chem, 1998. 453(1-2): 231-
238. 
150. N.K Guimard, N Gomez, C.E Schmidt, Prog. Polym. Sci, 2007. 32(8-9): 876-
921. 
151. B.K Beyreuther, C Heers, N Krebsfanger, U Scharfenecker, T Stohr, CNS 
Drug Rev, 2007. 13(1): 21-42. 
152. B Zinger, L.L Miller, J. Am. Chem. Soc, 1984. 106(22): 6861-6863. 
153. L.E Guselnikov, N.S Nametkin, Chem. Rev, 1979. 79(6): 529-577. 
154. N Gomez, C.E Schmidt, BJP, 2006. 81A(1): 135-149. 
155. D Gea, X Tian, R Qi, S Huang, J Mu, Sh Hong, Sh Ye, X Zhang, D Li, W 
Shi, Electrochemica Acta, 2009. 55: 271-275. 
156. D Svirskis, J Travas-Sejdic, S Garg, J. Chromatogr. Sci, 2011. 49(10): 780-
785. 
157. B.C Thompson, S.E Moulton, J Ding, R Richardson, A Cameron, S O'Leary, 
G. G Wallace, G.M Clark, JCR, 2006. 116: 285-294. 
 
66 
 
158. R.T Richardson, B.C Thompson, B.O Flynn, P. J Atkinson, N.J Fretwell, J.B 
Fallon, G.G Wallace, R.K Shepherd, G.M Clark, S.J O'leary, Biomat, 2009. 
30: 2614-2624. 
159. M Mulder, 1991: Kluwer Academic Publishers, Dordrecht, Boston, London. 
160. J.E Shriver, D.P Dikhhaut, 1987: John Whiley and sons Inc., New York. 
161. N Lakshminarayanaiah, 1984: Academic Press, U.S.A. 
162. K.C Khulbe, T Matsuura, Syn. Plym Memb. 2008: Springer. 
163. K.T Chen, Bull. Amer. Math. Soc,1977. 83:831-879. 
164.  W Pusch, A Walch, J. Membr. Sci, 1982. 10(2-3): 325-360. 
165. N Lakshminarayanaiah, 1969: Academic Press, New York. 
166. D.W Van Krevelen, K.T Nijenhuis, 1987: John Whiley and sons Inc., New 
York. 
167. J Jabs, C.M Devine, J Sobal, 1991: Plenum press, New York, USA. 
168. H Budka, C.A Wiley, P Kleihues, J Artigas, 1991: John Wiley, New York, 
USA. 
169. R.H Fish, J.J Komlenic, Anal.Chem, 1984. 56(3): 510-517. 
170. A Diaz, Handbook ofconducting polymer, ed. E.T. Kotheim S. 1986. 
171. W Erkang, D Shaojun, D Jie, J. Chemm. Soc. Faraday Trans, 1990. 86: 2243-
2247. 
172. E Wang, Y Liu, Z Samec, C Dvorak, Electroanalysis, 1990. 2(8): 623-629. 
173. I.H Loh, R.A Moody, J.C Huang, J. Membr. Sci, 1990. 50(1): 31-49. 
174. T Shimidzu, A Ohtani, T Iyoda, K Honda, J. Electroanal.Chem, 1987. 
224:123–135. 
175. P Burgmayer, R.W Murray, J. Am. Chem. Soc, 1982. 104(22): 6140-6142. 
176. P Burgmayer, R.W Murray, J. Phys. Chem, 1984. 88(12): 2515-2521. 
177. Y.C Liu, B.J Hwang, Thin Solid Films, 1999. 339(1-2): 233-239. 
178. H Zhao, P.R Teasdale, G.G Wallace, Reactive Plym, 1994. 23: 213. 
179. A Mirmohseni, W.E Price, G.G Wallace, H Zhao, J. Intell. Mater. Syst. 
Struct, 1993. 4: 43-49. 
180. D Zhou, W.E Price, G.G Wallace, J. Membr. Sci, 1995. 98: 173-176. 
181. H Zhao, C.O Too, G.G Wallace, D Zhou, J. Membr. Sci, 1996. 119: 199-212. 
182. A Mirmohseni, W.E Price, G.G Wallac, H Zhao, J. Intell. Mater. Syst. Struct, 
1993. 4(1): 43-49. 
183. V.M Schmidt, J Heitbaum, Synt Met, 1991. 41-43: 425-428. 
 
67 
 
184. M.R Anderson, B.R Mattes, H Reiss, R.B Kaner, Synt Met, 1991. 
41(1151):41-43. 
185. M.R Anderson, B.R Mattes, H Reiss, R.B Kaner, Sicence, 1991. 252(5011): 
1412-1415. 
186. K Kamada, A Motonaga, T Iwasaki, H Hosokawa, J. Polymer, 1994. 26(2): 
141-149. 
187. G Inzelt, Conducting Polymers, Monographs in Electrochemistry, 2012: 
Springer-Verlag Berlin Heidelberg. 
188. F.C Carvalho, M.L Bruschi, R.C Evangelista, M.P.D Gremio, Braz. J. Pharm. 
Sci, 2010. 46(1):1-17. 
189. M Tagliazucchi, I Szleifer, Materials. Today, 2015. 18(3): 131-142. 
190. A.I Skoulidas, D.S Sholl, J.K Johnson, J. Chem. Phys, 2006. 124(054708): 1-
7. 
191. L.M Robeson, J. Membr.Sci, 1991. 62:165. 
 
68 
 
2 GENERAL EXPERIMENTAL  
 
2.1 Chapter aims 
 
The aim of this chapter is to outline the experimental techniques, characterization 
methods and materials which have been utilized throughout this thesis.  
 
2.2 Materials 
2.2.1 Pyrrole 
 
Pyrrole monomer was purchased from Merck with >99% purification. The 
distillation process was performed out in the organic laboratory of Intelligent 
Polymer Research Institute (IPRI), and then stored under nitrogen at -18º C. 
Solutions of 0.2 and 0.1 M aqueous pyrrole with different dopants were prepared to 
perform all of the electropolymerization experiments. The concentration of dopant 
molecules and electropolymerization condition were different and are be present in 
the respective chapters. Paratoluene sulfonic acid sodium salt (pTS), chondroitin 4-
sulphate sodium salt (CS), poly (4-styrene sulfonic acid) sodium salt (PSS), 
doddecylbenzeneslfonic acid sodium salt (DBSA), hyaluronic acid (HA) and dextran 
sulphate sodium salt (DS), were used as dopants to grow polypyrrole 
galvanostatistically. All of these chemicals were purchased from Sigma-Aldrich Pty. 
Ltd.  
  
2.2.2 Lacosamide 
 
Lacosamide with the generic name of Vimpat (SPM 927, (R)-2-acetamido-N-benzyl-
3-methoxypropionamide) is a functionalized amino acid which has been synthesized 
to be used as anticonvulsive drug. This drug has demonstrates a significant effect on 
reducing seizure in animal models. Also, safety pharmacology and toxicity 
experiments conducted to examine lacosamide. Results showed that this drug in rats, 
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mice, rabbits and dogs was well tolerated[1]. The chemical structure of lacosamide 
with abbreviation of LCM is shown in Figure 2.1. To make a solution of this drug, 
artificial cerebrospinal fluid (ASCF) was prepared as media [2]. The preparation and 
dissolving of LCM in ACSF is explained in more detail in Chapter 3.   
 
 
Figure 2.1 The chemical structure of Lacosamide (LCM) molecule.  
 
2.3 Polymer Polymerisation 
 
Several different growth cells were used to synthesis PPy throughout this thesis and 
all are based on the standard 3 electrode cell design. Figure 2.2 shows a typical 3 
electrode polymerisation cell incorporating the working electrode (upon which PPy 
is deposited), counter electrode and the reference electrode. 
 
Figure 2.2 Three electrode cell used in the electropolymerisation of polypyrrole. The 
3 electrode cell comprises of a working electrode, Pt mesh as auxiliary electrode and 
the Ag/AgCl reference electrode. 
 
Reference electrode(Ag/AgCl)
Working electrode Counter electrode
Monomer solution
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The growth cells and procedures used to polymerise PPy on the Pt/PVDF membranes 
described in Chapters 3 and 4 are detailed in the respective chapters.  
 
All of the conducting polymer films were rinsed with excess amounts of Milli-Q 
water to remove oligomers, monomers and loosely bounded dopants. After that, 
these composite membranes were dried at room temperature.  
 
2.4 Characterization techniques 
2.4.1 Scanning electron microscopy (SEM) 
 
Scanning Electron Microscopy (SEM) images of conducting polymer film surfaces 
were taken using a field emission SEM (JOEL JSM-7500FA). Figure 2.3 presents an 
image of this instrument. For flat PPy coated platinized PVDF membranes, SEM 
images from the surface and cross section were taken. Scanning electron microscopy 
(SEM) was used to observe the cross-sectional morphology of the membranes. The 
conducting polymer coated membranes were freeze fractured to expose the cross-
section. Briefly, the membranes were immersed in liquid nitrogen and then cut using 
a sharp blade along their cross-sections. The membranes specimens were sputter 
coated with gold layer before observation using a field emission SEM (JOEL JSM-
7500FA). X1,000, X6,000, X20,000 and X75,000 were used as magnification and 
also 5.0, 10 and 15 KV energy were utilized. The working condition of every SEM 
images have been taken is indicated inside of every images.  
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Figure 2.3 Scanning Electron Microscopy (SEM) instrument; (a) sample holder, (b) 
electron transmitter beam, (c) controller key pad, (d) accompanied PC which 
provides appropriate software. 
 
2.4.2 Cyclic voltammetry 
 
Cyclic voltammetry (CV) was used to investigate the electrochemical properties of 
the conducting polymer films which were grown on the surface of Pt/PVDF 
membranes. A three electrode electrochemical set up was used that contained a 
platinum mesh counter electrode, a Ag/AgCl reference electrode, and the conducting 
polymer films on the surface of platinized PVDF membranes as the working 
electrode. ACSF was utilized as the electrolyte and five cyclic voltammograms 
(CVs) were measured using an eDAQ e-recorder (v5.5.11) and potentiostat shown in 
Figure 2.4.  
 
 
 
72 
 
 
Figure 2.4 An eDAQ system; (a) electrode leads, (b) potentiostat box, (c) PC 
provides the required software. 
 
When an applied potential is swept between an upper and lower potential at a 
constant rate, the generated current can be measured. This technique is called cyclic 
voltammetry (CV). Some other techniques including staircase voltammetry (SV) and 
differential pulse voltammetry (DPV) can be used to investigate the electrochemical 
experiment[2, 3]. However, CV is most extensively used. CV can provide some 
useful data such as number of oxidation states and the reversibility of them. This 
technique has been widely utilized to study the electroactivity of conducting 
polymers. 
 
A rectangular generated current is observed for a non-faradaic experiment. Non-
faradaic experiment happens when no electrode neither solution is associated with 
redox active species.  For this experiment the CV curve shows sharp charging and 
discharging behaviour which is demonstrated in Figure 2.5. In Figure 2.5 arrows 
indicate the scan directions.  
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Figure 2.5  typical cyclic voltammograms of a non-faradaic response[4]. 
 
Figure 2.6 presents the typical CV of Fe(CN)6. The redox reaction of this reagent is 
shown in the following equation[5]; 
 
Fe(CN)63- +e-          Fe(CN)64-                                                                                 (2.1) 
 
At point 1 in Figure 2.6 the initial applying potential is more negative than the 
required potential for the oxidation reaction to occur. By scanning the potential in the 
positive potential direction oxidation of the Fe(CN)6 redox pieces in solution occurs 
at the electrode surface (point 3).. As the oxidising species becomes depleted at the 
electrode surface the oxidation current decrease as the potentials is continued to be 
scanned positively. The scan process is reversed at point 4and at a specific potential 
the oxidised redox species in the vicinity of the electrode surface is reduced and as 
the reducing species is depleted the current decreases.  
 
 
For a completely reversible system which is shown in equation (2.1) the CV 
possesses identical oxidation and reduction peaks characteristics (i.e., amount of 
charge passed). Therefore, the ratio of reduction to oxidation (i/i’) peak current is 1 
for fully electrokinetically reversible redox reaction. In this case the difference 
between reduction potential (Ep) and oxidation potential (Ep’) which is indicated by 
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∆E in Figure 2.6 is 59.2 mV/n at room temperature. n is the number of transferred 
electrons in the redox reaction.    
 
 
Figure 2.6 Typical cyclic voltammograms of a completely reversible redox reaction; 
Ep represents the reduction potential and i is the created current at this potential. Ep’ 
is the oxidation potential and i’ presents the created current through the oxidation 
process [5].  
 
The capacitive behaviour of electrode can affect the CV[6]. The following equation 
presents the capacitive charging current; 
 
ic = dQc/dt = Cdl dE/dt = CdlV                                                                              (2.2)  
Where ic is the capacitive charging current, Qc presents the amount of dielectric 
charge, the capacitance of double layer is Cdl, dE/dt (V) indicates the applied 
potential scan rate. Cdl can be change throughout the experiment. Therefore, ic is not 
constant.   
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2.4.3 Goniometry  
 
Measurement of solid-liquid (γsl) interfacial tensions is the consideration of a wide 
variety of issues in applied science[7]. Direct measurement of surface tension 
accompanied with some difficulties. Therefore, some indirect approaches have been 
utilized to estimate the tension between the liquid and solid phase [8-16]. Among all 
of the techniques, measurement of contact angle seems to be the simplest one.  
The base of this method is measurement of the angle of a liquid droplet with a solid 
surface. In 1805 Yong[17] recognized a relation which makes it possible to estimate 
the estimating the solid surface tension from contact angle. 
 
The mechanical equilibrium of the droplet with three interfacial tensions is the base 
of contact angle measurement. These three tensions are solid-vapour, γsv, solid-
liquid, γsl, and liquid-vapour, γlv tensions.  Figure 2.7 exhibits the schematic of a 
droplet contact angle.  
 
 
Figure 2.7 Droplet contact angle schematic; γsv is solid-vapour, γsl is solid-liquid, 
and, γlv is liquid-vapour tensions. θ presents the Yung contact angle.  
The following equation is known as Young’s equation and presents the equilibrium 
relation between three interfacial tensions; 
 
γlvcosθY = γsv - γsl                                                                                              (2.3) 
 
where θY presents the Yung contact angle. 
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A Dataphysics optical contact angle goniometer was used to measure the mean static 
contact angle of the conducting polymer films. The volume of deionised water 
droplets of 1 µl for each reported value. Figure 2.8 (a) exhibits a schematic of contact 
angle.  
 
 
Figure 2.8 (a) schematic of measured angle of droplet on the OCP surface; (a’) 
Dataphysics optical contact angle goniometer; (a) camera, (b) sample holder, (c) 
syringe, (d) PC provides the required software. 
 
Figure 2.8 (a’) shows the Dataphysics optical contact angle goniometer which has 
been used in thesis. Measuring the contact angles reveals any differences in 
wettability of the surface of OCPs.  
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2.5 High Pressure Liquid Chromatography (HPLC)  
 
Chromatography is one of the most common methods which can be used in chemical 
analysis whereby different components of a mixture separate and the quantitative 
values of each component can be determined. The basis of separation is the 
variation in movement of each component through a column.  HPLC relies on the 
pressure of mechanical pumps on a liquid solvent to carry a sample mixture into a 
column where separation occurs. A HPLC separation column is filled with solid 
particles such as silica, polymers, or sorbents. The sample mixture is separated into 
compounds as it interacts with the column particles. HPLC separation is influenced 
by the liquid solvent’s condition like pressure and temperature and also chemical 
interactions between the sample mixture and the liquid solvent. Chemical 
interactions between the sample mixture and the solid particles packed inside of the 
separation column are the main reason of component separation.  The chemical 
interaction occurs because of differences between the molecule polarity or affinity 
and ion exchange. Every HPLC instrument needs a digital microprocessor for 
controlling the HPLC components and user software. Figure 2.9 shows the Agilent 
HPLC system which has been used in this thesis. The concentration of transported 
and released lacosamide across the conducting polymer coated flat PVDF 
membranes and also PVDF tubes were measured using HPLC.  
The mobile phase consisted of 65% distilled water, 26.2% acenotirile and 8.8% 
methanol. A C18 column was used as separation column with the flow rate of 
mobile phase set at 0.8 ml/min and detection wavelength was 210 nm.  
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Figure 2.9 HPLC instrument; (a) Pump, (b) UV-VIS detector, (c) auto sampler, (d) 
column and (e) PC. 
 
2.6 Quartz Crystal Microbalance (QCM) 
 
The signal transition in quartz crystal microbalance (QCM) works on the basis of 
piezoelectric effect of a quartz crustal[18]. In 1880 the Curie brothers discovered the 
piezoelectric effect in quartz crystal via application of pressure on quartz[19]. Later 
Lord Rayleigh utilized the changes of the vibrating crystal inertia to shift the 
frequency (ƒ) of its resonant[20]. Subsequently, some researches have been 
developed an appropriate stability of crystal while applying electric resonators[21] 
and also the stability of AT-cut crystals at room temperature[22]. Mostly for QCM 
applications, the thickness of quartz crystal is a few tenths of mm and cut with AT 
form by 35º 10´ angle with the Z-axis. With this geometry a stable oscillation 
without any frequency vibration at room temperature is provided. picture schematic 
of AT-cut quartz crystal is presented in Figure 2.10[23-25]. 
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Figure 2.10 At-cut quartz crystal which is used to produce metal coated QCM 
sensor[18]. 
 
The QCM technique is an efficient and economical technique capable of sensing 
mass change at interface with very high resolution. QCM has sensitive solution-
surface measurement ability suitable for analytical chemistry and electrochemistry 
applications. The detection range of this technique is much extended.  For instance, a 
monolayer surface coverage which has been generated by very small molecules such 
as drug molecules or polymer films can be detectable using QCM instrument. 
Bounding of much bigger molecules such as protein molecules or biopolymers to the 
surface is also detectable by this technique.  Furthermore, the energy dissipation 
properties of the adlayer are available using QCM. One of the special and unique 
characteristics of the QCM technique is the capability of mass measurement while 
conducting electrochemistry on the solution or upon the QCM crystal adlayer. These 
capabilities provide the feasibility of electropolymerization of an electroactive film 
or can enable ion or solute exchange between the adlayer and environment as a result 
of electrical stimulation which can be driven by the underlying surface potential. 
In-situ polymerisation of conducting polymer films using the Q-Sense 
electrochemical cell provides physical and mechanical properties analyses by using 
QCM-D measurement parameters. Absorption of a material to the surface of the 
sensor electrode leads to a decrease in the sensor oscillating frequency. Where a pure 
elastic mass added to the surface, an explicit linear equation which known as 
Sauerbrey equation is utilized to accurately quantify the mass of added layer to the 
surface with ng sensitivity[26].  
 
∆ ƒ= -2∆ ƒ2/A(µρq)0.5= -Cf∆m                                                                               (2.4) 
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Where ∆ ƒ indicates the decrease in resonant frequency (Hz), ƒ is the inherent 
frequency of quartz crystal, ∆m shows the changes in elastic mass (g), A suggests the 
electrode area which equals to 0.196 cm2 in many applications, ρq demonstrate the 
quartz crystal density (i.e. 2.65 g cm-3), and finally µ represents the shear modulus 
which equals to 2.95 × 1011 dyn cm-2. Putting all of these values results is Cf which is 
the integrated QCM sensitivity to have a value of 0.903 Hz/ng by having a ~ 9 MHz 
frequency of crystal. Therefore, QCM has a mass sensitivity which is 1000 times 
greater than an electronic mass balance. The electronic mass balance sensitivity is 
0.1 µg. According to this unique mass sensitivity of QCM it can be called as a nano-
balance. The Sauerbrey equation is just applicable for small molecules which form 
an elastic adlayer at the interface. Larger molecules generate a soft and viscoelastic 
adlayer with the mass which is more than 2% greater than quartz crystal mass. In 
these cases the Sauerbrey equation is not accurate. In this case more complicate 
models are required to calculate the amount of absorbed mass on the sensor surface. 
The first use of QCM as a sensing mode was in 1959 when a linear relationship 
between ƒ changes of oscillating quartz crystal and the mass of deposited metal was 
reported by Sauerbrey[26]. The mass binding of a gas to the surface of quartz crystal 
was the very early application of QCM for chemical analyses. For instance, this 
technique was utilized to study chemical sensors for moisture and volatile organic 
compounds [27, 28], environmentally pollutant reagents[29], and gas detectors[30]. 
An advanced QCM technique to measure frequency alterations of damping liquid 
media was developed in 1980s. In this case frequency changes were related to 
changes of viscosity and density of the liquid[31, 32]. 
 
Using QCM as a sensor for liquid phase measurements is not as simple as its other 
applications, such utilizing QCM as a gas phase sensor.  However, utilizing QCM 
technique for this application provides important data regarding interactions and 
reactions which may occur at the liquid-solid interface. Despite its difficulties 
researchers have used the QCM technique to study depositing polymeric films; 
electrochemically generating polymeric films; creating biomacromolecular films 
incorporating protein molecules and nucleic acids as well as investigating biosensors 
including living cells[18, 33-43]. In all of these studies the adlayer does not behave 
as an elastic mass on the QCM sensor surface, therefore, as it has been mentioned 
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before, the Sauerbrey equation is not applicable.   The versatility of the QCM 
technique is demonstrated in Figure 2.11 where the QCM is used to study cell 
attachment by placing the QCM system in  a cell culture [44]. In this case, frequency 
(f) and yielding the motional resistance (R) at the interface of quartz crystal-solution 
were measured.  
 
Figure 2.11 Schematic of a QCM crystal for investigating of cell attachment to the 
surface of QCM gold coated crystal in a cell culture incubator[44].   
    
In developed and advanced QCM systems where samples are immersed in liquid the 
QCM system delivers the fluid to the QCM electrode surface via automated flow 
injection. This automated flow injection delivers very small volumes (i.e. L)  with 
constant flow rate to the QCM crystal surface with minimal effect on the QCM 
performance[45]. This capability has provided an opportunity for researchers to 
utilize the QCM technique to undertake the following biomedical studies: (a) 
generate and investigate biomimetic systems; (b) study a wide area of fundamental 
biochemical processes; (c) form biosensors by encapsulating of nucleic acids and 
proteins or even cells upon the quartz crystal surface or incorporated with a 
polymeric films which have been deposited on the QCM sensor; (d) study the 
interaction of drug molecules with the target surface for drug discovery 
applications[46-51]. 
 
QCM or quartz crystal microbalance technique has been utilized in this thesis to 
calculate the mass of absorbed lacosamide molecules to the surface of conducting 
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polymers. The Q-tools software package v.3.0.10.286 (Biolin Sci, AB) was utilized 
to apply Sauerbrey model to determine layer thickness of the conducting polymer 
and also absorbed mass layer. 
Frequency responses of quartz crystal can be because of one of these following 
reasons or a combination of them such as firm bounding of an elastic mass to the Q-
sense surface; or changing of viscosity-density of the aqueous solution and bounding 
mass in inelastic and dissipates the energy. 
 
The f decrease changes due to dried mass absorption will be used to calculate the 
amount of mass with the assumption of dried mass density is used to calculate film 
thickness. 
 
Interaction of an elastic mass with surface of oscillating quartz crystal leads to f 
decreasing changes and developed Sauerbrey model is utilized to calculate the 
amount of bounded mass to the surface which is the base of absorbed mass 
calculation in this thesis. The experimental protocol and detail of these experiments 
will be presented in chapter 5.  
 
2.7 Profilometry Topography 
 
Optical profilometry has been developed during last decades. This technique is 
utilized for surface roughness measurements. There are two types of profilometer; a 
stylus and laser type. Application of optical devices has some advantages such as, 
contact less scanning of the material which leads to avoiding any possible damage 
especially for the soft surface materials[52]. 
  
The surface roughness of the polymer films were examined by using a Veeko Wyko 
NT9100 optical profilometer (Figure 2.12). For each sample at least three 
measurements were carried out. To measure surface roughness of conducting 
polymer films Q-sense sensors were used since optical profilometer does not damage 
the quartz crystal.  
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Figure 2.12 (a) optical profilometer; (b) PC provides the Veeco’s Vision® analysis 
software. 
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3 DRUG TRANSPORT STUDIES THROUGH 
CONDUCTING POLYMER COATED PLATINIZED 
PVDF FLAT MEMBRANE  
 
3.1 Chapter aims 
 
In this chapter we investigated the transport of the anti-epilepsy drug, lacosamide 
through polyvinylidene fluoride (PVDF) membranes. The aim is to develop a system 
whereby the membrane acts as a “gate” to mediate the transport of drug upon the 
application of an appropriate electrical stimulation protocol. The membranes used in 
this study have been coated in platinum and subsequently coated electrochemically 
with the conducting polymer, PPy using a range of dopants.  
 
3.2 Introduction 
  
The OCP polypyrrole (PPy) is routinely used in controlled drug delivery [1] due to 
its ease of synthesis from aqueous solutions and demonstrated [2]. There have been 
many reports published detailing the use of organic conducting polymers (OCPs) as 
novel drug delivery devices [3-8]. It is the ability for the OCP to incorporate a drug 
during synthesis and undergo subsequent reduction-oxidation (RedOx) process that 
facilitates the use of OCPs as drug delivery devices. In addition to drug delivery this 
simple redox switching facilitate the use of OCPs in application in actuators [9-11], 
electrochromics [12] and micro fluidic devices [13]. 
 
Whilst OCPs have shown to be suitable materials for drug delivery they also suffer 
from some limitations such as; 
(i) inherently low drug loading levels,  
(ii) passive loss of loaded drug molecules by diffusion,  
(iii) poor control and unpredictability of the release kinetics and,  
(iv) incomplete delivery of all incorporated drug.  
Hence, One approach to overcome these limitation is by utilizing the OCP as a 
membrane in which drug can pass through from a drug loaded reservoir (Figure 3.1). 
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This membrane approach utilizes the OCP as a “gate” upon which drug can pass 
through. In this way the reservoir can be loaded with higher amounts of drug that can 
be otherwise be attained within the OCP film.  
 
 
Figure 3.1 Schematic of drug transport through an OCP coated membrane via 
electrical stimulation of OCP membrane surface 
  
Conducting polymer membranes have been reported previously [1, 2]. Most of these 
membranes were supported membranes due to the limited mechanical properties of 
the polymer. Burgmayer et al [1, 2] reported that the ionic resistance or ion 
permeability of a PPy membrane can be varied by changing the redox state of the 
membranes. The permeation rate through a PPy membrane in an oxidised state was 
found to be much higher than when in the reduced state. The use of OCP membranes 
to control the movement of a range of molecules has been reported previously [14-
16]. Whilst the use of a polypyrrole (PPy) coated membrane was used to 
electrochemically control the transport of metal ions. Fan et al [1] demonstrated the 
use of an OCP membrane (Polyaniline) as a drug delivery system. 
Electrical stimulation of 
OCP membrane
OCP membrane
Drug Loaded 
Reservoir
(i)
(ii)
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3.3 Experimental 
3.3.1  Materials 
 
Polypyrrole was purchased from Merck, purified by distillation, and stored at -18  ͦC. 
Parra toluene sulfonic acid sodium salt (pTS) was purchased from BOH Chem. 
Chondroitin 4-sulphate sodium salt form bovine trachea (CS) was purchased from 
Fluka. Poly (4-styrene sulfonic acid) sodium salt (PSS), dodecylbenzenesulfonic acid 
sodium salt (DBSA), dextran sulphate sodium salt (DS) and hyaluronic acid (HA) 
had been supplied by Aldrich chemistry. Lacosamide (LCM) with the generic name 
of Vimpat was provided form St. Vincent Hospital in Melbourne. Figure 3 shows the 
chemical structure of pTS, CS, PSS, DBSA, DS and HA dopants and also LCM 
molecules. 
 
 
Figure 3.2 Chemical structure of; (a) Parra toluene sulfonic acid sodium salt (pTS), 
(b) Chondroitin 4-sulphate sodium salt form bovine trachea (CS), (c) Poly (4-styrene 
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sulfonic acid) sodium salt (PSS), (d) Dodecylbenzenesulfonic acid sodium salt 
(DBSA), (e) dextran sulphate sodium salt(DS), (f) hyaluronic acid (HA) and (g) 
lacosamide (LCM) molecules. 
 
Artificial cerebrospinal fluid of the brain (ACSF) was prepared from two solutions 
with the proportion of 50:50 v/v; solution A was made from NaCl (8.66 g), KCl 
(0.224 g), CaCl2.2H2O (0.206 g), MgCl2.6H2O (0.163 g) which has been dissolved in 
500 ml pyrogen-free water. Solution B was made of Na2HPO4.7H2O (0.214 g), 
NaH2PO4.H2O (0.027 g) which has been dissolve in 500 ml pyrogen-free water. 
ACSF was stored at 4  ͦ C prior to use. All of the ingredients to make ACSF were 
purchased from BASF. 
 
Polyvinylidene fluoride (PVDF) flat membranes (type HVHP) were purchased from 
Millipore and utilized as substrate membranes. The nominal pores size of these 
membranes is 0.22 µm. The surface of these substrate PVDF membranes was coated 
with a layer of platinum (Pt) using Edwards sputter coater 302 Auto instrument with 
four different thickness of Pt layer. Sputtering coating has been carried out under 
2.5×10-3 Pa vacuum. Desired thickness of Pt layer was achieved through instrument 
set up with a sputtering power for Pt of 40 W.  
 
3.3.2   Electrochemical Polymerization of Polymer Films 
 
Polypyrrole coated platinised PVDF membranes (PPy/Pt/PVDF) were 
electrochemically synthesized. The electrochemical polymerisation of PPy composite 
membranes process was carried out using a cell which will be called the growth cell 
which was designed using the software Solidworks 2013 (X64)(Figure 3.3(E)) . 
Objet Connex 350 printer was utilized to fabricate this growth cell. Using 
photocurable Acralate Fullcure720 material supplied by Objet Pty. Ltd. Figure 3.3 
demonstrates the growth cell for electropolymerization of the conducting polymer on 
the surface of the Pt/PVDF membrane. Region (a) in Figure 3.3(A) shows the cell 
opening where the reference (Ag/AgCl) and auxiliary (Pt mesh) electrodes are 
placed. The volume of the growth cell is approximately 10 ml. A platinized PVDF 
membrane (the working electrode) is placed between the two parts of the cell which 
has been shown in figure 3.3 (C) and (D) (indicated by a red arrow). Then these two 
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parts of the cell which is presented in Figure 3.3 (B) are screwed together to form a 
sealed unit.  
 
 
Figure 3.3 (A) Picture of growth cell which has been used to prepare composite 
PPy/Pt/PVDF membranes. Region (a) shows where the reference and auxiliary 
electrodes go into the cell; and (b) indicates where a Pt/PVDF membrane is placed; 
(B) presents two parts of the cell and O ring washers; (C) is a picture of the cell from 
side view; and (D) is a top view of the cell; (E) Schematic of growth cell; (a) overall 
view and (b) cross section view. 
 
The dopants, current density and polymerisation time used to form the PPy polymers 
are presented in Table 3.1. 
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Table3.1 Electropolymerisation conditions used for form the PPy polymers on the 
Pt/PVDF membrane. The polymerisation area is defined by the O-ring of the growth 
cell (1.8 cm2) (Figure 3.3). 
Dopants Current 
Density 
(mA/cm2) 
Applied 
Currents (mA) 
Polymerisation 
time (min) 
pTS 0.5,1, 2, 3 0.9, 1.8, 3.6, 5.4 1, 1.5, 2, 5 and 
10 
CS 0.25 0.45 1.5 
DBSA 2 3.6 1.5 
PSS 1 1.8 6 
HA 0.25 0.45 12 
DS 0.5 0.9 15 
 
Each solution was deoxygenated with nitrogen gas bubbling for 10 min prior to 
commencing polymerisation. Conducting polymer films were grown galvanostaticly 
on the surface of Pt/PVDF membranes using an eDAQ e-corder 410 recorders and 
EA163 potentiostat which is connected to the growth cell. Three electrode growth 
cell set up and connection to the potentiostat have been shown in figure 3.4. During 
galvanostatic growth the voltage was recorded, which provides information on the 
oxidation voltage generated during conducting polymer growth. 
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Figure 3.4 Growth cell set up and connection to the potentiostat; (a) platinised 
surface of PVDF membrane as the working electrode, (b) platinum mesh as auxiliary 
electrode, (c) Ag/AgCl reference electrode all connecting to the (d) EA163 
potentiostat. 
  
Electropolymerisation experiments were carried out at room temperature. 
Subsequently, at the end of the electropolymerisation processes the conducting 
polymer coated Pt/PVDF membranes were removed from the growth cell and rinsed 
with distilled water and dried using a stream of nitrogen gas. These membranes were 
stored at room temperature and then used for drug transport studies.  
 
3.3.3   Polypyrrole coated PVDF membrane characterization 
3.3.3.1   Water flux measurements 
 
Water flux is the volume of water which passes through the PPy coated flat 
membrane per second and is measured in mL/sec. Water flux measurements provides 
information of the deposited coatings influence on the ability of a solution to transfer 
through the membrane. A very thick coating my decrease the porosity and hence 
decrease the ability of solution (in particular solution containing drug) to pass 
through the membrane. A Pt/PPy coating that does not impede flow but can be 
stimulated to control flow is ideal. For flat conducting polymer coated membranes 
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water flux was measured using the transport cell (Figure 3.5). However, in this 
experiment the reservoir side contained water and the receiving side was left empty. 
 
The PPy coated flat Pt/PVDF membrane was placed between the two halves of the 
transport cell. The feed side of the cell (Figure 3.5B-(b)) was filled with Milli-Q 
water with the transported water passing into the receiving side (Figure 3.5B-(c)) 
collected every min for 10 min with the volume plotted against time. The water flux 
measurement experiment was repeated 3 times for every sample. 
 
3.3.3.2   Cyclic voltammetry 
 
In order to investigate the electrochemical properties of the conducting polymer films 
grown on the surface of Pt/PVDF flat membranes, the PPy/Pt/membrane was placed 
in a three electrode electrochemical set up containing a platinum mesh counter 
electrode, Ag/AgCl reference electrode, with the conducting polymer films being the 
working electrode. ACSF was utilized as the electrolyte and five cyclic 
voltammograms (CVs) were measured using an eDAQ e-recorder (v5.5.11) and 
potentiostat shown in Figure 3.4. The potential ranges and voltage scanned rates of 
have been presented in the caption of every CVs. In all of the Figures showing the 
CVs it is the 5th CV of each PPy that is shown. 
In addition, to study the electroactivity of lacosamide, four solution of lacosamide in 
PBS with concentration of 12.5, 25, 50 and 100 µg/ml were prepared. Cyclic 
voltammograms of this solution in the presence of glassy carbon electrode (GCE) 
working electrode was then measured. Cyclic voltammograms were run from -600 
mV to +600 mV at a scan rate of 50mV/sec. 
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3.3.4  Anti-epilepsy drug transport through flat polypyrrole coated Pt/PVDF 
membrane  
3.3.4.1   Non-stimulated state 
 
The controlled transport of an anti-epilepsy drug across PPy coated Pt/PVDF flat 
membranes was carried out at non-stimulated state using a “transport cell” shown in 
Figure 3.5.   
 
 
Figure 3.5 (A) schematic of transport cell; (B) photo of transport cell; (a) is a place to 
put the polypyrrole coated Pt/PVDF membranes, (b) shows anti-epilepsy drug 
feeding side and (c) demonstrates the receiver side of transported anti-epilepsy drug; 
(C) cross-section view photo of transport cell. 
 
As Figure 3.5 exhibits a PPy coated Pt/PVDF flat membrane was placed in between 
of two parts of transport cell with the PPy coating facing the drug/ACSF reservoir 
side. The two parts of the cell are connected using 4 screws and O-rings to ensure a 
leak proof seal is formed. Section (b) of the cell shows the feed side of the transport 
cell which contains the drug/ACSF solution whilst section (c) is the receiving side 
and only contains ASCF. Samples were taken from the receiving side at set intervals 
to assess the transport properties of the PPy/PVDF membrane.  
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3.3.4.2   Stimulated state 
 
The same transport cell set up described above was used for studying the 
electrochemically controlled transport of lacosamide through the PPy/PVDF 
membrane. However, in these experiments the cell was connected to the 
electrochemical equipment described above and shown in Figure 3.6.  
 
 
Figure 3.6 Transport cell connection to an e-DAQ system for stimulation studies; (a) 
transport cell, (b) Pt/PVDF membrane as working electrode; (c) auxiliary electrode, 
(d) Ag/AgCl reference electrode (section 3.2.4.2). 
 
Controlled potential stimulation was employed to electrochemically control the 
transport of lacosamide through the PPy coated Pt/PVDF membranes. Three different 
oxidizing and reducing potentials were applied to the surface of the PPy coated 
Pt/PVDF flat membranes. The oxidizing and reducing potential were chosen from 
the cyclic voltammograms of PPy coated membranes.  Additional voltages were 
investigated ±100 mV about each oxidising and reducing voltage. The aim of this 
procedure was to achieve the fully oxidized and fully reduced states of conducting 
polymer layer which has been deposited on the surface of the membranes.  These 
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potentials were chosen from the cyclic voltammograms of these conducting polymer 
coated composite membranes.  
 
3.3.5 Scanning Electron Microscopy 
 
Scanning Electron Microscopy (SEM) images of conducting polymer film surfaces 
were taken using a field emission SEM (JOEL JSM-7500FA). SEM analysis was 
conducted using the SEM instrument described in Chapter 2. 
3.3.6 Transported anti-epilepsy drug concentration measurement using HPLC 
system 
 In this study Agilent HPLC instrument was utilized to measure the concentration of 
transported lacosamide molecules. In this HPLC instrument a C18 column T3, 5 
µm which is supplied by Atlantis columns utilized in conjunction with a UV/Vis 
detector to detect lacosamide from ACSF solution. Figure 3.7 presents a picture of 
Agilent HPLC instrument. This instrument includes;  
(a) solution pumps; 
(b) UV-VIS detector; 
(c) Auto sampler and; 
(d) Column 
This HPLC instrument is connected to a PC which provides Agilent Chemstation 
Rev.B.04.02 SPI software for the instrument. 
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Figure 3.7 HPLC instrument; (a) Pump, (b) UV-VIS detector, (c) auto sampler, (d) 
column and (e) PC. 
 
3.4   Results and Discussion 
3.4.1  Electroactivity 
3.4.1.1   Study the electroactivity of lacosamide molecules 
 
Since transport studies will be performed at an applied voltage (stimulated release in 
section 3.4.3.2 below) it is important to investigate if the drug lacosamide has any 
electroactivity. This will indicate if the lacosamide molecule is likely to be effected 
by the stimulating voltage. If the lacosamide molecules are electrically active, it can 
have significant influence on the concentration of transported dug molecules across 
the membrane. If lacosamide molecules carry positive or negative charge, applying 
positive or negative voltages can repulse or absorb these molecules to the surface of 
membranes. This absorption/repulsion can effect on the amount of transporting drug 
molecules across the membrane. 
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Figure 3.8 present the cyclic volammogram of lacosamide/PBS solution. This 
experiment has been carried out to study the electroactivity of lacosamide. The 5th 
CV of each concentration is shown Figure 3.8 with no redox peaks observed 
suggesting that the lacosamide molecule does not possess any electroactivity in the 
potential window investigated. The large current at voltages lower than -0.2V is due 
to the reduction of residual dissolved oxygen in the solution. 
 
 
Figure 3.8 Cyclic voltammograms of lacosamide (12.5, 25, 50 and 100 µg/ml) in 
PBS, scan rate = 50 mV/s. Arrows show the direction of the potential scan. 
 
3.4.2 Conducting polymer film characterization 
3.4.2.1   Polypyrrole coated Flat Pt/PVDF membrane 
 
Cyclic voltammetry was used to investigate the redox peaks of the conducting 
polymers deposited on the surface of flat Pt/PVDF membranes. Figure 3.9 (a) shows 
the 5th cycle of the CVs of PPy/pTS deposited on the Pt/PVDF with different 
electropolymerisation conditions (Table 3.1). This Figure reveals that longer 
electropolymerisation time led to a PPy/pTS film which has higher electrical 
capacitance. By increasing the electropolymerization time, the amount of charge 
passing was higher and leads to more polymer growth. The amount of charged 
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passed by applying 1 mA/cm2 for 1, 2, 5 and 10 min is 108, 216, 540 and 1080 mC 
respectively (surface area of growth region is 1.8 cm2). The area encompassed by CV 
curve represents the capacity of the conducting polymer.  
 
Similar to Figure 3.9 (a) the effect of applying longer electropolymerization time has 
been observed in Figure 3.9 (b). However, the current density is higher in Figure 3.9 
(b). Longer electropolymerisation time caused deposition of PPy/pTS film with a 
higher electrical capacity; however no clear redox peaks are seen in Figure 3.9 (b).  
The charge passed for growth for 1 mA/cm2 for 10 min is 1080 mC which is exactly 
the same as the amount of charge passed for 2mA/cm2 for 5 min. Therefore, the 
currents generated during the CVs of these PPy/pTS films are very similar as is 
expected. 
 
 
Figure 3.9 (a) Cyclic voltammograms of PPy/pTS which has been deposited on the 
surface of Pt/PVDF flat membrane with different electropolymerisation condition, 
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scan rate = 50 mV/s. The CV of PPy/pTS which is grown by applying 1 mA/cm2 for 
1 min is overlapped with the CV of Pt/PVDF; (b) Cyclic voltammograms of PPy/pTS 
which has been deposited on the surface of Pt/PVDF flat membrane with different 
electropolymerisation condition, scan rate = 50 mV/s.  
 
 
According to Figure 3.10 the highest electrical capacitance is seen for PPy/pTS 
which has been synthesized by applying 1 mA/cm2 for 10min (total charge passed is 
1080mC).  
 
 
Figure 3.10 Cyclic voltammograms of PPy/pTS which has been deposited on the 
surface of Pt/PVDF flat membrane with different electropolymerisation condition, 
scan rate = 50 mV/s. The electrolyte was ACSF. 
 
A board range of electropolymerisation conditions were investigated to synthesise 
PPy/pTS/Pt/PVDF as a means of optimizing the best growth cell (Figure 3.3) 
configuration and connection to the e-DAQ system (Figure 3.4). The grow cell was 
newly fabricated and PPy/pTS was chosen as the first dopant to initiate the 
preliminary experiments. Figure 3.11 shows the CV of PPy/DBSA/Pt/PVDF flat 
membrane which has been synthesized by applying 2mA/cm2 for 90 seconds. The 
PPy/DBSA polymer appears to be electroactive; however it is difficult to observe 
redox peaks of this conducting polymer.  
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Figure 3.11 Cyclic voltammograms of PPy/DBSA which has been deposited on the 
surface of Pt/PVDF flat membrane by applying 2mA/cm2 for 1.5 minute, scan rate is 
50mV/s. The electrolyte was ACSF. 
 
CVs of PPy/DS/Pt/PVDF flat membrane which has been synthesized by applying 
0.5mA/cm2 for 15 min. According to the redox switching property of PPy (Figure 
3.12) the oxidizing and reducing peak were seen in this CV at approximately +250 
mV and 0.0 mV respectively.  
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Figure 3.12 Cyclic voltammograms of PPy/DS which has been deposited on the 
surface of Pt/PVDF flat membrane by applying 0.5mA/cm2 for 15 min, scan rate is 
50mV/s. The electrolyte was ACSF. 
 
Figure 3.13 exhibits the cyclic voltammograms of PPy/HA conducting polymer 
which has been deposited on the surface of Pt/PVDF membrane by applying 
0.25mA/cm2 for 12 min. An oxidizing peak is seen around +450 mV. For reducing 
voltage around -500 mV a very small peak can be observed.   
 
 
Figure 3.13 Cyclic voltammograms of PPy/HA which has been deposited on the 
surface of Pt/PVDF flat membrane by applying 0.25mA/cm2 for 12 min, scan rate is 
50mV/s. The electrolyte was ACSF. 
 
-0.003
-0.002
-0.001
0
0.001
0.002
0.003
0.004
0.005
0.006
-1 -0.5 0 0.5 1
Cu
rre
nt (
A)
Potential (V)
Pt/PVDF
-0.002
-0.001
0
0.001
0.002
0.003
0.004
-1 -0.5 0 0.5 1
Cu
rre
nt (
A)
Potential (V)
Pt/PVDF
 
103 
 
Figure 3.14 is the cyclic voltammograms of the PPy/PSS/Pt/PVDF membrane. This 
conducting polymer was synthesized by applying 1 mA/cm2 for 6 min. According to 
Figure 3.14 two clear oxidizing and reducing peak are seen for this conducting 
polymer. 
 
 
Figure 3.14 Cyclic voltammograms of PPy/PSS which has been deposited on the 
surface of Pt/PVDF flat membrane by applying 1 mA/cm2 for 6 min, scan rate is 
50mV/s. 
 
The electropolymerisation conditions are different for each dopant. For instance, to 
fabricate PPy/PSS on the surface of Pt/PVDF membrane longer time than PPy/pTS 
was applied. By applying shorter electropolymerisation time the uniform PPy/PSS 
did not form on the surface of the membrane. In some cases because of the 
concentration of pyrrole or dopants or electropolymerisation condition, an additional 
oxidation wave can be seen in the CV [17]. According to the literature, if the 
concentration range of pyrrole monomer is 0.01-0.5 M, an additional oxidation wave 
occurs. By lower concentration of pyrrole, the higher switching potentials are 
required. Counterion movement to the polymer structure was completed at around 
+300 mV. In the reverse direction counterions (PSS-) began to move out from the 
polymer and this process was saturated at around -500 mV. 
 
Table 3.2 presents the summary of oxidizing and reducing peaks of conducting 
polymer coated Pt/PVDF membranes. 
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Table 3.2 Oxidizing/reducing peaks of composite membranes. 
Dopants Oxidizing peak 
(mV) 
Reducing peak 
(mV) 
Electrical 
capacitance 
(mF) 
DS +250 0.0 3.24 
HA +450 -500 0.34 
PSS +300 -500 0.81 
pTS +300 -400 0.23 
CS +400 -300 0.06 
  
3.4.2.2   Morphology 
3.4.2.2.1   Optimization of the sputter coated platinum layer on the surface of 
flat PVDF membrane 
 
SEM studies revealed that sputter coating of the membrane surfaces did not cover 
and block all of the pores on the surface even with 200 nm layer of Pt (figure 3.15 
(d)). Figure 3.15 exhibits that platinising with the lowest thickness to the highest had 
a minor effect on the microporous structure of the membrane. Figure 3.15 (a) has 
higher porous structure than figure 3.15(d). The thickness of Pt layer has been 
determined by instrumental setting. In order to confirm the visual observation made 
of the porosity from the SEMs water flux experiments were conducted.  
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Figure 3.15 SEM images of platinised PVDF flat membrane of nominal 0.22 µm 
pore size. Thickness of platinum layer is (a) 30 nm, (b) 75 nm, (c) 100 nm (d) 200 
nm. 
 
3.4.2.2.2   Study the effect of sputter coated platinum layer on the surface of flat 
PVDF membrane 
 
The water flux tests carried out on the flat PVDF membranes which have been 
sputter coated with different thickness of Pt layers. Thickness of platinum layer was 
30, 75, 100 and 200 nm. Figure 3.16 exhibits the water flux values for these Pt/PVDF 
flat membranes. 
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Figure 3.16 Water flux of sputter coated PVDF membranes with 30, 75, 100 and 200 
nm of Pt layer. Error bars represent 95% confidence.  
 
The largest water flux belongs to the 30 nm Pt layer coated Pt/PVDF flat membrane 
and followed by 75 nm Pt coated membrane. Water flux of 75 nm coated Pt/PVDF 
membrane is approximately 83.3% less than the water flux for 30 nm coated 
membrane. Therefore, utilizing thicker sputter coated layer of Pt would lead to have 
much less water flux. By moving from 75 nm coated Pt/PVDF membrane to 100 and 
200 nm sputter coated Pt layer on the surface of PVDF membrane, the value of water 
flux has reached the zero. In the other word, increasing the thickness of sputter 
coated layer of Pt to more than 75 nm has blocked some of the pores on the surface 
of flat PVDF membrane. For 100 and 200 nm sputter coated flat Pt/PVDF 
membrane, the structure of flat membrane is much less porous than the PVDF 
membrane which has been coated with 30 and 75 nm thickness of Pt. Hence, these 
membranes are not appropriate candidates to be utilized for drug transport study.  
 
3.4.2.2.3   Polypyrrole coated Flat Pt/PVDF membrane 
3.4.2.2.3.1   Thickness of Pt coating layer  
 
Figure 3.17 exhibits cross sectional SEM images of the polymer coated Pt/PVDF 
membrane with the coated Pt indicated by the shiny region.  The other bright line 
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which exists next to the resin side of the membrane is the gold coated layer. To make 
the polymer layer more distinguishable, a layer of gold with 18 nm thicknesses was 
sputter coated on the conducting polymer membrane. 
 
As a part of this study the thickness of Pt coated layer which has been deposited on 
the surface of PVDF membrane by using sputter coater machine, has been measured. 
This measurement was done for three different samples in three different areas and 
the average of these measurements is 79.15±0.62 nm.  To confirm the Pt and gold 
coated layers (for Figures 3.19) the backscattered mode imaging was used which 
highlights dense regions. In addition, EDS analysis was performed to confirm these 
two shiny regions are Pt and gold.  
    
 
Figure 3.17 Thickness of Pt layer in PPy/pTS/Pt/PVDF membrane 
 
3.4.2.2.3.2 Thickness of deposited polypyrrole layer 
 
SEM images of PPy coated Pt/PVDF membrane demonstrates formation of a typical 
nodular morphology of electropolymerized polypyrrole films [20, 21]. However, the 
surface of these polymers coated Pt/PVDF membranes still remained porous. SEM 
images in figure 3.18 shows the effect of increasing electropolymerisation time on 
the porosity of conducting polymer PPy/pTS coated Pt/PVDF membranes.  
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Figure 3.18 SEM images of PPy/pTS deposited on PVDF membrane grown at a 
current density of 1 mA/cm2 for (a) 5 min and (b) 10. 
 
Electropolymerisation for longer time (figure 3.18 (b)) leads to have a decrease in the 
porosity of the membrane. Porosity is an important factor as it will have an effect on 
the transport properties of the drug solution from one side of the composite 
membranes to the other. To gain a better understanding of the thickness of the 
deposited PPy layer on the surface of these platinized PVDF membranes, some cross 
sectional SEM images were obtained.  
 
The PPy was deposited on the surface of Pt/PVDF membranes. In the SEM images 
which are presented in figure 3.19, this conducting polymer layer is sandwiched 
between two bright lines. These bright lines are a gold coating layer deposited on the 
surface of the PPy and Pt from the PVDF coating process. The resin and membrane 
sides have been indicated in the Figure. The thickness of deposited polymer layer on 
the surface of Pt/PVDF membranes is quiet uniform for both 10 and 5 min polymer 
synthesis. The lack of any membrane porosity observed in Figure 3.19 is due to the 
epoxy (used for sample preparation) filing in those pores. 
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Figure 3.19 SEM images of the cross section of PPy/pTS (grown at 1 mA/cm2) 
coated Pt/PVDF membranes; (a) for 10 min and (b) after 5 min; the resin and 
membrane sides have been indicated in the SEM images. 
 
 
The thickness of PPy/pTS deposited layer on the surface of Pt/PVDF membrane was 
measured using a similar procedure for measurement of Pt layer thickness. Thickness 
measurements have been done in five different points of a sample. The measured 
values and average value are presented in Table 3.2. 
   
Table3.2 Measuring the thickness of polymer layer 
Electropolymerisation 
condition of PPy/pTS 
Point 1 
(nm) 
Point 2 
(nm) 
Point 3 
(nm) 
Point 4 
(nm) 
Point 5 
(nm) 
Average 
(nm) 
10 min at 1 mA/cm2 278.7  276.2  292.3  300.9  285.0  286.7 
5 min at  1 mA/cm2 141.8 198.7 141.2  145.0  183.7  162.1 
 
Results from the conducting polymer layer thickness measurements have revealed 
that the average PPy/pTS layer thickness increases with longer electropolymerisation 
time. The thickness of PPy/pTS layer which has been deposited for 10 min is roughly 
1.8 times thicker than the PPy/pTS layer that has been electropolymerized for 5 min. 
This result is not surprising since the thicker polymer had twice the amount of charge 
applied during growth. 
 
 
 
 
110 
 
3.4.2.2.3.3   Water flux of flat Pt/PVDF polypyrrole coated membrane 
 
The effect of PPy deposition and also the electropolymerisation condition on the 
amount of water flux of PPy/pTS/Pt/PVDF flat membrane was investigated. Figure 
3.20 shows the differences between water flux of plain PVDF, Pt/PVDF (75 nm), 
PPy/pTS coated (grown at 1 mA/cm2) Pt/PVDF by applying for 5 min and 10 min.  
 
 
 
Figure 3.20 Water flux of PVDF, Pt/PVDF, PPy/pTS/Pt/PVDF (5 min and 10 min at 
1mA/cm2); Error bars represents 95% accuracy confidence.  
 
Sputter coating of 75 nm Pt layer on the surface of PVDF membrane has decreased 
approximately 93.5% of the water flux of the plain flat PVDF membrane with 0.22 
µm pore size. Afterwards, the water flux of PPy/pTS/Pt/PVDF which have been 
electro synthesised for 5 min and 10 min by applying 1 mA/cm2 current density, was 
measured. According to Figure 3.20 deposition of PPy/pTS layer on the surface of 
Pt/PVDF membrane decreased the water flux to 61.5% (5 min growth) and 69.2% 
(10 min growth). Therefore, deposition of PPy/pTS layer significantly decreases the 
water flux values. Water flux of 10 min grown PPy/pTS grown membrane is 20% 
less than the water flux of 5 min grown membrane.   
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3.4.2.2.4   Porosity of conducting polymer coated flat Pt/PVDF membranes 
 
The effect of applying different current density on the porosity of membranes was 
investigated. Three different composite membranes have been fabricated with the 
same electropolymerisation time but different applied current densities. Figure 3.21 
exhibits the SEM images of these conducting polymer coated Pt/PVDF membranes. 
These three composite membranes have been fabricated by growing the PPy/pTS for 
10 min at 0.5 (a), 1 (b) and 2(c) mA/cm2 current density. 
 
Figure 3.21 SEM images of PPy/pTS grown on PVDF membrane for 10 min at (a) 
0.5mA/cm2, (b) 1 mA/cm2, and (c) 2mA/cm2. 
 
According to SEM images (Figure 3.21) the porosity of these composite membranes 
has decreased by moving from image (a) to (c). This indicates that by applying 
higher current density (i.e. 2mA/cm2) more PPy/pTS was deposition on the surface 
of Pt/PVDF membrane. As has been mentioned before, the degree of porosity will 
have an affective on the amount of drug that can be transported through these 
composite conducting polymer coated platinized PVDF membranes. 
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3.4.2.2.4.1   Effect of polypyrrole dopant on the porosity of flat membranes  
 
The SEMs presented in Figure 3.22 exhibit the effect of using different counterions 
during electropolymerisation of PPy on the surface morphology. Similar to the other 
SEM images which have been presented in Figures 3.18 and 3.21, formation of a 
typical nodular morphology is observed [20, 21]. According to Figure 3.22 (a) and 
3.15(b), after sputter coating of a 75 nm Pt layer on the surface of PVDF membrane, 
the surface has become less porous. The PVDF membrane which is the base of 
composite membrane has a porous structure and when it coated with Pt and 
conducting polymer the porous structure remains evident. The porosity is reduced as 
a result of Pt coating and also CP deposition which is discussed in the following 
section.  
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Figure 3.22 SEM images of the surface of PPy coated PVDF membranes; (a) is plain 
PVDF, (b) is PPy/pTS coated Pt/PVDF with 1 mA/cm2 for 1.5 min, (c) is PPy/DBSA 
coated Pt/PVDF with 2 mA/cm2 for 1.5 min, (d) is PPy/DS coated Pt/PVDF with 0.5 
mA/cm2 for 15 min, (e) is PPy/HA coated Pt/PVDF with 0.25 mA/cm2 for 12 min, 
(f) is PPy/PSS coated Pt/PVDF with 1 mA/cm2 for 1.5 min and (g) is PPy/CS coated 
Pt/PVDF with 0.25 mA/cm2 for 1.5 min. 
 
Upon visual inspection of the SEMs it appears that the porosity of PPy coated 
membranes varied from one counterion to the other. The electropolymerization 
condition for each membrane was different based on using deferent dopant to 
fabricate each of them. 
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The highest porosity belongs to PPy/pTS (figure 3.22 (c)) followed by PPy/CS 
(figure 3.22 (i)), PPy/DS (figure 3.22 (e)) and PPy/HA (figure 3.22 (f)). The porosity 
of PPy/DBSA (figure 3.22 (d)) and PPy/PSS (figure 3.22 (h)) is very much less than 
the other PPy coated membranes. Therefore, among all of these PPy coated Pt/PVDF 
membranes PPy/pTS, CS and DS seem to be the better choice to study drug 
molecules transport through a polymer coated membranes. These membranes still 
possess sufficient porosity after PPy deposition which may allow drug molecules to 
transport from one side of these membranes to the other side. 
 
To confirm the results from SEM images, water flux experiments (Figure 3.23) were 
conducted for all of conducting polymer coated Pt/PVDF membranes shown in 
Figure 3.22.  
 
 
Figure 3.23 Water flux of PPy/pTS, PPy/CS, PPy/DS, PPy/HA, PPy/DBSA and 
PPy/PSS conducting polymer films grown at same condition which has been 
presented in Figure 3.22. Error bars represents 95% accuracy confidence. 
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have had less porous structure according to the SEM images (Figure 3.22). For better 
understanding of the characteristics of deposited PPy layer on the surface of 
Pt/PVDF membranes, SEM images from the cross-section of these membranes have 
been taken which are presented in figure 3.24.  
 
 
Figure 3.24 SEM images of the cross section of; (a) PPy/pTS coated Pt/PVDF, (b) 
PPy/DBSA coated PVDF, (c) PPy/DS coated Pt/PVDF, (d) PPy/HA coated 
Pt/PVDF, (e) PPy/PSS coated Pt/PVDF and (f) PPy/CS coated Pt/PVDF membranes. 
The side which is indicated by number (1) is the resin side and number (2) side is the 
membrane side. 
 
The PPy layer is the area which has been encapsulated in between two shiny bright 
lines (as indicated by the arrows in Figure 3.24). The line which is in the resin side 
represents the gold coated layer and the other line which is in the membrane side is 
the Pt layer. For all PPy coated membranes, the polymer layer covered the surface 
uniformly. However, the thickness of this layer varied due to the different dopants 
used to form PPy. PPy/PSS exhibited the largest thickness at 1.7±0.37 µm followed 
by PPy/DBSA (1.38±0.2 µm), PPy/HA (0.46±0.11 µm), PPy/DS (0.24±0.05 µm), 
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PPy/CS (0.12±0.03 µm) and finally the thinnest layer was PPy/pTS (0.09±0.04 µm). 
This layer has been deposited on the surface of Pt/PVDF membrane by applying 1 
mA/cm2 for 90 seconds. The PPy/pTS layer possesses the thinnest layer and also 
exhibited the highest porosity (Figure 3.22) in addition the PPy/pTS coating 
demonstrated the highest water flux value (Figure 3.23).   
 
3.4.3   Lacosamide transport study through flat PPy coated Pt/PVDF membrane 
 
In this work an aqueous solution of lacosamide (0.1 mg/ml) prepared in ACSF is 
placed in the feed side of the transport cell (Figure 3.1), whilst on the other side 
(receiving side) there is ACSF only. The composite membrane is placed between the 
both sides. The transport of the lacosamide through the composite membrane, from 
the feed side to the receiving side, is monitored over a 10 min period with samples 
taken from the receiving side at 1 min intervals. A transport time of 10 min was 
chosen due to the final application of these composite membranes. The in vivo 
application of these membranes to deliver therapeutic level of anti-epilepsy drug to 
the brain was the clue of choosing drug transport studies time intervals. In his study 
the rapid release of drug after detection of pre seizure brain activity is important. 
Therefore, we limited the stimulated and non-stimulated transport studies only on the 
first min and continue that just only for10 min. The longer time than 10 min was not 
the concern and main goal of this project. 
Analysis of lacosamide in the samples taken from the receiving side was performed 
using HPLC and the UV-vis detector. It is not possible to just use UV-vis as a 
detection system for lacosamide due to interferences at the wavelength of lacosamide 
detection coming from the transport media (ACSF). The HPLC separate the 
lacosamide from the interfering species in the ACSF. The HPLC procedure for 
detection of lacosamide involves the use of a mobile phase consisting of Milli-Q 
water, acetonitrile and methanol (65: 26.2: 8.8, v/v/v) that was filtered and degassed. 
Separation was carried out isocratically at ambient temperature using a flow rate of 
0.8 ml/min. Detection was achieved with UV-vis detection set to the wavelength of 
lacosamide adsorption of 205 nm. Figure 3.25 exhibits the calibration curve 
constructed for the lacosamide.  
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Figure 3.25 Lacosamide calibration curve 
 
3.4.3.1  Non-stimulated state 
 
In the non-stimulated state no external voltage is applied to the membrane with the 
transport properties determined purling on the characteristics of the PPy coated 
composite membrane. According to the fabrication and characterisation of composite 
membrane, PPy/pTS, PPy/PSS and PPy/CS were chosen to be utilized for drug 
transport studies. These four conducting polymers exhibited more suitable electrical 
activity and redox properties on the base of their cyclic voltammograms.    Figure 
3.26 presents the concentration of transported lacosamide molecules through 
composite membranes at non-stimulated state. PPy/CS shows the maximum 
concentration of transported drug after 10 min (22.7 µg/ml) followed by PPy/pTS 
(3.9 µg/ml). PPy/PSS does not shows any drug transport at non-stimulated state 
which confirms the porosity of PPy/PSS composite membrane completely impedes 
the transport. According to the water flus result (Figure 3.23) the minimum amount 
of water transported through PPy/PSS coated Pt/PVDF membrane.   
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Figure 3.26 Concentration of lacosamide transported through PPy/pTS (1 mA/cm2, 
1.5 min), PPy/PSS (1 mA/cm2, 1.5 min) and PPy/CS (0.25mA/cm2, 1.5 min) coated 
flat membrane under non stimulated state for 10 min.  
 
3.4.3.2   Stimulated state 
 
In the stimulated state a voltage is applied to the membrane which causes charge to 
flow through the conducting polymer coated membrane. Hence, an electric filed 
begins to establish within the membrane pores[22]. Electromechanical materials such 
as conducting polymers are capable of changing their dimensions physically when an 
external electrical signal is applying through them.   Upon the application of a 
sweeping voltage to the PPy ions move into and out of the polymer main structure 
during redox[23]. Because of this phenomenon, the volume of conducting polymer 
can change by more than 10% and also an approximate 30% change in length and 
thickness have been reported recently[24-26]. Changing in the dimension of 
deposited conducting polymer on the surface of Pt/PVDF membrane as a result of 
redox switching caused a dimension changing of this porous structure. In the other 
word, applying and external voltage causes redox switching which can lead to 
change in the dimension of pores on the surface of conducting polymer coated 
Pt/PVDF membranes. Applying an external voltage can influence the surface pore to 
change dimension which is the one of the basis for drug transport studies at the 
stimulated states in this system. All of stimulated drug release figures (Figures 3.27-
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3.34) includes a passive (non-stimulated) release curve of lacosamide to compare the 
release profile between stimulated and non-stimulated states easier. 
3.4.3.2.1   Oxidized state 
  
To study the transport of lacosamide molecules across PPy coated Pt/PVDF 
membrane at oxidized states, an oxidizing potential of each PPy film was chosen 
based on the redox peaks in their respective cyclic voltammograms. To study drug 
transport through conducting polymer coated Pt/PVDF membrane for each PPy film, 
three oxidizing potential were applied to the surface of deposited PPy. One of these 
three oxidizing potentials was chosen based on oxidation potential observed from the 
CV whilst the other two represent ±100mV about the oxidation voltage.  
 
Figure 3.27 shows the concentration of transported lacosamide through PPy/pTS 
membrane while applying three different oxidizing potentials. +300 mV is the 
oxidising potential which was chosen from the cyclic voltammograms of PPy/pTS (1 
mA/cm2, 90 sec) film (Figure 3.10). The oxidized state of PPy/pTS is accompanied 
by pTS movement and absorption from the solution to the polymer structure [27-30]. 
Therefore, the structure of conducting polymer expands and swells. The surface 
pores of PPy/pTS membrane are more closed at this state. However, the diffusion 
mechanism across the PPy/pTS membrane caused transport of some lacosamide 
molecules. Figure 3.27 also demonstrates the effects of applying potentials 100 mV 
either side of the oxidation potential. The transport values vary depending on the 
voltage applied. Therefore, under different electrical stimulation the transport 
properties vary. This variation can be the result of several things combined such as 
porosity, electrostatic attraction/repulsion. The minimum transported concentration 
belongs to +200 mV. Therefore, the porosity of PPy/pTS membrane was at the 
minimum state while applying +200 mV. Drug transported concentration for +300 
mV and +400 mV is roughly the same. At +300mV the PPy/pTS is oxidized and at 
+400mV it is still fully oxidized, so it would not expect to see a significant difference 
between 300 and 400. However, at 200mV the PPy/pTS is not fully oxidized.  
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Figure 3.27 Concentration of transported lacosamide through PPy/pTS (90 sec, 1 
mA/cm2) coated flat membrane while applying three oxidized potential for 10 min.   
 
  Figure 3.28 presents the concentration of transported lacosamide through 
PPy/CS/Pt/PVDF flat membrane after 10 min. Samples were collected every minute. 
+300 mV was picked up from PPy/CS film CV as an oxidizing potential. Figure 3.28 
shows that the minimum transport concentration belongs to +400 mV potential 
which means the PPy/CS/Pt/PVDF flat membrane structure is less porous at this 
state. The concentration of transported lacosamide for +300 mV and +200 mV is 
approximately the same. Therefore, for PPy/CS film applying the highest oxidizing 
potential leaded to have more effect on the movement of CS counterions from the 
solution to the main structure of pyrrole. 
 
Drug transport study at oxidized state was carried out for PPy/PSS/Pt/PVDF flat 
membrane as well as the other conducting polymer coated flat membranes. -350 mV 
was the oxidising potential of the PPy/PSS film according to its CVs. -250, -350 and  
-450 mV were applied to the surface of PPy/PSS/Pt/PVDF film to study transport of 
lacosamide across this conducting polymer coated flat membrane. For all of these 
oxidizing potentials the concentration of transported lacosamide through the 
membrane was zero. In the other word, the structure of PPy/PSS/Pt/PVDF membrane 
while applying all of the oxidizing potentials was non-porous.  
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Figure 3.28 Concentration of transported lacosamide through PPy/CS/Pt/PVDF 
coated flat membrane while applying three oxidized potential for 10 min. 
 
3.4.3.2.2   Reduced state 
 
Similar to the oxidized state, the concentration of transported lacosamide through 
conducting polymer coated Pt/PVDF flat membrane was investigated at reduced 
state. Three different reducing voltages were applied to the surface of PPy coated 
Pt/PVDF membranes. One of these reducing potentials was chosen according to the 
cyclic voltammograms of conducting polymer films and two other potentials were 
that chosen potentials which has been pulsed and subtracted by 100 mV. At reducing 
state, counterion leaves the polymer structure and move to the solution [27-30]. 
Hence, the structure of conducting polymer and also the membrane become more 
contracted. The contraction of PPy coated Pt/PVDF membrane makes the surface 
pores of the membrane more open. In the other word, porosity of membranes at 
reducing state is higher than oxidizing and also passive states. Therefore, the 
concentration of transported drug at this state supposed to be higher.  
Figure 3.29 exhibits the concentration of transported lacosamide through 
PPy/pTS/Pt/PVDF membrane after 10 min while applying three reducing potentials. 
-400 mV was the voltage that reduction peak has happened in the PPy/pTS cyclic 
voltammograms. However, the maximum transport concentration was observed by 
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applying -300 mV which means at this state the porosity of PPy/pTS/Pt/PVDF flat 
membrane is the highest. 
 
 
 
 
Figure 3.29 Concentration of transported lacosamide through PPy/pTS/Pt/PVDF (90 
sec, 1 mA/cm2) coated flat membrane while applying three reducing potential for 10 
min. 
 
 
Figure 3.30 shows the concentration of transported lacosamide through 
PPy/PSS/Pt/PVDF membrane by applying -400, -500 and -600 mV. -500 mV was 
peaked up according to the cyclic voltammograms of PPy/PSS film and the 
maximum transport of lacosamide is seen by applying this potential. Applying -400 
mV shows any detectable transport of lacosamide molecules and the concentration of 
transported drug by applying -600 mV is lower than drug concentration at -500 mV. 
Hence, the porosity of PPy/PSS/Pt/PVDF membrane by applying -500 mV is at the 
highest state.  
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Figure 3.30 Concentration of transported lacosamide through PPy/PSS/Pt/PVDF (90 
sec, 1 mA/cm2) coated flat membrane while applying three reducing potential for 10 
min. 
 
Concentration of transported lacosamide through PPy/CS/Pt/PVDF membrane is 
presented in figure 3.32. -200, -300 and -400 mV was applied to the surface of the 
membrane. -300 mV was chosen as a reducing potential according to the cyclic 
voltammograms of PPy/CS film. However, the highest transport concentration of 
lacosamide molecules was observed by applying -400 mV and then followed by -300 
mV and -200 mV. Therefore, the porosity of PPy/CS/Pt/PVDF membrane, while 
applying -400 mV is much higher than the porosity of this composite membrane at 
the other reducing states.  
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Figure 3.31 Concentration of transported lacosamide through PPy/CS/Pt/PVDF (90 
sec, 1 mA/cm2) coated flat membrane while applying three reducing potential for 10 
min. 
 
 
Figure 3.32 shows the comparison between concentrations of transported lacosamide 
across PPy/pTS/Pt/PVDF membrane at fully reduced and fully oxidized states. As it 
has been explained before, the porosity of conducting polymer coated Pt/PVDF 
membrane is at the higher state while applying oxidizing potential. In comparison, 
the porosity of the composite membrane is at the lowest state by applying educing 
potential to the surface of composite membrane. Hence, the concentration of 
transported lacosamide across this composite membrane is higher at the fully 
oxidized state and lower at the reduced state. 
 
For PPy/pTS/Pt/PVDF membrane concentration of transported lacosamide molecules 
across the composite membrane at fully reduced state by applying -300 mV is 
41.25±0.35 µg/ml. the concentration of transported drug at fully oxidized state is 
22.30±0.12 µg/ml. Results reveals that the amount of transported drug molecules at 
fully reduced state is roughly 1.85 times higher than fully oxidized state. The surface 
pores of PPy/pTS/Pt/PVDF flat membrane at reduced state are 2 times more open 
than these pores at oxidized state. Hence, PPy/pTS responds sufficiently to an 
external stimulation and applying an external voltage to the surface of this 
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conducting polymer leaded to significant dimensional changes in the porous structure 
of flat composite membrane.   
 
 
Figure 3.32 Comparison between concentrations of transported lacosamide through 
PPy/pTS/Pt/PVDF (90 sec, 1 mA/cm2) flat membrane at fully reduced and fully 
oxidized states. 
 
Figure 3.33 exhibits the results of the comparison between concentrations of 
transported lacosamide molecules at fully reduced and fully oxidized states for 
PPy/PSS/Pt/PVDF flat membrane. For this conducting polymer coated membrane, at 
fully oxidized state (i.e. -350 mV) any drug molecules transported from the feed side 
to the receiver side. This means at this state, this composite membrane does not have 
any porous structure. At reduced state by applying -500 mV the surface pores has 
become open gradually during 10 min time. At the end of the experiment 
concentration of transported drug molecules to the receiver side was 10.05±0.65 
µg/ml. The difference between the concentration of transported drug for this 
conducting polymer at fully reduced and fully oxidized states is very obvious. By 
changing between fully oxidized states to the fully reduced state, the non-porous 
structure of PPy/PSS/Pt/PVDF turned to a porous structure.  
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Figure 3.33 Comparison between concentrations of transported lacosamide through 
PPy/PSS/Pt/PVDF (90 sec, 1 mA/cm2) flat membrane at fully reduced and fully 
oxidized states. 
 
Figure 3.34 presents the difference between concentrations of transported lacosamide 
at full reduced and fully oxidized states across PPy/CS/Pt/PVDF flat membranes. 
Applying -400 mV to the fully reduce PPy/CS conducting polymer leaded to 
transport of 83.16±0.85 µg/ml. At oxidized state by applying +400 mV 35.35±54 
µg/ml drug transported from the feed side to the receiver side. Final concentration of 
transported lacosamide at fully reduced state is roughly 2.34 times higher than the 
concentration of transported drug at fully oxidized state. Concentration differences 
between fully oxidized and fully reduced state for PPy/CS/Pt/PVDF membrane is 
highest one among all of the conducting polymer coated Pt/PVDF membranes.  
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Figure 3.34 Comparison between concentrations of transported lacosamide through 
PPy/CS/Pt/PVDF (90 sec, 1 mA/cm2) flat membrane at fully reduced and fully 
oxidized states. 
 
 
Considering all of the drug rlease figures, the maximum level of lacosamide release 
is 83.16±5.4 µg/ml which occured when the PPy/CS/Pt/PVDF membrane was 
stimulating under the reducing voltage (-400 mV). Also for both fully oxidized (-350 
mV) and passive state of PPy/PSS/Pt/PVDF membrane no release was observed. 
According to the literature [34,35], the recommended effective dosage of lacosamide 
is 200-400 mg/day with this dosage being able to reduce 38-41% seizure frequency 
in adluts. The comparison of highest release concentration through composite 
membranes and the approved effective dosage shows a huge difference. However, 
the point is the release concentration from composite memebrane occured in just 10 
mintues of stimulation, and more importantly this amount of drug will be introduced 
directly into the brain tissue. However, the effective dosage which is suggested in 
literature is the concentration of drug in blood stream and there is no study no show 
how much of drug molecues in the blod stream can pass the blood rain barrier and 
affect the brain tissue. Therefore, making an accurate comparison about the 
effectiveness of the concentration of released drug from composite flat memebranes 
is very difficult.   
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3.5 Conclusion 
 
In this chapter the fabrication of conducting polymer coated Pt/PVDF flat membrane 
has been presented. These membranes played the role of a gating system to study 
transport of an anti-epilepsy drug from reservoir side to the receiver side.  
Different characterization methods were utilized to find the optimize condition to 
fabricate these membranes. As a result of characterization experiments PPy/pTS, 
PPy/CS and PPy/PSS were chosen to be used for drug transport studies. The 
electrical activity of lacosamide molecules was examined and revealed that this drug 
molecule does not have electrical activity. 
Non-stimulated drug transport study showed that PPy/CS coated membrane has the 
maximum and PPy/PSS coated membrane has the minimum amount of passive 
transport.   
By applying constant oxidizing or reducing voltages for all of the composite 
membranes, it has revealed that transport of lacosamide molecules at reduced state is 
higher than oxidized state. Among all of the conducting polymers PPy/CS showed 
the maximum amount of transport drug at stimulated state and then followed by 
PPy/pTS and PPy/PSS. 
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4 DRUG TRANSPORT STUDIES THROUGH 
CONDUCTING POLYMER COATED PLATINIZED 
TUBE MEMBRANES  
4.1 Chapter aims 
 
Release of lacosamide from the inside of a PVDF tube membrane has been 
investigated in this chapter. The outer surface of these tube membranes were coated 
with a Pt layer followed by polymerisation of a layer of polypyrrole using a range of 
dopants. These tube membranes act as a drug reservoir and a gating system 
simultaneously. Different characteristics of these tube membranes were investigated 
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as well as their transport properties under non-stimulated, stimulated (constant and 
pulsed potential) states.  
 
4.2 Introduction 
 
Utilizing nanofibers for drug delivery applications is based on their unique 
functionality such as using both biodegradable and non-degradable material, 
possibility to deliver a wide range of therapeutic agents and applying different 
technique for drug loading. These drug loading techniques include coating, 
embedding, and also encapsulating of drug or the other therapeutic agents. A more 
controllable drug release kinetics can be achieved by these techniques[1] with hollow 
nanofiber structures providing a promising opportunity to encapsulate target drug 
molecules[2]. Figure 4.1 show transmission electron microscopy (TEM) images from 
the surface and cross section of PCL nanofibers. These hollow/nano tube membranes 
were prepared by coaxial electrospinning technique. The inset SEM images clearly 
show the hollow structure of this tube membrane. This tube membrane was utilized 
to release BSA protein[2].   
 
 
 
Figure 4.1 TEM images of hollow tube membrane structure composed of PCL. The 
core is BSA-loaded PEG. The inset in picture c shows the cross section of this tube 
membrane. Scale bars represent 500 nm[2].  
 
Therefore, high drug loading concentration and also loading of insoluble and 
intractable drugs are possible. Some therapeutic agents such as antibiotics[3], anti-
cancer drugs[4], polysaccharides[5], proteins[6], and growth factors[7] have been 
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incorporated into nanofiber tube membranes, produced by electrospinning process. 
These nanofibers have the potential to be used in different biological applications 
including scaffolds for tissue engineering [8-11]. In addition, the adhesiveness 
property of these tube membranes to the biological surfaces is an ideal feature for 
using these tube membranes as topical drug delivery devices[12]. Figure 4.2 
demonstrates three different protocols for drug loading of an electrospun nanofiber 
tube membrane.   
 
 
Figure 4.2 Three physical techniques of drug loading on the surface of an electrospun 
tube membrane[12]. 
 
Carbon nanotube membranes (CNTs) are the other tube membrane shape materials 
which recently have been utilized in biological applications [13-16]. Some 
therapeutic agents such as peptides [17-19], nucleic acid[20-22] and drugs[23-25] 
have been investigated to be delivered by using CNTs. It has been shown that CNTs 
are able to penetrate into the cell which offers the potential of using this material as a 
carrier of small drug molecules[26, 27]. 
The development of novel and efficient drug delivery systems is very important to 
improve the pharmacological profiles of some therapeutic molecules. There are so 
many different drug delivery systems currently available which have been presented 
in chapter 1[13]. Using flat composite PVDF membranes has been explained in the 
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previous chapter. In this chapter the PVDF membranes in a tube membrane format 
have been utilized as drug delivery system. 
  
4.3 Experimental 
4.3.1 Materials 
 
Pyrrole was purchased from Merck, purified by distillation, and stored at -18  ͦ C. 
Parra toluene sulfonic acid sodium salt (pTS) was purchased from BOH Chem. 
Chondroitin 4-sulphate sodium salt form bovine trachea (CS) was purchased from 
Fluka. Poly (4-styrene sulfonic acid) sodium salt (PSS), dodecylbenzenesulfonic acid 
sodium salt (DBSA), dextran sulphate sodium salt (DS) and hyaluronic acid (HA) 
had been supplied by Aldrich chemistry. Lacosamide (LCM) with the generic name 
of Vimpat was provided from St. Vincent Hospital in Melbourne. Figure 3.2 in 
chapter 3 shows the chemical structure of pTS, CS, PSS, DBSA, DS and HA dopants 
and also LCM molecules. 
Artificial cerebrospinal fluid (ACSF) was prepared to be used as electrochemistry 
solution and also drug transport study experiment. The preparation protocol of ACSF 
was explained in chapter 3 section 3.3.1.   
The PVDF membrane tube membrane was supplied by Ecofine Water Treatment 
Equipment Co (China).  The tube membrane diameters are; outer diameter is 1000 
m with an inner diameter of 630 m. Similar to the flat membranes (section 3.3.1 in 
Chapter 3) work, these tube membranes were coated on the outer surface by a 75 nm 
layer of platinum (Pt) (as optimized in Chapter 3)  using an Edwards Auto 306 
magnetron sputter coater. 
The outer surface of these substrate PVDF membranes was coated with a layer of 
platinum (Pt) using Edwards sputter coater 302 Auto instrument with four different 
thickness of Pt layer. Sputter coating was carried out under 2.5×10-3 Pa vacuum. The 
desired thickness of the Pt layer was achieved through instrumental set up with a 
sputtering power for Pt of 40 W.  Homogeneity was tested by SEM cross section 
imaging and tube membranes were put horizontally in the sputter coater.  
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4.3.2 Electrochemical Polymerization of Polymer Films 
 
Polypyrrole coated platinised tube membrane PVDF membranes (PPy/Pt/PVDF) 
were electrochemically synthesized. The electrochemical polymerisation of 
polypyrrole composite tube membranes process was carried out using a three 
electrode set up which is shown in Figure 4.3. 
 
 
Figure 4.3 Three electrode set up for electropolymerisation onto platinized hollow 
tube membrane PVDF membrane; (a) platinised tube membrane as working 
electrode, (b) platinum mesh as auxiliary electrode and (c) Ag/Ag/Cl reference 
electrode. All of these electrodes are connected to the potentiostat using connection 
leads. 
 
The electropolymerisation of conducting polymers on the outer surface of Pt/PVDF 
tube membranes was achieved by applying a current density of 1 mA/cm2 for 60 sec. 
A platinum mesh was used as an auxiliary electrode. Reference electrode was 
Ag/Ag/Cl and the platinized surface of the PVDF tube membrane worked as working 
electrode. In Figure 4.3 the outer surface of the tube membrane is black which due to 
deposition of PPy. After electropolymerisation the PPy coated tube membrane PVDF 
membranes were remove from the electropolymerisation set up, rinsed with 
sufficient amount of Milli-Q water and dried at room temperature.  
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4.3.3 Polypyrrole coated PVDF membrane characterization 
4.3.3.1 Electroactivity 
4.3.3.1.1 Cyclic voltammetry 
 
In order to investigate the electrochemical properties of the conducting polymer films 
grown on the surface of Pt/PVDF tube membranes, the PPy/Pt/tube membrane was 
placed in a three electrode electrochemical set up as the working electrode combined 
with a platinum mesh counter electrode and an Ag/AgCl reference electrode. ACSF 
was utilized as the electrolyte and five cyclic voltammograms (CVs) were measured 
using an eDAQ e-recorder (v5.5.11) potentiostat. The potential range was ±800 mV 
with the voltage scanned at a rate of 50mV/s.  
 
4.3.3.1.2 Scanning Electron Microscopy 
 
Scanning Electron Microscopy (SEM) images of conducting polymer coated tube 
membrane surfaces and cross sections were taken using a field emission SEM (JOEL 
JSM-7500FA). This technique has been described in Chapter 2.  
 
4.3.4 Anti-epilepsy drug transport through the PPy coated Pt/PVDF tube 
membrane  
4.3.4.1 Non-stimulated state 
 
Investigation of lacosamide transport from inside of polypyrrole coated Pt/PVDF 
tube membranes was carried out at non-stimulated state. Once the tube membranes 
were coated with PPy they were filled with drug using a 5ml syringe (BD 
PrecisionGlideTM needle 25G 1 - 0.5mm × 25mm).  Both ends of the tube membrane 
were sealed with wax to prevent the drug from leaching out. The drug filled tube 
membrane was placed in a petri dish which contains 15 ml ACSF solution with 
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samples taken every 60 sec for 10 min. Drug transport studies through flat PVDF 
membranes was carried out for 10 min. Therefore, drug release studies by using these 
conducting polymers coated Pt/PVDF tube membrane was conducted for 10 min.   
 
4.3.4.2 Stimulated state 
 
To perform the stimulated release of lacosamide from inside of tube membrane 
polypyrrole coated membranes a three electrode set up was employed.  The drug 
filled PPy/PVDF tube membrane was placed vertically in a beaker containing 15 ml 
ACSF (Figure 4.4). The PPy/PVDF tube membrane was the working electrode with 
the Ag/AgCl and Pt mesh acting as the reference and auxiliary electrodes 
respectively (Figure 4.4). As Figure 4.4 shows, the Pt/PVDF tube membrane was 
hold by a tweezer and the other end of this tweezer was connected to the potentiostat 
by a connection lid. The applied voltages to the conducting polymer coated tube 
membrane were chosen according to the redox peaks of these polymers in their 
cyclic voltammograms.  
 
 
Figure 4.4 Stimulated drug release study from inside of polypyrrole coated tube 
membrane. (a) Polypyrrole coated outer surface of tube membrane, (b) platinum 
mesh as an auxiliary electrode, and (c) Ag/AgCl reference electrode.  
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4.3.5 Released anti-epilepsy drug concentration measurement using HPLC 
system  
  Agilent HPLC instrument was used to analyse the concentration of released 
lacosamide from inside of conducting polymer coated tube membranes. HPLC 
system has been explained in detail in chapter 2. 
4.3.6 Water flux measurements 
  
To investigate water flux for polypyrrole coated platinised tube membranes, Milli-Q 
water was injected into the polymer coated tube membranes and both ends of these 
tube membranes were sealed by melted wax (Figure 4.4). The water filled tube 
membranes were placed horizontally in a petri dish and amount of transported Milli-
Q water from inside of these polymer coated tube membranes to the outside were 
measured every 60 sec for 10 min overall. This experiment was repeated 3 times for 
each sample.  
 
4.4 Results and Discussion 
4.4.1 Conducting polymer film growth and characterization 
4.4.1.1 Electroactivity 
4.4.1.1.1 Study the electroactivity of lacosamide molecules 
 
Investigating the electroactivity of lacosamide molecules is important because if the 
lacosamide molecule is electroactive, it may have significant influence on the 
released properties of the drug molecules in the drug transport experiments, release 
of lacosamide from inside of conducting polymer coated tube membrane were 
carried out at stimulated and pulsed potential states. The electroactivity of 
lacosamide has been investigated at section 3.4.1.1.1 in Chapter 3.   
4.4.1.1.2 Pt/PVDF polypyrrole coated tube membrane  
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Immediately after application of the current density (i.e. 1 mA/cm2) the generated 
oxidation potential for PPy/pTS and PPy/CS during electropolymerisation was +0.7 
V and +0.65 V for PPy/DBSA and PPy/PSS. The electropolymerization conditions 
were chosen based on the optimized growth conditions which have been presented in 
chapter 3. The potential generated during polymer deposition has an influence on the 
formation and structure of the electro polymerized polypyrrole with films exhibiting 
this oxidation potential leading to a highly conjugated and electroactive polymer 
[28]. Previous work has reported on variations in electrochemistry and physical 
properties of PPy when different size dopants are used during growth [29, 30]. In 
addition all of these dopants have been shown to be compatible with a range of 
biological cells [31, 32] making them ideal candidates for materials to be used in 
drug delivery and biological applications. 
 
 
Figure 4.5 Comparison between oxidation voltage generation during galvanostatic 
electropolymerisation of polypyrrole with pTS, PSS, CS and DBSA counterions with 
a three electrode set up; Ag/AgCl as a reference and an auxiliary Pt mesh as 
counterion electrode. The electropolymerization condition was applying 1mA/cm2 
for 60 sec for all of the conducting polymers.  
 
 Cyclic voltammograms of the PPy coated tube membranes were measured (Figure 
4.6). The CVs shows variation between PPy/pTS, PPy/DBSA, PPy/CS and PPy/PSS 
coated Pt/PVDF tube membranes. According to this figure, PPy/PSS demonstrates 
the highest capacity and clear redox peaks, followed by PPy/CS. The CV of 
PPy/DBSA was unusual and PPy/pTS does not show electrical activity. According to 
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Figures 3.13 and 3.12 in Chapter 3 PPy/DBSA and PPy/pTS exhibited redox peaks. 
However, using a hollow tube membrane as working electrode leads to having a 
conducting polymer film with unusual electroactivity. The cylinder shape of working 
electrode in comparison with the flat working electrode in the previous chapter can 
be one of the reasons of having unusual electrical activity of grown conducting 
polymer films. In addition, the growth cell which was utilized in Chapter 3 (Figure 
3.3) provided much better configuration to synthesized polypyrrole on the surface of 
flat membranes. In the growth cell, the platinum mesh electrode covers the whole 
surface of working electrode. However, in three electrode set up to synthesize 
polypyrrole on the outer surface of PVDF tube membranes (Figure 4.4), the platinum 
mesh did not surrounded the whole surface of PVDF tube membrane which is based 
on the electropolymerization cell set up shown in Figure 4.4  
 
 
 
 
 
 
Figure 4.6 Comparison of cyclic voltammograms of PPy/pTS, PPy/DBSA, PPy/CS 
and PPy/PSS which has been deposited on the outer surface of Pt/PVDF tube 
membrane; Scan rate is 50mV/s. 
 
The cyclic voltammograms of PPy/PSS coated Pt/PVDF tube membrane a broad 
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around -500 mV. PPy/CS showed a very broad oxidizing peak around +100 mV and 
a reducing potential around -300mV. According to the cyclic voltammograms of 
PPy/PSS and PPy/CS, these conducting polymers are more appropriate candidates to 
study drug release at stimulation state in comparison with PPy/pTS and PPy/DBSA. 
As previously mentioned and according to the CVs in Figure 4.6, the redox peaks for 
these two composite tube membranes are clearer. Therefore, PPy/PSS and PPy/CS 
possess sufficient electrical activity to be stimulated by an external electrical field to 
act as drug release gate.  
 
4.4.1.2 Morphology of tube membrane Pt/PVDF polypyrrole coated membrane 
 
The surface and cross-section SEM morphology studies were carried out for the 
PPy/Pt/tube membranes. Figure 4.7 show the surface of the PPy coated Pt/PVDF 
tube membranes to be typical for polypyrrole films [33-36]. All of these PPy coated 
tube membranes exhibit porosity indicating the polymer growth conditions 
maintained a porous structure which is critical to ensure drug transport. The 
differences between using different counterions for electropolymerisation of 
polypyrrole on the surface morphology of tube membranes is not as obvious in 
comparison with flat composite membranes (Figure 3.27 in Chapter 3). This could be 
due to different geometry of the tube membranes.  
For each composite tube several SEM images were taken from different areas of the 
tube. According to these images which all of them have not presented in this thesis 
because of the similarity, there was no distinguishable difference in morphology, 
porosity or topography of different areas of a conducting polymer coated tube.  
 
141 
 
 
Figure 4.7 SEM images of (a) PVDF, (b) Pt/PVDF, (c) PPy/pTS/Pt/PVDF, (d) 
PPy/CS/Pt/PVDF, (e) PPy/DBSA/Pt/PVDF and (f) PPy/PSS/Pt/PVDF tube 
membrane surfaces. The scale bar indicates 1 µm. 
 
 
Figure 4.8 presents the cross section SEM images of PVDF, Pt/PVDF, 
PPy/pTS/Pt/PVDF, PPy/CS/Pt/PVDF, PPy/DBSA/Pt/PVDF and PPy/PSS/Pt/PVDF 
tube membranes. 
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Figure 4.8 SEM images from the cross section of (a) PVDF, (b) Pt/PVDF, (c) 
PPy/pTS/Pt/PVDF, (d) PPy/CS/Pt/PVDF, (e) PPy/DBSA/Pt/PVDF and (f) 
PPy/PSS/Pt/PVDF composite tube membranes; (b’), (d’) and (f’) are higher 
magnification images of Pt/PVDF, PPy/CS/Pt/PVDF and PPy/PSS/Pt/PVDF 
respectively.  
 
There is no obvious difference between images (a) and (b) in Figure 4.8 despite the 
outer surface of the PVDF tube membrane being coated by 75 nm Pt layer. Using 
high magnification SEM images it was possible to measure the PPy thickness 
deposited on the Pt/tube membrane PPy/pTS coated tube membrane; there is 
10.01±0.35 µm polymer layer which has been deposited on the outer surface of the 
tube membrane. For PPy/CS and PPy/DBSA coated tube membranes (Figure 4.8 (d) 
and (e)) there does not appear to be any significant changes in the diameter of the 
tube membrane. Figure 4.8 (f) belongs to the PPy/PSS coated PVDF tube membrane. 
The greatest changes in the diameter of tube membrane occurred for this sample 
(Figure 4.8 (f) and (f’)). Thickness of PPy/PSS deposited layer on the surface of tube 
membrane is 20.12±0.62 µm. Therefore, similar to the PPy coated flat PVDF 
membrane studies (Chapter 3, section 3.4.1.2.2.1), PPy/PSS deposited film possesses 
the highest thickness.   
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4.4.2 PPy/Pt/tube membrane drug release study 
4.4.2.1 Non-stimulated state 
  
Prior to conducting the non-stimulated release experiments water flux of these PPy 
coated tube membranes was measured. However, due to the small scale of the 
PPy/Pt/tube membrane it was not possible to measure the very small quantity of 
Milli-Q water passing through the membrane. Therefore no data was obtained from 
the water flux experiments on the Pt/tube membrane prior to coating with PPy (as 
was performed in Chapter 3). Visually it possible to observe Milli-Q water passing 
through the membrane indicating that the Pt coating did not block the pores of the 
membrane. 
Before starting drug release studies in this session, it has to be menitioned that 
molecular interactions are extensively dependent on the condition under which 
theexperiment is being carried out. For instance, sample material, surface chemical 
modification, and more importantly the surrounding medium, are the experimental 
conditions which can have an important impact on the interactions between 
molecules. The condensation of water vapor in the experimental medium caused the 
capillary forces. However, if the experiment is being conducted in fluids or aquoes 
solutions, the capillary force vanishes [37, 38]. All drug release experiments of this 
chapter has been performed in aquos solution, therefore, the callipary force 
practically dose not have an influence on the result.  
The release properties of the PPy/Pt/tube membrane were investigated under a non-
stimulated state. The outer surface of these PVDF tube membranes was coated by 
PPy which had been doped with pTS, CS, DBSA or PSS counterions. As Figure 4.9 
exhibits, concentration of released lacosamide from inside of these composite tube 
membranes is very low in comparison with the concentration of drug transport 
results in Chapter 3.  The lower concentration of release with PPy coated tube 
membranes in comparison with flat membranes may be due to much smaller volume 
of drug solution. The amount of LCM/ACSF solution inside of tube membranes is 
much less than the amount of drug solution in the feed side of transport cell that was 
utilized or drug transport through flat membranes.  
The maximum release was measured from the PPy/pTS coated Pt/PVDF tube 
membrane (2.0 ± 0.1µg/ml) followed by PPy/PSS (1.8 ± 0.4 µg/ml) then PPy/CS 
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(1.4 ± 0.5 µg/ml). The minimum drug release concentration was observed from 
PPy/DBSA (0.5 ± 0.0 µg/ml) according to the SEM images of these conducting 
polymer coated Pt/PVDF tube membranes the thickness of PPy/PSS is the highest. 
Therefore, this sample exhibited the minimum drug transport at the passive state. 
Diffusion mechanism is the main driving force facilitating drug release in the non-
stimulated state. 
 
 
 
 
Figure 4.9 Concentration of released lacosamide from inside of PPy/pTS, PPy/CS, 
PPy/DBSA and PPy/PSS coated platinized tube membranes at passive state for 10 
min.   
4.4.2.2 Stimulated state 
4.4.2.2.1 Oxidized state 
 
Similar to section 3.4.3.2.1 in Chapter 3 three oxidizing potentials were applied to 
the outer surface of conducting polymer coated tube membranes. One of these 
oxidizing voltages was chosen from the cyclic voltammograms of these conducting 
polymer films and two other voltages was that oxidizing potential which has been 
added and subtracted by +100 mV. Drug release study at stimulated state was 
performed only for the PPy/CS/Pt/PVDF and PPy/PSS/Pt/PVDF tube membranes. 
These PPys were chosen as they exhibited the best electroactivity (Figure 4.6). 
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Having sufficient electrical activity is very important and an effective factor in terms 
of investigating drug release at stimulated states. The conducting polymer which 
possesses better electrical activity is able to respond to the electrical stimulation 
more effectively. At oxidized, reduced and also pulsed potential states, release of 
drug from polymer coated tube membranes occurs due to the response of the 
deposited conducting polymer layer to the applied voltages.  
Figure 4.10 shows the concentration of released lacosamide from inside of the 
PPy/CS coated Pt/PVDF tube membrane. +250 mV was the oxidizing potential 
according to the cyclic voltammograms of this conducting polymer. However, the 
lowest released concentration has been observed by applying +350 mV and then 
followed by +150 mV and +250 mV.  This release result may be due to the less 
porous structure of PPy/CS/Pt/PVDF tube membrane by applying +350 mV than the 
other voltages. According to the literature [39] at the oxidized state, the structure of 
conducting polymer swells. Because of deposition of PPy/CS on the surface of 
Pt/PVDF tube membrane, the conducting polymer has a porous structure (Figure 
4.7). Swelling of PPy/CS at oxidized state could lead to covering some of the surface 
pores and ban drug release. At fully oxidized state, the structure of conducting 
polymer becomes more hydrophilic [40] and swollen, which could cause minimum 
drug release.    
 
 
Figure 4.10 concentration of released lacosamide from inside of PPy/CS coated 
Pt/PVDF tube membrane at oxidized state. 
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Concentration of released lacosamide from inside of the PPy/PSS coated Pt/PVDF 
tube membrane is presented in Figure 4.11. The stimulating voltage of +100 mV was 
chosen from the cyclic voltammograms of this conducting polymer as the oxidation 
peak voltage (Figure 4.6). As for the PPy/CS work presented above stimulation was 
examined ±100 mV of this potential Stimulation of the outer surface of this 
conducting polymer by +200 mV leaded to having minimum drug release 
concentration and then followed by 0.0 and 100 mV. 
 
 
Figure 4.11 Concentration of released lacosamide from inside of PPy/PSS coated 
Pt/PVDF tube membrane at oxidized state (+100mV) and at potentials ±100mV of 
the oxidation potential. 
 
According to Figures 4.10 and 4.11, the oxidation potentials which have been picked 
from the cyclic voltammograms of these polymers (Figure 4.6) exhibited the 
maximum concentration of drug release for both PPy/CS and PPy/PSS coated 
Pt/PVDF tube membranes. While, applying the oxidation potentials which were 
+100 mV higher than the potential in their CVs (Figure 4.6) leads to have minimum 
drug transport release. Maximum drug release concentration from PPy/CS coated 
Pt/PVDF tube membrane is 7.1% higher than maximum drug concertation for 
PPy/PSS coated tube membrane. In addition, the minimum drug release concertation 
for PPy/CS film is 9.2% higher than the minimum release concentration for 
PPy/PSS. 
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For PPy/CS coated Pt/PVDF tube membrane, by applying +150 mV which is 100 
mV less than the oxidation potential indicated by CV (Figure 4.6) leaded to 25.0% 
decrease in the concentration of drug release. Also, applying +350 mV which is 100 
mV higher than the oxidation potential indicated by CV (Figure 4.6) caused 31.3% 
decrease in drug release concentration. 
7.53% decrease was observed for PPy/PSS film by applying 0.00 mV. This potential 
is 100 mV less than the oxidation potential which was indicated by CV (Figure 4.6). 
In addition, applying 200 mV leaded to have 32.83% decreases in the concentration 
of drug release in comparison with drug concentration by applying +100 mV. A 
potential of+100 mV was chosen as the oxidation potential from the cyclic 
voltammograms of PPy/PSS film (Figure 4.6).  
4.4.2.2.2 Reduced state 
 
To study the effect of applying reducing voltage to the surface of conducting 
polymer coated Pt/PVDF tube membranes three reducing voltages were applied. One 
of them was chosen according to the cyclic voltammograms of conducting polymer 
films. The other applied potentials were ±100 mV to that chosen voltage to stimulate 
conducting polymer layer until its fully reduced state by applying one of these 
reducing voltages. 
Figure 4.12 exhibits the concentration of released lacosamide from inside of PPy/CS 
coated Pt/PVDF tube membrane. The voltage of -220 mV was chosen from the CV 
of this conducting polymer (Figure 4.6) as the reducing voltage, although the highest 
concentration of released lacosamide was observed at -120 mV. Concentration of 
released lacosamide by applying -220 mV is less than the concentration of release 
drug molecules by applying -120 mV. Finally, by stimulating the PPy/CS by -320 
mV the minimum amount of drug molecules released from inside of the tube 
membrane. 
According to the literature [39, 40], at reduced state in comparison with oxidized 
state, the structure of conducting polymer is contracted. Because of deposition of 
PPy/CS on a porous structure which is Pt/PVDF tube membrane (Figure 4.7), 
applying reduction potential caused shrinkage in the structure of polymer coated tube 
membranes. Therefore, surface pores become more open and facilitate the release of 
drug molecules to the outside.  
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Figure 4.12 Concentration of released lacosamide from inside of PPy/CS coated 
Pt/PVDF tube membrane at reduced state (-220 mV) and at potentials ±100mV of the 
reduction potential. 
 
Figure 4.13 shows the concentration of released lacosamide from PPy/PSS coated 
Pt/PVDF tube membrane at reduced state. From the recorded CVs (Figure 4.6) the 
reduction peak is observed at -550 mV. Maximum released concentration observed 
by applying -650 mV. Released concentration for -450 mV and -550 mV is 
approximately the same. 
 
0
2
4
6
8
10
12
0 2 4 6 8 10 12
Co
nce
ntr
atio
n o
f T
ran
spo
rte
d 
lac
osa
mid
e (µ
g/m
l)
Drug Transport Time (mins)
-120 mV
-220 mV
-320 mV
 
149 
 
 
Figure 4.13 Concentration of released lacosamide from inside of PPy/PSS coated 
Pt/PVDF tube membrane at reduced state. 
 
For PPy/CS (Figure 4.12) maximum concentration of released drug occurred by 
applying -120 mV which is 100 mV lower than the redox reduction potential (Figure 
4.6). For PPy/PSS (Figure 4.13) this maximum release was observed by applying -
650 mV which is 100 mV higher than the redox reducing potential (Figure 4.6). 
Maximum release concentration for PPy/CS is 21.14% higher than the maximum 
concentration for PPy/PSS. 
Figure 4.14 presents the comparison between concentrations of released lacosamide 
at fully oxidized (+350 mV) and fully reduced (-120 mV) states for the PPy/CS 
polymer. To achieve fully oxidized state +350 mV applied to the surface of PPy/CS 
coated Pt/PVDF tube membrane. After 10 min in the fully oxidised state 4.4 ± 0.2 
µg/ml of lacosamide was released compared to 10.3 ± 0.2 µg/ml from the fully 
reduced state indicating approximately 2.3 times higher release under an oxidized 
state.  In Figure 4.14 after 10 min of applying -120 mV which is the fully reduced 
potential the PPy/CS film exhibited a burst release of lacosamide.    
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Figure 4.14 Comparison of released lacosamide from PPy/CS/Pt/PVDF tube 
membrane at fully oxidized (+350 mV) and fully reduced (-120 mV) states. 
 
Comparison between concentrations of released lacosamide from inside of PPy/PSS 
coated Pt/PVDF tube membrane at fully oxidized (+200 mV) and fully reduced state 
(-650 mV) is presented in Figure 4.15. The concentration of released lacosamide 
after 10 min at fully oxidized state is 4.0 ± 0.3 µg/ml, whilst in the reduced state the 
concentration of released lacosamide was 8.1 ± 0.4 µg/ml. The concentration of 
released lacosamide at fully reduced state is approximately 2 times greater than when 
in the fully oxidized state.  
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Figure 4.15 Comparison between concentrations of released lacosamide from inside 
of PPy/PSS/Pt/PVDF tube membrane at fully oxidized and fully reduced states. 
 
At fully reduced state the total concentration of release LCM from PPy/CS coated 
Pt/PVDF tube membrane is 27.2% higher than the concentration of LCM release 
from PPy/PSS coated membrane. However, the concentration of released LCM at 
fully oxidized state is approximately similar for bot conducting polymers.  
One noticeable difference between release profile of PPy/PSS and PPy/CS is the rate 
of release concentration after 5 min applying of reducing potential. For PPy/CS the 
concentration of release LCM at time = 10 min is 57.3% higher than the 
concentration of LCM at time = 5 min. For PPy/PSS this increase percentage is 
23.5%.  Therefore, drug molecules could release from PPy/CS coated Pt/PVDF tube 
membrane approximately 2.4 times faster than PPy/PSS coated Pt/PVDF tube 
membrane.  
According to drug release figures, the maximum level of lacosamide release is 
10.31±6.3 µg/ml which was observed by applying -120 mV (reducing potential) to 
PPy/CS/Pt/PVDF tube membrane. In addition, the minimum concentration of release 
is 4.03±0.1 µg/ml and has happened for PPy/PSS/Pt/PVDF tube membrane by 
applying +200 mV as an oxidizing voltage. Based on studies have been done on the 
efficient level of lacosamide molecules in human body [41, 42], the recommended 
level of lacosamide is 200-400 or 200-600 mg/day which is approved as an effective 
dosage. Obviously, there is a huge difference between the recommended level of 
lacosamide and the higest level of drug release from conducting polymer coated tube 
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membrnes. Similar to the flat membrane studies, the recomnded concentration 
represents the level of drug on blood stream which is much higher than the actual 
amount of drug concentration needed on the brain tissue. As it has been mentioned in 
chapter 3, it is practically not possible to make a valid comparison about the sizures 
supressing efficiency of the concentration of release lacosamide from neither flat nor 
tube membranes.  
It should be mentioned that before switching the potential to oxixdized or rduced 
states, there might be some drug molecules in the recievrr side which is the ouside of 
the tube mmembrane. Therefore, a ∆C concentration difference of drug molecules 
exsits between inside and ouside of the membrane. However, the difference in ∆C 
can be an issue when a very concentrated or saturated solution is being used. In these 
cases the peresence of drug molecules ouside of the tube membrane can block the 
release pathway of inside drug molecules. In the expereminets of this chapter, the 
concentration of drug molecules in both inside and outside of the tube is very low; 
therefore, the effect of changing ∆C is negligible. Sicne, the drug molecules which 
already exsit outside of the membrane can not shut the release pores of the tube 
membrane.  
 
 
4.4.2.2.3 Pulsed potential state 
 
One of the most important goals of this project is fabricating a drug release device 
which is capable of releasing an anti-epilepsy drug to provide an on/off release 
profile. Therefore, release of lacosamide from PPy coated Pt/PVDF tube membranes 
were investigated at pulsed potential. 
Figure 4.16 presents the results of lacosamide release from PPy/CS/tube membrane. 
The initial potential is the reducing voltage (i.e. -120 mV) which is applied for 2 min 
followed by switching the potential to the oxidizing voltage (i.e. +350 mV) for a 
further 2 min. The pulse width is 4 min and two pulses were applied. The first 2 min 
of applying a reducing potential resulted in a release of lacosamide and upon 
switching to an oxidising potential the release was effectively stopped. When the 
potential was switched back to the reducing voltage release was again recorded over 
the 2 min, which stopped when an oxidising voltage was applied. 
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The concentration of released drug while applying oxidizing potentials in Figure 4.16 
is approximately 4.2 less than the concentration of transported drug at single 
oxidizing state. In addition, the concentration of released lacosamide by switching to 
reducing potentials is 1.75 times higher than the concentration of released drug under 
applying single reducing potential.    
 
 
 
Figure 4.16 Concentration of released lacosamide from inside of PPy/CS/Pt/PVDF 
tube membrane at pulsed potential state; Right hand side y-axis indicates potential 
(mV) and left hand side y-axis exhibits the concentration of released lacosamide 
(µg/ml).  
 
Figure 4.17 exhibits the release of lacosamide from PPy/PSS/tube membrane at 
pulsed potential state. The initial potential is reducing voltage (i.e. -650 mV) which 
is applied for 1 min. The voltage is then switched to the oxidizing voltage (+200 mV) 
1 min. One pulse cycle last for 2 min and four cycles are applied. By applying the 
reducing potential for the first min initiated drug release from PPy/PSS/Pt/PVDF 
tube membrane. However, switching from the reducing state to the oxidizing state 
did not stop drug release. Continuing to pulse potential state for this conducting 
polymer coated Pt/PVDF tube membrane did not show the on/off release profile. 
Switching from reducing to oxidizing state did not stop drug release because not all 
of the conducting polymer can response to the external electrical stimulation very 
fast. Switching from reduced to oxidized or from oxidized to reduced state does not 
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happen as soon as the electrical stimulation is applied. Since reducing and oxidizing 
happens because of ion transfer between conducting polymer and the electrolyte, and 
this process takes time. The size of the counterion plays very important role on the 
speed of reduction or oxidization of conducting polymer. This may be the main 
reason of seeing difference between release profile of PPy/PSS and PPy/CS. The PSS 
counterion has larger molecules than the CS. Therefore, the movement of PSS 
between polymer structure and electrolyte takes longer time.  
PSS molecules are larger than CS molecules so it takes longer for PPy/PSS than 
PPy/CS to react to the electrical stimulation which leads to drug release profile that is 
not as sufficient as PPy/CS release profile.  
  
According to Figure 4.17 the concentration of released lacosamide while application 
of reducing voltage is approximately 1.6 times higher than the concentration of 
released drug by applying constant reducing voltage. Furthermore, the concentration 
of released lacosamide at single oxidizing state is 1.4 times less than the 
concentration of transported lacosamide at pulsed oxidizing state.   
 
 
Figure 4.17 Concentration of released lacosamide from inside of PPy/PSS/Pt/PVDF 
tube membrane at pulsed potential state; Right hand side y-axis indicates potential 
(mV) and left hand side y-axis exhibits the concentration of released lacosamide 
(µg/ml). 
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For both conducting polymer coated Pt/PVDF tube membranes, the overall 
concentration of release lacosamide at pulsed potential state is less than drug released 
concentration at single reduced states. According to the previous results (Figures 
4.10 and 4.11) application of oxidizing potential decreases the release of drug 
molecules. At pulsed potential state, when a reducing potential is applying drug 
release happens and otherwise application of oxidizing potentials declines the release 
of drug. Therefore, the overall drug release at pulsed potential is less than drug 
release at application of single reducing potential. 
The concentration of drug release for PPy/CS coated Pt/PVDF tube membrane at the 
end of two pulses is almost the same as concentration of released drug at single 
oxidized state after 8 min. However, the concentration of released drug at single 
reduced state after 8 min is 56.82% higher than the overall concentration at the end 
of pulsed potential studies. These results reveal that by utilizing the pulsed potential 
state, the total concentration of release drug is less, but the release profile is much 
more controllable. Continuing the pulsed potential states can increase the 
concentration of released drug. 
Results for PPy/PSS coated Pt/PVDF tube membrane are different from PPy/CS tube 
membrane. After applying two pulses to the surface of PPy/PSS coated Pt/PVDF 
tube membrane, the total concentration of released lacosamide is just 3.33% higher 
than the concentration of released lacosamide after 8 min of applying single reducing 
potential and 56.95% higher than the concentration of release lacosamide after 8 min 
of applying single oxidizing voltage. Therefore, it seems that for PPy/PSS applying 
pulsed potential state leaded to release more lacosamide molecules. However, unlike 
to the PPy/CS coated Pt/PVDF tube membrane the PPy/PSS did not show the 
controllable release profile as sufficient as PPy/CS. For PPy/PSS applying more 
pulses may be leaded to have more suitable release profile. The concentration of 
released lacosamide for PPy/PSS is 65.75% higher than concentration of drug release 
for PPy/CS after two pulses and 78.71% after applying 4 pulses.      
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4.5 Conclusion 
 
Conducting polymer coated Pt/PVDF tube membranes have been fabricated and been 
utilized as gating and reservoir system simultaneously to study release of an anti-
epilepsy drug. The pTS, DBSA, CS and PSS were used to synthesize polypyrrole on 
the outer surface of Pt/PVDF tube membranes. This surface had been coated with 75 
nm layer of Pt before conducting the electropolymerization experiments. For all of 
these dopants, 1 mA/cm2 current density for 60 sec was applied.  
Later on, the characterization of these conducting polymer coated tube membranes 
was investigated. According to their cyclic voltammograms PPy/CS and PPy/PSS 
coated tube membranes exhibited more sufficient electrical activity and redox 
properties. Therefore, these two conducting polymer coated tube membranes were 
chosen to be utilized for drug release studies. Similar to the flat composite PVDF 
membrane, the concentration of released drug at reduced state was higher than 
oxidized and also non-stimulated states. The total concentration of released 
lacosamide from PPy/CS coated Pt/PVDF tube membrane at stimulated states was 
higher than PPy/PSS. 
By applying the pulsed potential state, composite tube membranes exhibited the 
on/off release profiles. The on/off release profile of PPy/CS is more sufficient than 
PPy/PSS. PPy/CS coated tube membrane showed better respond regards switching 
between reduced and oxidized states in comparison with PPy/PSS coated tube 
membrane. However, the overall concentration of release lacosamide from PPy/CS at 
pulsed state was less than the total release concentration at single reduction state. For 
PPy/PSS the total concentration after applying four pulses was higher than the 
release concentration by applying single reducing voltage.  
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5 INVESTIGATING DRUG INTERACTIONS WITH CP 
SURFACES USING QCM TECHNIQUE 
5.1 Chapter aims  
Transport of lacosamide drug molecules through flat and tube Pt/PVDF membranes 
coated with polypyrrole has been investigated in Chapter 3 and 4. However, one of 
the important factors in the case of drug delivery study which is the affinity of drug 
molecules to the surface of CPs has not been studies. Therefore, the main focus of 
this chapter is investigation of the interaction of the anti-epilepsy drug lacosamide 
with the surface of CPs by using QCM technique.  
 
5.2 Quartz Crystal Microbalance 
Researchers have been interested quantify the absorption of molecules such as 
protein and drug molecules to the surface of conducting polymers. A number of 
techniques which have been utilized are QCM[1], surface plasma resonance 
(SPR)[2], ellipsometry[3], FTIR[4] and atomic force microscopy (AFM)[5].  Among 
all of these techniques, QCM has been utilized to carry out a number of studies to 
investigate the existence of drugs with different concentrations. Much research has 
been developed on the base of QCM for drug discovery studies in the pharmaceutical 
industry, and, a number of drugs have been detected using QCM technique at nM to 
mM concentrations[6-13].  Moreover, other media such as serum or urine have been 
used to study drug detection with a range of nm to µM[14-16].  
The recent improvement of the QCM technique is the capability to measure the 
interaction of even tiny molecules such as ions or solute transport[17] at the liquid-
solid interface. In addition, with this advanced technique, energy dissipation 
characterization or viscoelastic behavior study of the deposited mass upon the 
material coated quartz crystal sensor is possible.   
The most explicit factor of changing f is adsorption or desorption of mass. Hence, 
many researchers design their experiments with maximized detectable mass binding 
with the metal coated quartz crystal surface. For example studying the immobilized 
enzyme biosensors on the QCM sensors[18, 19]. 
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Despite of an explosive growth which has been made in the development of QCM 
application to investigate a wide variety of molecular systems at the solution-surface 
interface, a lack of study in terms of drug-drug carrier surface interaction has been 
observed. In this chapter the interaction of an anti-epilepsy drug with the surface of 
PPy polymerized using a range of different dopants was investigated. 
5.3 Experimental 
 
5.3.1 Materials 
 
Pyrrole was purchased from Merck, purified by distillation, and stored at -18  ͦ C. 
Parratoluene sulfonic acid sodium salt (pTS) was purchased from BOH Chem. 
Chondroitin 4-sulphate sodium salt from bovine trachea (CS) was purchased from 
Fluka. Poly (4-styrene sulfonic acid) sodium salt (PSS) and dodecylbenzenesulfonic 
acid sodium salt (DBSA) had been supplied by Aldrich chemistry. Lacosamide 
(LCM) with the generic name of Vimpat was provided form St. Vincent Hospital 
Melbourne (Professor Mark Cook). Figure 5.1 shows the chemical structure of pTS, 
CS, PSS and DBSA dopants and also LCM molecules. 
 
Figure 5.1 chemical structure of; (a) Parratoluene sulfonic acid sodium salt (pTS), (b) 
Chondroitin 4-sulphate sodium salt form bovine trachea (CS), (c) Poly (4-styrene 
sulfonic acid) sodium salt (PSS), (d) Dodecylbenzenesulfonic acid sodium salt 
(DBSA) and (e) lacosamide (LCM) molecules. 
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Artificial cerebrospinal fluid of the brain (ACSF) was prepared from two solutions 
with the proportion of 50:50 v/v; solution A was made from NaCl (8.66 g), KCl 
(0.224 g), CaCl2.2H2O (0.206 g), MgCl2.6H2O (0.163 g) which has been dissolved in 
500 ml pyrogen-free water. Solution B was made of Na2HPO4.7H2O (0.214 g), 
NaH2PO4.H2O (0.027 g) which was dissolve in 500 ml pyrogen-free water. ACSF 
was stored at 4  ͦ C prior to use. All of the chemicals used to prepare ACSF were 
purchased from BASF. 
5.3.2 Electrochemical Polymerization of Polymer Films 
 
Electrochemical polymerization of the Polypyrrole (PPy) conducting polymer film 
was carried out using a Q-sense electrochemistry module (QEM 401) axial flow cell 
with a Q- Sense E4 quartz crystal microbalance system (Q-Sense AB, Vӓstra, 
Frӧlunda, Sweden, Figure 5.2). During the electropolymerization process the 
deposited film QCM-D parameters were recording.  The QCM sensor was an AT cut 
quartz crystal with a 10 mm diameter gold electrode (QSX301) with a fundamental 
resonance frequency of 5 MHz. The gold sensor surface of the quartz crustal was 
cleaned prior to electropolymerization. Cleaning process was performed using 
piranha solution (70% sulphuric acid and 30% hydrogen peroxide) for 3 min, and 
then gold sensor surface was rinsed thoroughly with deionized water and dried with 
nitrogen gas. The electropolymerization aqueous monomer solution composition is 
presented in Table 5.1. 
  
Table5.1 Electropolymerisation aqueous monomer solution composition 
Conducting 
polymer Film 
Pyrrole 
concentration (M) 
Counterion 
concentration 
PPy/pTS 0.2 0.05 M 
PPy/CS 0.2 2 mg/ml 
PPy/PSS 0.1 0.1 M 
PPy/DBSA 0.1 0.1 M 
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Each monomer solution was deoxygenated with nitrogen gas bubbling for 10 min 
prior to use to remove dissolved oxygen. The Q-sense electrochemistry cell consisted 
of a platinum counter and a gold working electrode with a World Precision 
Instruments® Dri-RefTM reference electrode (Figure 5.2). Conducting polymer 
films were grown galvanostatically (current density of 1 mA/cm2 for 1 min for all 
films) on the surface of gold-coated Q-Sense quartz sensors using an eDAQ e-corder 
410 recorders and EA163 potentiostat which is connected to the Q-Sense instrument 
(Figure 5.2). Electropolymerization was performed in a three electrode system 
utilizing the gold QCM crystal as the working electrode, a Ag/AgCl (3 M NaCl) 
reference electrode and a platinum auxiliary electrode) with the resulting voltage 
generated during polymerization being recorded. The monomer solution was flowed 
through the Q-Sense electrochemistry axial flow cell at 60µl/min. 
Electropolymerization process was executed with applying constant current. The 
temperature within the Q-Sense chamber was maintained at 22 ± 0.02oC using the 
instrument software. Subsequently, the conducting polymer coated quartz sensors 
were removed from the E-cell and rinsed in distilled water and dried with nitrogen 
gas bubbling (Figure 2.4 in Chapter 2).   
 
Figure 5.2 Quartz crystal microbalance (QCM) instruments; (a) Q-sense sensors, (b) 
pump, (c) QCM main body, (d) PC accompanied with QCM instrument which 
provide appropriate software.  
(a)
(b)
(c)
(d)
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Figure 5.3 Q-sense electrochemistry axial flow cell chamber schematic; (a) and (a’) 
present the O-ring washer, (b) is the inlet of QCM cell; and (c) is the outlet.  
Reference, counter and working electrodes are labelled in the figure.  
 
5.3.3 Film Characterization 
5.3.3.1 Electroactivity 
5.3.3.1.1 Cyclic voltammetry 
 
In order to investigate the electrochemical properties of the PPy films they were 
grown on the surface of a gold Mylar sheet in place of the QCM crystals with the 
electropolymerization conditions being exactly the same. The OCP films grown on 
the surface of gold Mylar were then placed in a three electrode electrochemical cell 
containing a platinum mesh counter electrode, Ag/AgCl (3M NaCl) reference 
electrode, and the conducting polymer films on the surface of the gold Mylar as the 
working electrode. ACSF was utilized as the electrolyte and 5 cyclic voltammograms 
(CVs) were measured using an eDAQ e-recorder (v5.5.11) and potentiostat (Figure 
4.4). The potential ranges were ± 600 and ±800 mV with scan rates of 25 and 
50mV/s used. 
5.3.3.2 Profilometry Topography 
 
The surface roughness of the polymer films were examined by using a Veeko Wyko 
NT9100 optical profilometer (Figure 2.12 in Chapter 2). For each sample at least 
three measurements were carried out. To measure surface roughness of conducting 
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polymer films Q-sense sensors were used since optical profilometer does not damage 
the quartz crystal.  
5.3.3.3 Goniometry Measurement 
A Dataphysics optical contact angle goniometer was used to measure the mean static 
contact angle of the conducting polymer films. For each sample at least three 
measurements were carried out using deionized water droplets of 1 µl for each 
reported value. Figure 2.8 in Chapter 2 shows the Dataphysics optical contact angle 
goniometer used in this study. Applying oxidizing and reducing potential to the 
surface of OCPs changes the wettability of the surface which is distinguishable by 
measuring the contact angles. In addition electropolymerisation of polypyrrole with 
different counterions leads to have different surface properties. Measuring the 
contact angles reveals any differences in wettability of the surface of OCPs.  
 
5.3.3.4 Scanning Electron Microscopy 
Scanning Electron Microscopy (SEM) images of conducting polymer film surfaces 
were taken using a field emission SEM (JOEL JSM-7500FA). Figure 2.3 in Chapter 
2 presents an image of this instrument. Conducting polymer samples for SEM 
analysis were produced on gold Mylar sheet. Electropolymerisation solution 
composition has been displayed in Table 5.1. SEM was conducted in order to 
perform surface morphology analysis. 
 
5.3.4 Quartz Crystal Microbalance with Dissipation Monitoring (QCM-D)  
In this study according to the frequency and associated dissipation shift the absorbed 
layer to the polymer surface is a rigid, non-viscoelastic layer. Therefore, the 
Sauerbrey model is applicable to extricate measurements from the resulting data set.  
The Q-tools software package v.3.0.10.286 (Biolin Sci, AB) was utilized to apply 
Sauerbrey model to determine layer thickness of the conducting polymer and also 
absorbed mass layer. Layer density (1500 kg m-3)[20] and 5th overtone were 
employed for all modelling to achieve the best data fit. The QCM technique has been 
described in section 2.5 Chapter 2.  
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5.4 Results and discussion 
5.4.1 Study the cyclic voltammetry 
The potentials generated during electropolymerisation of the polypyrrole films on the 
surface of Q-sense sensors at a constant current of 1 mA/cm2 with four different 
counterions, namely pTS, CS, DBSA and PSS is shown in Figure 5.4. These four 
counterions were chosen as they possess a negative charge (Figure 5.1) however pTS 
has the smallest molecular weight. Among these counterions pTS and PSS molecules 
are synthetic in nature whilst CS and DBSA are large organic molecules derived 
from nature. Previous work[21, 22] has reported on variations in electrochemistry 
and physical properties of PPy when different size dopants are used during growth. 
In addition, all of these dopants have been shown to be compatible with a range of 
biological cells[23, 24], making them ideal candidates for materials to be used in 
drug delivery and biological applications. It has to be mentioned that Q-tools which 
is the software combined with QCM-D instrument normalizes the amount of 
absorbtaion by the surface. Although, a rougher surface area has a higher total 
surface area; however, it does not necessarily have an increased active surface area. 
Not all areas of the surface are available and accessible to interact with drug 
molecules. Therefore, calculation of actual amount of active surface area is not 
possible practically.   
Even though the effect of active surface area has not been applied in this chapter, the 
main point of this chapter was studying the effect of doping polypyrrole with 4 
different dopants on the affinity of LCM molecules to the CP surfaces.  
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Figure 5.4 Potential (V) generated during electrochemical polymerization of PPy 
doped with varying dopants; pTS, PSS, CS and DBSA at a current density of 1 
mA/cm2 in the monomer growing solution. 
 
Immediately after application of the constant current (employing a current density of 
1mA/cm2) the generated potential for PPy/pTS and PPy/CS during 
electropolymerisation was +0.7 V.  For PPy/DBSA this potential is +0.65 V and +0.6 
V for PPy/PSS. The potential generated during polymer deposition has an influence 
on the formation and structure of the electropolymerized polypyrrole with films 
grown and lower potential leading to a higher conjugated and electroactive polymer. 
Cyclic voltammetry (section 5.3.3.1) was utilized to investigate the electrochemistry 
of the conducting polymer films (Figures 5.12). The polymer was cycled between the 
upper and lower potential limits which were ±800 mV. Figure 5.5(a) present the 
cyclic voltammograms of PPy/PSS coated Pt/PVDF membrane. The oxidation occurs 
at +150 mV and reduction peaks was seen at -500 mV. When PPy/pTS coated 
Pt/PVDF membrane was scanned between ±800 mV (Figure 5.5(b)), reduction of 
this membrane started at about -400 mV, accompanied by the anions movement out 
of the polymer structure. The cations started to move into the polymer at a more 
positive potential and this process continued until the potential reached +300 mV. 
This point is the point that cations stopped moving in and ready to move out on its 
reverse scan. In Figure 5.5(c) when PPy/CS coated Pt/PVDF membrane scanned 
from -800 mV to +800 mV, the cation starts to move out of the polymer structure 
until reaching oxidizing peak which was happened around +200 mV. Continuing 
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potential application resulted in anions in solution began to move into the polymer 
and this anion movement continued until reducing peak which was happened at -300 
mV.  Finally for PPy/DBSA coated Pt/PVDF membrane anion and cation movement 
between the conducting polymer structure and solution which was ACSF leads to 
having redox peak. As Figure 5.5(d) presents the oxidizing peak was observed at -
350 mV and reducing peak was seen around -500 mV.   
 
Figure 5.5 Cyclic voltammograms of PPy/PSS (a), PPy/pTS (b), PPy/CS (c) and 
PPy/DBSA (d) coated gold Mylar cycled at 25 mV/s scan rate in ACSF solution at 
room temperature from -800 mV to +800 mV. Arrows show the direction of the 
potential scan. 
 
5.4.2 Thickness of Conducting Polymer Films 
In-situ electrochemical polymerization of polypyrrole using the QCM-D provided 
fundamental characterization analyses of the deposited polymer layer. Figure 5.6 
presents the Sauerbrey modelled results of OCP thicknesses from each PPy/pTS, CS, 
PSS and DBSA films. To calculate the thickness of the conducting polymer layer the 
Sauerbrey model has been used. The thickness calculation equation requires the 
density of the adlayer at the interface which in this case is polypyrrole. According to 
the literature [11] the density of polypyrrole is 1.47 g cm-3. As it has been described 
in section 5.3.4, the Sauerbrey model is utilized to analyze rigid and non-viscoelastic 
adlayers such a deposited conducting polymer layer.  
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Figure 5.6 Conducting polymer layer thickness values for PPy/pTS, PPy/CS, 
PPy/DBSA and PPy/PSS modelled from QCM-D data using the Sauerbrey Model. 
Data is the average value (n = 3) with the error bars representing 95% confidence 
intervals around the mean. 
 
Thickness of the CP film deposited during electrochemical polymerization for 
PPy/DBSA is the highest followed by PPy/PSS, PPy/CS and PPy/pTS.  Thickness of 
PPy/DBSA layer on the surface of quartz crystal is 315.8 ± 6.7 nm which is 6.8 times 
greater than PPy/pTS layer thickness (i.e. 46.8 ± 5.3 nm).   
 
5.4.3 Polymer Morphology, Surface Roughness and Contact Angle 
SEM images of the conducting polymer surfaces show the formation of a non-porous 
layer (Figure 5.7) and reveal a typical nodular morphology of electropolymerized 
polypyrrole films[25, 26]. However, the surface characteristics of the OCPs grown 
with different counterions exhibited varying surface roughness value (Figure 5.8). 
Surface roughness (Rrms) is one important property that imparts significant interfacial 
properties in terms of the attraction of molecules to the interface [27-29]. Surface 
roughness data was obtained by using a described method in section 5.3.3.2. The 
values presented in Figure 5.8 show that PPy/PSS has the highest Rrms value (i.e. 
29.5±0.4 nm) followed by PPy/pTS, PPy/CS and PPy/DBSA. These results are in a 
good agreement with the other researchers results[30, 31]. According to the SEM 
images (Figure 5.7) possessing larger nodules on the surface for PPy/PSS film leaded 
to having larger surface roughness[32]. Surface roughness for PPy/pTS film is higher 
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than PPy/CS and PPy/DBSA. Despite that the surface roughness values for all of 
OCP films presented here are approximately the same to the other studies which have 
been performed under the same experimental condition[30]. 
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Figure 5.7 Low magnification SEM images (a, c, e and g) and high magnification 
SEM images (b, d, f and h) of PPy/pTS (a and b), PPy/CS (c and d), PPy/PSS (e and 
f) and PPy/DBSA (g and h) films. 
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Figure 5.8 Random Mean Square Roughness (Rrms) (nm) for PPy/pTS, PPy/CS. PPy/PSS and PPy/DBSA films calculated by optical profilometry. Error bars 
represent 95% confidence intervals surrounding the mean (n=3). The p-value for 
these data is less than 0.05 (p* = 0.015). 
 
The effect of different counterions on the wettability property of the OCPs was 
investigated using static water contact angle measurements (Figure 5.9). PPy/pTS 
produced the highest water contact angle (i.e. 60.8±9.6 )ͦ.The PSS, CS and DBSA 
molecules contain a number of hydrophilic residual groups respectively (Figure 5.1) 
which possibly leads to the OCP films grown using these molecules as dopants 
possessing high hydrophilicity and thus low contact angles[33].  
 
Figure 5.9 Average (n = 3) static contact angle (deg) for PPy/pTS, PPy/CS, PPy/PSS 
and PPy/DBSA films. Error bars represent 95% confidence intervals surrounding the 
mean.  
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5.4.4 Electrochemical polymerization and Electroactivity 
As it has been indicated in section 5.3.2 a QCM-D instrument was utilized to prepare 
conducting polymer coated quartz crystals. A solution of pyrrole monomer and 
counterion (Table 5.1) were introduced to the QCM-D chamber and constant current 
applied (current density used was 1 mA/cm2) to the chamber using an eDAQ system 
(section 5.3.2). Figure 5.10(a) exhibits the frequency (ƒ) responses which occurred as 
a result of growing conducting polymer on the surface of the quartz crystal. At time 
= 0 the constant current was applied to the surface of gold quartz crystal to initiate 
conducting polymer growth. For all of the conducting polymers with different 
dopants a negative frequency shift was observed indicating an increase in mass at the 
surface of the crystal. This increase in mass is attributed to the formation of a 
conducting polymer film. The maximum ƒ shift occurred for PPy/BDSA followed by 
PPy/PSS, PPy/pTS and PPy/CS. Furthermore, a decrease in the gradient of frequency 
decrease (mass increase) for PPy/DBSA is higher than PPy/PSS, PPy/pTS and 
PPy/CS respectively indicating that the rate of PPy/DBSA deposition is faster. 
Energy dissipation (D) shifts shown in Figure 5.10(b) are associated with ƒ shifts (5th 
overtone) and provide an understanding of viscoelastic characteristics of deposited 
conducting polymer film by measuring the energy dissipative properties of this 
absorbed layer at the interface[34]. From Figure 5.10(a) and b it is observed that a 
negative ƒ shift results in a positive D shift. The positive D shifts are highest for 
PPy/DBSA followed by PPy/PSS, PPy/CS and PPy/pTS. However, in general all of 
the D shifts changes are less than 2.5 units and are therefore considered to be 
negligible. Hence, D shifts show that a non-viscoelastic and rigid layer has been 
formed on the surface of quartz crystal[17].  
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(a) 
 
(b) 
Figure 5.10 (a): Frequency (f) responses to the electropolymerization of pyrrole with 
the dopants pTS, CS, PSS and DBSA; (b): Energy dissipation (D) responses to 
electropolymerization of pyrrole with; pTS, CS, DBSA and PSS counterions. 
 
5.4.5 Study the interaction of ACSF 
In order to study the interaction of the drug to the OCP films it is first necessary to 
study any interaction effects arising from the ACSF used to prepare the drug 
solutions as the drug solutions are prepared in ACSF. 
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5.4.5.1 QCM crystal in the Passive state 
 
To study the interaction of ACSF anions and cations a separate solution of each ion 
were prepared. ACSF includes six different ions which have been mentioned in 
section 5.3.1.  Each solution introduced to the QCM chamber (Figure 5.3) separately 
with the OCP coated gold QCM crystal being held in the passive state (i.e., no 
electrical stimulation applied). As Figure 5.11 presents CaCl2 shows the maximum 
affinity to the surface of the gold coated quartz crystal and after 20 minutes 34.4 
ng/cm2 of mass has absorbed to the surface followed by KCl (34.0±0.2 ng/cm2), 
MgCl2 (30.0±0.5 ng/cm2), Na2HPO4 (27.1±0.7 ng/cm2), NaH2PO4 (20.0±0.3 ng/cm2) 
and NaCl (18.0±0.4 ng/cm2).  Although NaCl possess the highest concentration 
among all of these ions, total absorbed mass from this solution after 20 minutes is the 
lowest one. 
 
Figure 5.11 Sauerbrey modelled calculated mass due to interaction of ACSF anions 
and cations. 
 
5.4.5.2 QCM in a stimulated state 
Interaction of ACSF solutions with the OCP coated QCM crystal was performed 
with the OCP under an electrically stimulated state. ACSF were introduced to the 
QCM chamber. After a period of time an equilibrium state was achieved where by 
changes in the QCM crystal frequency reached a constant value. At time ≥ 10 min 
which was after equilibrium state, a negative voltage of -400 mV was applied to the 
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surface of OCP coated QCM crystal while the solution was flowing through the 
QCM cell and across the surface of the OCP. When drug molecules interaction at 
stimulated states was studied for PPy/pTS film, a very large negative frequency shift 
was observed by applying -400 mV. This large f changes was not seen at the 
oxidized state. This part of experiments was designed to clarify that large f changes is 
a result of ASCF absorption to the surface and also hydration of the quartz crystal 
surface. f changes for PPy/pTS film at stimulated states will be presented in section 
5.4.7.2. 
Figure 5.12(a) exhibits the f changes as a result of mass absorption to the surface of 
gold coated quartz crystal. A negative frequency shifts occurred as soon as the -400 
mV voltage was applied to the surface which means there was an affinity between 
fluid and the surface. ACSF shows a very large frequency decrease of approximately 
600 Hz. Therefore, there was an interaction between ACSF and the surface of the 
OCP coated QCM crystal surface although after a period of time an equilibrium state 
will be achieve as is discussed below in section 4.4.8.2.   
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                                           (b) 
Figure 5.12 (a): Frequency (f) responses to flowing of ACSF on the surface of gold 
coated quartz crystal; (b): Energy dissipation (D) responses to flowing of ACSF on 
the surface of gold coated quartz crystal. 
 
Figure 5.12(b) presents the energy dissipation shift due to ACSF introducing to the 
QCM chamber. As it has been shown in Figure 5.12(b) for negative f changes, 
positive D shifts occurred. However, dissipation change is less than 2 units which 
means absorption of ACSF makes a rigid and non-viscoelastic layer upon gold 
coated quartz crystal. According to the literature [35] absorption of small molecules 
leads to generating non-viscoelastic layer on the surface. 
 
5.4.6 Study the electroactivity of lacosamide molecules 
The chemical structure of lacosamide molecule (LCM)  has been shown in Figure 5.1 
and suggests that LCM does not carry any overall charge[36]. The electrical charge 
of LCM molecules was studied by flowing a solution of ACSF solution across the 
surface of Q-sense sensor without any conducting polymer coating. The frequency of 
the crystal decreased indicating mass adsorption at the surface and after a period of 
time an equilibrium state was achieved. At this stage a negative voltage (i.e. -400 
mV) was applied to the surface of gold coated quartz crystal and after a period of 
time, a stable state was observed. After second equilibrium state a solution of 
LCM/ACSF at time ≥ 0 with concentration of 100 mg/ml was introduced upon the 
surface which is biased at –400mV. As Figure 5.13 presents a negative frequency 
shift of approximately 800Hz occurred. It has been discussed above that a negative f 
shift is due to mass absorption to the surface of Q-sense sensor[20, 32]. However, in 
this case this large negative f shift did not occur just because of LCM molecule 
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absorption. LCM molecules had been dissolved in ACSF solution and in the previous 
section (section 5.4.6) study the interaction of ACSF with quartz crystal surface 
revealed that there was a noticeable interaction between ACSF and Q-sense surface. 
In figure 22 a -600 Hz f shift resulted due to absorption of ACSF. Therefore, a large 
proportion of the f shift in Figure 5.13 is due to the absorption of ACSF and not 
LCM molecules. Due to the interactive nature of ACSF ions and LCM it is not 
possible to determine how much of frequency shift is due to LCM absorption and 
how much is due to ACSF.  
 
 
Figure 5.13 Frequency (f) of Q-sense sensor due to introducing LCM/ACSF to the 
chamber with applying a negative (i.e. -400 mV) and a positive (+300 mV). 
 
The affinity of LCM molecules under the influence of a positive surface was 
assessed by applying positive voltage through the surface of Q-sense sensor.  Figure 
5.13 shows f changes due to application of +300 mV to the surface of gold coated 
quartz crystal. The f alteration is negligible and it suggests there was no noticeable 
affinity between LCM molecules and the positively charged surface. From this data it 
appears that there is no considerable affinity between LCM molecules and the 
surface of gold coated quartz crystal neither in negatively charged state nor in 
positively charged. Therefore, ionic attraction-repulsion does not have any effect on 
the interaction of LCM molecules to the surface of quartz crystal, especially at 
reduced and oxidized state. Because at reduced and oxidized state the surface of 
conducting polymer is partly carrying a negative or positive charge respectively. In 
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this case just the surface characteristics of conducting polymer such as surface 
roughness or wettability played an important role on absorption of LCM molecules. 
 
5.4.7 Lacosamide Adsorption  
5.4.7.1 Non-Stimulated State 
The Sauerbrey model is applicable only for elastic and rigid adlayers[32]. If this 
model is employed to calculate the mass of viscoelastic and soft layers; for instance 
adlayers with considerable ∆D; underestimation of the amount of adsorbed mass 
could occur as not all of the adsorbed mass contributes to the ∆ƒ[15]. That is to say, 
that in this situation decoupling of the adlayer from the motion of the sensor can 
affect the mass calculation. Herein, the D shifts demonstrated by the adsorption of 
LCM molecules to the surface of CP films were negligible. The D shifts for all of CP 
films were less than 0.4 units and suggests the formation of a non-viscoelastic and 
rigid layer at the interface and also non-viscoelastic contributions to the ƒ data. 
Therefore, we utilize the Sauerbrey model to calculate the overall hydrated absorbed 
mass to the CP surfaces (Figure 5.14(a)). It must be noted that the QCM-D mass 
measurements contain two mass contributions, one from the drug molecules and the 
other associated with the water molecules which are hydrodynamically coupled to 
the drug molecules due to the high water solubility of LCM molecule. 
QCM-D frequency (f) measurements are presented in Figure 5.14(a). Drug free 
ACSF was allowed to flow through the QCM chamber containing the OCP coated 
crystal until a steady f  base line was achieved (i.e., f did not vary by greater than 
2%), at this stage the CP surface is considered to possess a stable diffuse electrical 
double layer (EDL)[37]. Once a steady baseline was achieved, a solution of ACSF 
containing 100 mg/mL of LCM was introduced into the QCM chamber (at time≥ 
0min). Changing to the LCM/ACSF solution was achieved by switching the QCM 
chamber feed line from a vial containing ACSF to a vial containing the LCM/ACSF 
solution. A ƒ shift in response to introducing the LCM loaded ACSF solution is 
observed and is attributed to interactions between the LCM molecules and the 
PPy/pTS, PPy/CS, PPy/PSS and PPy/DBSA film surfaces. This LCM interaction was 
confirmed by repeating the same experimental only this time changing the feed line 
to an ACSF solution that did not contain LCM upon which no change in f was 
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observed. For all of the OCP films investigated there is an overall negative frequency 
shift indicating an increase in mass upon the crystal which is attributed to drug 
molecules adsorbing onto the surface of these OCP films[35]. 
 
 
                                                 (a) 
   
                                                 (b) 
Figure 5.14 (a) Frequency (ƒ) and (b) energy dissipation (D) responses of LCM mass 
absorption. The frequency responses are related to the adsorption of LCM from 
ACSF solution containing 0.1mg/mL LCM to PPy/pTS, PPy/CS, PPy/PSS and 
PPy/DBSA films. The ACSF solution containing the LCM was introduced into the 
QCM chamber at time = 0min. The mass (ng/cm2) calculated using the Sauerbrey 
and the geometric surface area of the QCM crystal is shown.  
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Given that for all of the CP films the amount of LCM entering the QCM chamber is 
the same (since the LCM concentration and flow rate is the same for both 
experiments) this results suggest the rate of interaction with the PPy surface varies 
based on the physical properties of the PPy film. The frequency decrease can be 
broken down into two distinct regions, namely rapid decrease (0min>time<5min - 
PPy/PSS; 10min>time<25min - PPy/pTS 2.5min>time<12.0min - PPy/CS; 
0min>time<10min – PPy/DBSA) followed by a slower decrease (time>5min – 
PPy/PSS; time>25min - PPy/pTS; time>12.0min - PPy/CS; time> 10min – 
PPy/DBSA). The rate of the ƒ shift for the PPy/PSS at rapid decrease region is the 
highest one. The trend value of f decrease for this polymer is -1.3 Hz/min. the second 
place belong to PPy/pTS by -0.6 Hz/min and then followed by PPy/DBSA with -0.3 
Hz/min and finally there is PPy/CS with the value of -0.2 Hz/min. Also, the rate of 
frequency decrease occurring in the slower region appears approximately 10 times 
faster for PPy/pTS (-0.2 Hz/min) than the other CPs. This frequency decrease rate for 
PPy/PSS is -0.07 Hz/min, for PPy/CS is -0.03 Hz/min and for PPy/DBSA is -0.015 
Hz/min. The appearance of two distinct regions indicates two adsorption processes 
occurring sequentially. It appears that under non-electrically stimulated conditions 
LCM has the highest affinity to the PPy/PSS surface and then followed by PPy/pTS, 
PPy/CS and PPy/DBSA. In addition, according to the rapid region of LCM 
adsorption LCM molecules absorbed to the surface of PPy/PSS with a very high 
affinity at the very first 5 min of flowing LCM/ACSF solution upon the CP surface. f 
decrease rate at this region for PPy/PSS is 2.2 times higher than PPy/pTS and more 
than 4 times greater than PPy/CS and PPy/DBSA. However, after the first 5 minutes 
PPy/PSS shows the slowest f decrease until to the end of the experiment. At this slow 
decrease region PPy/pTS exhibits the highest trend and then followed by PPy/CS and 
PPy/DBSA. 
LCM molecules are inherently neutral and are also electrochemically inactive (ref to 
section 5.4.7). Therefore, ionic interactions and chemical binding is unlikely to be 
the driving force for LCM absorption and the adsorption may be considered as 
nonspecific. However, surface roughness is an effective factor for drug molecule 
adsorption[38, 39]. Urbakh et al[40] also showed through QCM studies that the 
frequency shifts decreased rapidly with increasing the surface roughness when fluid 
interacted with thin layers. PPy/PSS has the roughest surface (Figure 5.8) which 
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leads to the highest interaction between LCM molecules and CP surface (Figure 
5.15) as evidenced by the large decease in frequency (increased mass loading).  
 
 
Figure 5.15 Sauerbrey modelled absorbed mass (ng cm-2) for PPy/pTS, PSS, CS and 
DBSA at non-stimulated state.  
 
Figure 5.15 presents values of absorbed LCM molecules to the surface of CPs which 
calculated by Sauerbrey model. As it has been mentioned before D shifts for all of 
the CP films are less than 0.4 units (Figure 5.15) therefore, Sauerbrey model is an 
appropriate method to analysis the amount of absorbed LCM molecules to the 
surface of CP films and also measuring the thickness of LCM absorbed layer (Figure 
5.17). Figure 5.17 exhibits the amount of absorbed drug molecules to the surface of 
conducting polymers. PPy/PSS possess the maximum amount of absorbed drug 
molecules (i. e. 157.9±37 ng cm-2). The second place belongs to PPy/pTS with the 
value of 85.8±2.8 ng cm-2. As figure 4.8 shows PPy/CS LCM absorption is higher 
than PPy/DBSA with the value of 34.2±2.6 ng cm-2 however the absorption of this 
CP is less than PPy/PSS and PPy/pTS. Finally PPy/DBSA has the minimum 
absorption with the value of 26.2±2.6 ng cm-2. In Figure 5.16 PPy/PSS showed the 
highest negative f shift and then followed by PPy/pTS, PPy/CS and PPy/DBSA. 
Results in Figures 4.14 and 4.22 are in a very good agreement. PPy/PSS with the 
highest f shifts possesses the highest amount of absorbed LCM molecules. The 
roughness of the surface can affect the f values in a given experiment. Surface 
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cavities in rough surfaces can entrap liquids. This phenomenon leads to having f 
decrease and mass increase detection by QCM[35].  
 
Whereas the surface of gold coated quartz crystal is in contact with an aqueous 
solution, the density and viscosity of that liquid can affect the f of oscillating quartz 
crystal. Therefore, f responses of quartz crystal can be because of one of these 
following reasons or a combination of them; 
(a) Firm bounding of an elastic mass to the Q-sense surface 
(b) Changing of viscosity-density of the aqueous solution 
(c) If the bounded mass in inelastic and dissipates the energy. 
When a firm mass bounded to the surface of oscillating quartz crystal the Sauerbrey 
equation 1 can be utilized to calculate elastic mass just only after it has been 
experimentally proven that the absorbed mass dose not dissipate any energy. 
Therefore, the f decrease changes due to dried mass absorption will be used to 
calculate the amount of mass with the assumption of dried mass density is used to 
calculate film thickness. 
To clarify which type of changes can affect the f changes, the ∆f, ∆R QCM data can 
be put together. Figure 5.16 shows the plot of changing R versus f in a QCM 
experiment while electrochemical deposition of polypyrrole is carrying out at 
constant current density. Binding of a pure and elastic mass leaded to f decrease and 
∆R=0. The horizontal line labelled from B to C is the response behavior of bounding 
this mass to the surface of quartz crystal. Dotted line labelled from A to D shows the 
response behavior of f and R due to absorption of pure liquid viscosity-density. These 
diagram is a result if viscous coupling of a solution to the quartz crystal. 
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Figure 5.16 f and R responses for the electrochemical polymerization of polypyrrole 
with constant current density; Point C is the time zero of starting 
electropolymerization which continued by a solid line moving forward to the left as 
polymer deposition proceeds.   
 
Therefore, the solution adds some mass to the surface of oscillating gold coated 
quartz crystal effectively. With the assumption of no slip existence between solution 
and surface of quartz crystal, the following relationship can be considered.  This 
equation was first developed by Kanazawa et al[41] and it was about the resulting f 
changes. 
 
∆f= -f 3/2 (ρLη/πµρq) 1/2                                                                                            (5.1) 
 
Where ρL is the liquid density and η is the liquid viscosity. However, it has to be 
considered when QCM operates in solution; there is no way to distinguish the 
amount of bounded mass from the amount of mass which has been contributed by 
solution. Therefore, in this case the earliest studies have been carried out by 
Muramatsu et al[42] as follows: 
 
∆R=(2πfρLη)½A/K2                                                                                                   (5.2) 
   
K is electromechanical coupling factor. As equation (5.1) and (5.2) exhibit both ∆f 
and ∆R, are proportional to (ρLη) 1/2. Therefore, the diagram of ∆f versus ∆R is linear 
for liquids with different densities and viscosities[35]. Considering all of these 
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equations and dissections, interaction of an elastic mass with surface of oscillating 
quartz crystal leads to f decreasing changes and developed Sauerbrey model is 
utilized to calculate the amount of bounded mass to the surface.    
    
  
 
Figure 5.17 Sauerbrey modelled thickness of LCM absorption to the surface of CP 
films (nm) at non-stimulated state. 
 
Figure 5.17 demonstrates thickness of bounded LCM molecules upon the surface of 
conducting polymer. Thickness of absorbed LCM molecules has the maximum value 
for PPy/pTS (i.e. 3.4±0.0 nm) and then followed by PPy/PSS (i.e. 0.4±0.0 nm). The 
thickness of PPy/CS and PPy/DBSA is roughly the same with the value of 0.2 nm. 
Considering the surface geometric area of CP films which is equals to the surface of 
gold coated quartz crystal with the value of 1 cm2 calculation of LCM layer density 
is possible using equation 4.4; 
 
ρ=m/V                                                                                                                     (5.3)  
 
Where ρ is density, m is mass and V represents the volume. Table 5.2 presents the 
amount of absorbed LCM molecules, thickness of bounded LCM layer, and volume 
of LCM layer and density of absorbed LCM layer upon the surface of conducting 
polymer film.  
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Table5.2 Mass, thickness, volume and density of absorbed LCM molecules upon the 
surface of CP films 
Conducting 
polymer film 
Absorbed 
LCM mass  
(ng) 
Thickness of 
absorbed 
LCM (nm) 
Volume of 
absorbed 
LCM 
 (nm3) 
Density of 
absorbed 
LCM  
(ng cm-3) 
PPy/PSS 157.9 0.4 40 3.9 
PPy/pTS 85.8 3.4 340 0.2 
PPy/CS 34.2 0.2 20 1.7 
PPy/DBSA 26.2 0.2 20 1.3 
 
As Table 5.2 shows the LCM adlayer with the highest density has been generated 
upon PPy/PSS film followed by PPy/CS, PPy/DBSA and PPy/pTS. According to 
Figure 4.9 PPy/PSS possesses the most hydrophilic surface among the other 
conducting polymer films and then followed by PPy/CS, PPy/DBSA and PPy/pTS. 
Conducting polymer surface cavities can entrap liquids if the surface is hydrophilic, 
and obviously more hydrophilic surfaces can entrap more aqueous liquid and fill out 
their cavities. On the other hand, air can be entrapped by the more hydrophobic 
surfaces and they often do not wet[35]. Entrapping more liquid and filling out more 
cavities can lead to generating denser adlayer upon the surface of PPy/PSS which is 
the most hydrophilic surface. Conversely, PPy/pTS, that has the most hydrophobic 
surface, (Figure 5.9) has the lowest density. However, the LCM absorbed layer 
density does not have any effect on the interaction of LCM molecules and the surface 
of CP films. Density of the absorbed layer can be interesting if removal of absorbed 
layer from the surface of CP is considered. At this state, the densest adlayer is the 
hardest choice for drug adlayer removal.  
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5.4.7.2 Stimulated State  
The influence of an applied potential to the CP films on LCM adsorption behavior 
was investigated. Adsorption of LCM was studied whilst the CP as held at either a 
reducing or oxidizing potential. These potentials were chosen from the cyclic 
voltammograms recorded for each CP films (Figures 4.25(a-c)). 
 
5.4.7.2.1 Application of a reducing potential 
The main aim of this study is to investigate the release of an anti-epilepsy drug which 
has been encapsulated within a reservoir upon application of an electrical 
stimulation. Considering that, the affinity of drug molecules to the surface of 
conducting polymers has been investigated at reduced and oxidized states. In this 
section the reduced state will be presented. 
Prior to present drug molecules interaction results the processes occurring at the PPy 
surface a series of mechanisms have been proposed and exhibited in Figure 5.18. 
ACSF solution was flowed through the QCM chamber and after approximately 30 
minutes an equilibrium state, indicated by steady f shifts was achieved (data not 
shown). Figure 5.18(a) shows the schematic of this equilibrium state. At this stage 
the conducting polymer surface is considered to be hydrated[35] and to possess a 
stable diffuse electrical double layer (EDL)[43]. 
 
 
 
 
 
 
 
189 
 
 
Figure 5.18 (a) Schematic mechanism of LCM absorption to the surface of CP films 
at reduced state, equilibrium state; (b and b’) EDL formation upon QCM sensor 
surface due to negative charge application; (c and c’) LCM molecule absorption to 
the surface and EDL disruption. 
   
In the reduced state the conducting polymer develops a negative charge which can be 
balanced by anion exchange with the surrounding media [71, 72] either by anion 
expulsion from the CP film or cation inclusion, with a combination of both processes 
likely to be occurring simultaneously as demonstrated by Moulton et al [73]. Figure 
5.18(b and b’) shows the schematic of EDL formation on the surface of CP films 
coated QCM sensor. 
The insertion/accumulation of positively charged species from the ACSF at the CP 
film surface has occurred at this stage. The cation accumulation also disrupts the 
stable EDL and results in mass accumulation at the CP film surface. When the 
flowing ACSF was changed to contain LCM the frequency started to increase 
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indicating mass loss from the CP film surface [15]. Encarnacao et al [70] 
demonstrated that increasing the ionic strength of a solution can cause an increase in 
frequency, however the ionic strength of the LCM/ACSF solution was the same as 
the ACSF solution and therefore ionic strength cannot account for this change. It 
may be possible that the LCM molecules in the ACSF disrupt the stable state. 
Therefore, according to the literature [74] the surface of CP films became more 
hydrophobic and therefore interaction between the LCM and the CP film may arise 
due to hydrophobic interactions between the LCM molecule (Figure 5.18(c and c’)) 
and the film. 
The QCM data for the experiment when a reducing voltage is applied to the 
conducting polymer films is shown in Figure 5.19.  Figure 5.125 presents the f and D 
shifts due to LCM molecules interaction with the surface of conducting polymer 
films while a negative voltage is applying to the surface. For all of the conducting 
polymer films a positive f shift has been observed. Considering to Figure 5.19 (a, b 
and c) and Figures 4.26-4.29 this positive f shifts are related to loosing mass from the 
interface. Flowing of LCM/ACSF through the QCM chamber while a negative 
voltage is being applied to the surface of conducting polymer interrupted the steady 
EDL at the interface and hydrophobic-hydrophobic interaction between the surface 
of conducting polymer and hydrophobic region of LCM molecule leads to ACSF 
cation removing from the interface and LCM molecules absorption to the surface. 
The total net of this absorption and desorption leads to positive f shifts and mass lost. 
Considering Figure 5.10(a) f decrease shifts can be separated into two parts. One part 
possesses the higher f changes rates and at the other part f shifts with slower rate. f 
decrease shifts at the very beginning of the experiment are faster. PPy/DBSA film 
has the highest f decrease rate (i.e. 3.5 Hz/min) which has occurred at 0< time < 6 
minutes. f shifts for PPy/PSS and PPy/CS are approximately the same (i.e. 3 Hz/min) 
and has happened at 0< time < 12 minutes for PPy/PSS and 0< time < 23 minutes for 
PPy/CS film. The lowest f changes rate at the faster part of the curves belongs to the 
PPy/pTS film with the value of 2.1 Hz/min and also it has occurred at 0< time < 13 
minutes. 
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                                                 (a) 
  
                                                (b) 
Figure 5.19 (a): Frequency (ƒ) responses from the adsorption of LCM to PPy/pTS 
and PPy/CS films; and (b) Energy dissipation (D) responses from the adsorption of 
LCM to PPy/pTS and PPy/CS films. A reducing potential was applied to the OCP 
films during adsorption of LCM. 
 
 
After the first part of the experiment which has the faster f changes Figure 5.10 
shows for all of the conducting polymer films the f increase changes rate has dropped 
down. At this part the fastest rate belongs to the PPy/PSS film with value of 1.0 
Hz/min and was observed at time >12 minutes. The second place belongs to the 
PPy/CS film which has f increase rate of 0.3 Hz/min for time>23 minutes. PPy/pTS 
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film is in the third place with the rate value of 0.1 Hz/min for time > 13 minutes. 
Finally, the slowest f increase rate was seen for time> 6 minutes of PPy/DBSA film. 
The f increase rate of this conducting polymer film is -6×10 -3 Hz/min. All of these 
conducting polymer films exhibits a general increasing trend in the f shifts except 
PPy/DBSA film. The f increase rate for this conducting polymer film at time> 6 
minutes in negative which means the f shift shows a decreasing trend. The f increase 
rate at the faster part is approximately 10 times higher than the f increase rate at the 
slower part of the curves except of PPy/DBSA film. For this conducting polymer 
film the f increase rate at faster part is about 1000 times higher than the slower part 
and also as it has been mentioned before the trend of the f shift has altered from 
increasing at faster part to decreasing at slower part. Therefore, it seems PPy/DBSA 
has shown different behavior in absorption of LCM/ACSF at the reduced state. 
Contact angles of conducting polymer films were measured to investigate any 
changes in surface energy of the conducing polymer films during the adsorption 
experiment (Figure 5.19). Contact angles were measured after a series of treatments 
of the conducting polymer films to mimic the adsorption experiment shown in Figure 
5.19 with the data presented in Figure 5.20. For the first treatment, contact angle of 
the as grown conducting polymer film was measured (Figure 5.20, PPy/dopant). The 
same conducting polymer film was the soaked in ACSF solution for 30 minutes and 
dried followed by measurement of the static contact angle (Figure 5.20, PPy/dopant-
ACSF). The next treatment involved applying a reducing voltage to the surface of 
conducting polymer for 60 minutes immersed in ACSF followed by rinsing with 
Milli-Q water, drying and static contact angle measurement (Figure 5.20, 
PPy/dopant-ACSF (mV)). In the final treatment the conducting polymer films were 
soaked in a solution of LCM/ACSF while the negative voltage was applying to the 
surface for 30 minutes. At the end of this treatment step, the surface of the 
conducting polymer was rinsed and dried and the static contact angle was measured 
(Figure 5.20, PPy/dopant-LAC (mV)).  
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Figure 5.20 Goniometry measurement of conducting polymer coated cover slip films 
for the four dopants (a) PSS, (b) pTS, (c) CS and (d) DBSA. PPy/dopant indicates 
the contact angle of as-grown film. PPy/dopant-ACSF shows the contact angle of 30 
min soaked film in ACSF. PPy/dopant-ACSF (mV) indicated the contact angle of 
film after 60 min application of reducing voltage in ACSF. PPy/dopant-LAC (mV) 
shows the contact angle of film after soaking in PPy/dopant in a solution of 
LCM/ASCF while application of the reducing voltage. Each reducing voltage is 
different and was obtained from the PPy film CVs shown in Figure 5.5. 
 
Figure 5.20 shows that for all of conducting polymer films the contact angle after the 
final step is higher than the mean of the untreated film indicating the surface of CP 
has become more hydrophobic at the final step. As it has been discussed before, an 
alteration in surface hydrophilicity may lead to large f changes. When a surface 
become hydrophobic liquids will not be entrapped within surface cavities longer[35] 
and there is also the possibility that hydrophilic entrapped molecules are expelled out 
from the surface cavities. This phenomenon leads to a loss in mass from the interface 
resulting in a f increase indicating mass loss. The relationship between surface 
hydrophobicity and the attached mass have been investigated and has demonstrated 
that the more hydrophobic a surface is less mass attachment to the surface occurs[16, 
44, 45]. 
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5.4.7.2.2 Application of an oxidizing potential  
The oxidizing voltage was determined from CVs shown in Figures 5.12. The ƒ shifts 
observed in Figure 5.24 and 5.28 are in opposite directions for oxidizing and 
reducing voltages. However, the total net positive ƒ shift in the oxidized state (Figure 
5.27(a)) is less than total net ƒ change in the reduced state (Figure 5.24(a)) and may 
be due to the more hydrophilic nature of the conducting polymer films in the 
oxidized state[67] thus absorbing more water molecules. Figure 5.22(c) exhibits the 
schematic of LCM molecules absorption to the surface of conducting polymer films. 
The ƒ shift for PPy/DBSA is roughly 380 times higher than PPy/PSS (Figure 5.27) 
and 1000 times higher than PPy/CS and PPy/pTS. After a period of time conducting 
polymer films reached another steady state. After reaching stable state, a solution of 
100mg/ml LCM/ACSF was introduced to the QCM chamber. The LCM molecules 
interact with the surface of conducting polymer films causing a ƒ negative shifts 
indicating LCM molecule absorption. These results indicate the f decrease shown in 
Figure 5.27(a) is most likely associated with the adsorption of LCM molecules. 
Because of the very high magnitude of f shift for PPy/DBSA in comparison with the 
other conducting polymer films, the f shifts for the other films has overlapped. These 
ƒ changes are less than 4 Hz for PPy/pTS and 10 Hz for PPy/CS. However, these f 
changes has become higher for PPy/PSS (about 30 Hz) and PPy/DBSA which is 
about 10994.1 Hz. The amount of absorbed lacosamide molecules to the surface of 
PPy/pTS is the lowest one with the value of 59.4±0.5 ng cm-2. LCM molecules 
absorbed for PPy/CS and PPy/PSS is approximately the same with the value of 
145.2±0.7 ng cm-2 and 143.6±0.8 ng cm-2 respectively. The highest mass at 
oxidized state absorbed to the surface of PPy/DBSA coated quartz crystal (i.e. 
3.27×105 ng cm-2). Mass absorption results at oxidized state exhibits opposite 
results from passive state. At the oxidized state the highest LCM absorption belongs 
to PPy/DBSA while PPy/DBSA coated quartz crystal has the lowest absorbed mass 
amount among conducting polymer films at the passive state. 
At time greater than 10 min the f shift for PPy/DBSA decreased at very fast rate (i.e. 
216.5 Hz/min), however, f decrease shift for time before 10 minutes is much slower 
(i.e. 18.8 Hz/min). f decrease rate for PPy/PSS film is faster at the beginning of the 
experiment which is from 0<time<46 min. At this part f decrease rate is 0.58 Hz/min 
and from time >46 min the f decrease rate is lower (i.e. 0.14 Hz/min). At times 
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greater than 54 minutes the f shift for PPy/CS film is decreasing at a rate of 4.5 × 10-
6 Hz/min while the PPy/pTS is decreasing at a much faster rate of 3.5 x 10-2 Hz/min. 
However, f decrease rate for times before 54 minutes is higher for PPy/CS film (i.e. 
0.14 Hz/min) than PPy/pTS (i.e. 0.06 Hz/min) film. 
These results indicate that there is still a greater extent of adsorption occurring at the 
PPy/DBSA film compared to the other conducting polymer films. Also, after 
PPy/DBSA the highest affinity between LCM molecules and the surface of 
conducting polymers belongs to the PPy/PSS. Between PPy/CS and PPy/pTS there 
are two different parts which can be recognizable by f decrease rates.  At the first 
part PPy/CS shows higher f decreases rate and at the final part PPy/pTS exhibits 
much faster affinity to entraps LCM molecules. 
Energy dissipation shifts (Figure 5.27(b)) for PPy/PSS, PPy/CS and PPy/pTS films 
was less than 6.5 units and is considered to be negligible indicating the existence of a 
non-viscoelastic and rigid layer at the interface due to applying positive oxidizing 
potential. However, the dissipation shifts for PPy/DBSA film is 8423.8 units and it 
revealed generation a soft and viscoelastic layer at the interface. 
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                                                         (b) 
Figure 5.21 (a) Frequency (ƒ) responses from the adsorption of LCM to PPy/pTS and 
PPy/CS films at oxidized state and (b) energy dissipation (D) from the adsorption of 
LCM to PPy/pTS and PPy/CS films at oxidized state; Frequency and dissipation data 
are from the fifth overtone. 
 
The ACSF solution had been flushed through the QCM chamber and the system 
reached an equilibrium state after approximately 30 minutes. At the equilibrium state 
the conducting polymer film has become hydrated and a stable EDL has been 
formed[46]. Figure 5.22(a) shows a schematic of this equilibrium state.  
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Figure 5.22 (a) Schematic of first equilibrium state due to absorption of ACSF 
cations to the surface of conducting polymer; (b) Schematic of cation migration from 
the EDL which leads to mass lost; (c) Schematic of LCM absorption mechanisms to 
the surface of conducting polymer films. 
 
After reaching the first steady state oxidizing voltages were applied to the surface of 
conducting polymer coated QCM sensors. Application of a positive charge to the CP 
films leads to generation of excess positive charge at the interface. At the oxidized 
state the CP can balance the excess positive charge by repulse the cations which have 
been absorbed to the surface before achieving steady state and generating a stable 
EDL. This phenomenon causes the migration of cations from the EDL and finally 
lead to positive frequency shifts (data not shown) which means an amount of mass 
has been lost from the interface. Results from reduced and oxidized states are in a 
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good agreement with the other researcher’s work [3, 55-57]. Figure 5.22(b) 
demonstrates the schematic of this state. 
 
5.5 Conclusion 
 
Investigation of drug molecules interaction with the surface of conducting polymers 
has not been fully developed before. Whereas, application of conducting polymers 
for centralized drug delivery have been enlarged in the recent decades. This study 
demonstrates the affinity of lacosamide which is an anti-epilepsy drug to the surface 
of polypyrrole doped with PSS, pTS, CS and DBSA counterions. At non-stimulated 
state the maximum interaction between drug molecules and conducting polymer 
surface belongs to polypyrrole doped with PSS and then followed by pTS, CS and 
DBSA. Surface roughness and surface wettability of the conducting polymer films 
are two effective factors on the adsorption of drug molecules to the surface at non-
stimulated sate. The roughest surface which was PPy/PSS entrapped much more 
LCM molecules.  The thickness of deposited polymer layer does not have any 
influence on the interaction of lacosamide molecules to the conducting polymer 
surfaces. 
Applying reducing voltage caused a mass absorption which is due to ion movement 
between EDL and ACSF as solvent. However, introduction of LCM/ACSF solution 
leaded to disruption of the stable EDL and a mass lost will happen. The repulsion 
effect between hydrophobic head of lacosamide molecules and hydrophobic nature 
of conducting polymer film surfaces at reduced state plays an important role at this 
stage. Goniometry results approved the more hydrophobic nature of conducting 
polymer surfaces at the final step of applying negative voltage. Unfortunately, we 
cannot distinguish the amount of absorbed LCM to the surface and the amount of 
desorbed ions from the surface using QCM technique. Oxidation state for all of the 
conducting polymers exhibited lower drug interaction compared to drug interaction 
at passive state. At oxidized state PPy/DBSA coated quartz crystal shows the highest 
interaction with LCM molecules and then followed by PPy/CS, PPy/PSS and 
PPy/pTS conducting polymer films.  For passive release of LCM molecules, 
PPy/BDSA seems to be more appropriate conducting polymer to fabricate as a drug 
delivery device. Although at stimulated state (oxidizing) the PPy/pTS illustrated 
 
199 
 
better functionality. In the other word, at oxidized state PPy/pTS shows the lowest 
interaction and this characteristic makes the PPy/pTS conducting polymer film more 
appropriate to fabricate a drug delivery device. 
At the other part of the QCM study, the interaction of ACSF ions with the surface of 
gold coated quartz crystal at passive state has been revealed that ACSF cations and 
anions have interactions with the surface. For all of these ions the absorbed amount is 
between 15 to 35 ng cm-2. Also the electrical activity of ACSF solution has been 
studied. Results present a hug affinity between ACSF ions and the surface of gold 
coated quartz crystal while applying negative voltage. Applying positive voltages 
exhibited a repulsion effect or ions desorption from the generated EDL at the surface 
of gold coated quartz crystal. 
The amount of absorbed and desorbed of LCM molecules at the surface of gold 
coated quartz crystal is pretty much the same of absorption and desorption of ACSF 
to the surface. This result means that lacosamide molecules do not have any affinity 
to the partially charged surface. Therefore, ionic attraction and repulsion force does 
not play an important role in the lacosamide molecules interaction with the 
conducting polymer surfaces.  
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6 CONCLUSION AND FUTURE WORK 
 
6.1 Flat composite membrane fabrication, characterization and drug 
transport study 
 
The aim of this section of the thesis was investigating transport of anti-epilepsy drug 
through conducting polymer coated Pt/PVDF flat and tube membranes. Transport 
study experiments have been conducted at stimulated (constant and pulsed potential), 
and non-stimulated states. 
In Chapter 3 work was undertaken to optimise the transport of the drug lacosamide 
through a flat PVDF membrane that was coated in polypyrrole (PPy). A variety of 
dopants including DS, HA, pTS, DBSA, PSS and CS were used to synthesise PPy on 
the surface of platinised PVDF flat membranes. Different electropolymerization 
conditions were applied to deposit the polymer layer. Cyclic voltammograms (CV) 
characterisation of these conducting polymer films revealed that PPy/pTS, 
PPy/DBSA, PPy/PSS and PPy/CS exhibited more appropriate redox switching 
property in comparison with PPy/DS and PPy/HA coated membranes. SEM images 
and water flux results showed that coating a platinum layer on the surface of PVDF 
flat membrane decreases the porosity and water flux. In addition, 
electropolymerization of conducting polymer decreased the porosity and water flux 
with different dopants having different effects on the porosity and water flux 
properties. PPy/pTS coated Pf/PVDF membrane showed the maximum water flux 
followed by PPy/CS, PPy/DS, PPy/HA, PPy/DBSA and PPy/PSS. There was no 
discernible difference in the water flux of PPy/DS and PPy/HA. 
After fabrication and characterization of PPy coated flat Pt/PVDF membranes, drug 
transport studies through these membranes were conducted. All of the composite 
membranes showed drug transport under passive (at non-stimulated) state. Maximum 
drug transport at this state was seen for PPy/CS followed by PPy/BDSA. The 
concentration of drug transport for these two composite membranes is about 8 times 
higher than the concentration of drug transport for PPy/pTS. PPy/PSS did not show 
any drug transport under non-stimulated state. 
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For all of these PPy membranes, transport under a stimulated reduced state is higher 
than drug transport at an oxidized state. Concentration of transported drug at reduced 
state for PPy/CS coated Pt/PVDF membrane is the highest followed by PPy/pTS, 
PPy/DBSA and PPy/PSS. The PPy/PSS coated membrane demonstrated the greatest 
difference in transported drug concentration between the reduced and oxidized state.  
For this composite membrane at oxidized state no drug transport was seen while 
10.05±0.65 µg/ml LCM molecule transported through this membrane at reduced 
state. PPy/CS coated membrane showed 2.5 time difference between concentration 
of transported drug at reduced and oxidized states. This difference for PPy/pTS is 2 
times and for PPy/DBSA is 1.5 times. 
 
6.2 Tube composite membrane fabrication, characterization and drug 
transport study 
 
Chapter 4 presented fabrication and characterization of PPy coted tube membranes. 
pTS, DBSA, CS and PSS were four dopants used in the synthesis of PPy on the 
surface of Pt/PVDF tube membranes. Cyclic voltammograms of these conducting 
polymer coted tube membranes showed that PPy/CS and PPy/PSS possessed the 
more ideal redox properties. SEM images of the surface of these conducting polymer 
coated membranes exhibited the porous structure. In addition, cross-section images 
of these membranes showed the formation of PPy layer on the outer surface of these 
membranes. 
After fabrication and characterization studies, drug transport was investigated 
through tube membranes.  The aim of using a tube PVDF membrane was in order to 
use the inner tube space as a reservoir in which drug could be stored. PPy/pTS, 
PPy/DBSA, PPy/PSS and PPy/CS were deposited on the outer surface of Pt/PVDF 
tube membranes. Among these conducting polymers, PPy/CS and PPy/PSS exhibited 
better redox properties. Therefore, PPy/CS and PPy/PSS were chosen for drug 
release studies. The concentration of release lacosamide at a PPy reduced state was 
higher than in the oxidized state. In addition, PPy/CS possesses the higher drug 
release concentration than PPy/PSS at stimulated state. 
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Pulsed potential drug release studies were investigated for these tube membranes. 
The aim of conducting this experiment was achieving an on/off drug release profile. 
Switching between fully reduced and fully oxidized states for each conducting 
polymer coated tube membrane led to have on/off LCM transport. The fully reduced 
and fully oxidized voltages were chosen according to the LCM transport studies by 
applying single voltages. Similar to the stimulated release studies, PPy/CS showed 
more sufficient results than PPy/PSS at pulsed potential state. 
 
6.3 Interaction of drug molecules with the surface of conducting polymers 
 
The affinity of drug molecules to the surface of conducting polymer has been 
considered in Chapter 5. The attachment of drug molecules to the surface of 
conducting polymer coated composite membranes is an effective factor on the 
amount of drug transport through these membranes. To investigate the interaction of 
lacosamide molecules and PPy/pTS, PPy/DBSA, PPy/CS and PPy/PSS, the QCM 
technique has been utilized. Interaction studies were conducted at non-stimulated and 
stimulated states. At non-stimulated state the maximum interaction was observed 
with PPy/PSS and then followed by PPy/pTS, PPy/CS and PPy/DBSA. Surface 
roughness and wettability are two important properties of conducting polymer films 
which can effect on the mass of adsorbed lacosamide.  
 
6.4 Future work 
 
Throughout this thesis it has been successfully showed that the release of an anti-
epilepsy drug across the polypyrrole coated Pt/PVDF membranes can be controlled 
upon an external electrical stimulation. The shape of membrane played an important 
role on having an on/off release profile. The tube shape membrane exhibited the 
satisfactory response to pulsed potential stimulation.  However, the concept of this 
project is fabricating and characterizing of an implantable device for in-vivo 
application for the treatment of epilepsy. To achieve this goal, some key issues need 
to be considered. In this section some suggestion to fabricate an implantable device 
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which is able to deliver anti-epilepsy drug directly to the brain tissue and also record 
the EEG signals of the brain will be presented. 
Before presenting the idea of fabricating implantable device, it is worthwhile to 
highlight that there is a potential to investigate release of the mixture of anti-epilepsy 
drugs across flat and tube polypyrrole coated membranes. A mixture of charged and 
neutral anti-epilepsy molecules can be encapsulated within tube membranes, and also 
in the feed side of the transport cell to investigate transport of them through flat 
membranes. In this case the polarity of applied voltage can interact with the molecule 
charge and effect on the transport profile of drug molecules.  
 
6.4.1 Two electrode stimulation implantable device 
 
As the last part of the Chapter 4 presented, applying the pulsed facilitated an on/off 
release profile of lacosamide. However, the three electrode set up which had been 
utilized to investigate drug release is not implantable. By changing the three 
electrodes set up to two electrodes set up the aim of implanting this drug carrier into 
the brain tissue is more possible. 
 
As Figure 6.1 presents the auxiliary electrode is placed inside of the polypyrrole 
coated Pt/tube. Similar to the PPy coated Pt/PVDF tubes, the outer surface of this 
tube can be coated by PPy.  This device can play the role of drug carrier, and also 
operates as a gating system.  
The surface of this tube which is coated with conducting polymer plays the role of 
working electrode and CP coated Pt/IrO2 can be connected to the e-DAQ system as 
an auxiliary electrode. The stimulation of this system is conducted with similar 
protocols which have been utilized through this thesis.  
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Figure 6.1 Two electrodes system.     
 
The inside electrode can be a Pt/IrO2 microelectrode. Iridium oxide (IrO2) is a 
biocompatible metallic oxide film. According to the literature[1, 2], IrO2 electrode 
possesses low impedance and high charge storage capacity. These features of this 
electrode provide the opportunity to utilized IrO2 or Pt/IrO2 as a superior candidate 
for recording of EEGs. To measure the neural signals, the key strategy is decreasing 
the impedance[2]. In addition, IrO2 is suitable in cases when an electrical stimulation 
is needed due to its electroactivity[3, 4]. The redox kinetics on the surface of this 
electrode is fast. By fixing the impedance, the electrode will stay at that value until 
application of a new voltage. This process is fully reversible[4].   
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